<SEC-DOCUMENT>0001193125-19-247756.txt : 20190918
<SEC-HEADER>0001193125-19-247756.hdr.sgml : 20190918
<ACCEPTANCE-DATETIME>20190918130905
ACCESSION NUMBER:		0001193125-19-247756
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20190918
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190918
DATE AS OF CHANGE:		20190918

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Encompass Health Corp
		CENTRAL INDEX KEY:			0000785161
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				630860407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10315
		FILM NUMBER:		191099114

	BUSINESS ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242
		BUSINESS PHONE:		205-967-7116

	MAIL ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH CORP
		DATE OF NAME CHANGE:	19950113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH REHABILITATION CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d760186d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehc="http://www.encompasshealth.com/20190918" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2019-09-18_to_2019-09-18">Encompass Health Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2019-09-18_to_2019-09-18">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2019-09-18_to_2019-09-18">0000785161</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="ehc-20190918.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2019-09-18_to_2019-09-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000785161</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-09-18</xbrli:startDate> <xbrli:endDate>2019-09-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, DC 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:12pt">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2019-09-18_to_2019-09-18">8-K</ix:nonNumeric> </span></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section&#160;13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the<span style="text-transform:uppercase">&#32;</span>Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt:datemonthdayyearen">September&#160;18, 2019</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:12pt"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Encompass Health Corporation</span> </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact Name of Registrant as specified in Charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or Other Jurisdiction of Incorporation)</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:50%;"></td>
<td style="width:1%;"></td>
<td style="width:48%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2019-09-18_to_2019-09-18">001-10315</ix:nonNumeric> </span></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2019-09-18_to_2019-09-18">63-0860407</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification No.)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2019-09-18_to_2019-09-18">9001 Liberty Parkway</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2019-09-18_to_2019-09-18">Birmingham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:stateprovnameen">Alabama</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2019-09-18_to_2019-09-18">35242</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of Principal Executive Offices, including Zip Code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2019-09-18_to_2019-09-18">(205)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2019-09-18_to_2019-09-18">967-7116</ix:nonNumeric> </span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Registrant&#8217;s Telephone Number, including Area Code)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2019-09-18_to_2019-09-18">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2019-09-18_to_2019-09-18">EHC</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934.&#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2019-09-18_to_2019-09-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:0"></p></div>

<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Item&#160;1.01. &#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On September&#160;18, 2019, Encompass Health Corporation (the &#8220;Company&#8221;) and certain of its subsidiaries, as guarantors (&#8220;Guarantors&#8221;), completed the previously announced issuance and sale in an underwritten public offering of $500,000,000 aggregate principal amount of 4.500% Senior Notes due 2028 (the &#8220;2028 Notes&#8221;) and $500,000,000 aggregate principal amount of 4.750% Senior Notes due 2030 (the &#8220;2030 Notes&#8221; and, together with the 2028 Notes, the &#8220;Notes&#8221;). The Notes are the Company&#8217;s senior unsecured obligations. The Notes rank equal in right of payment to the Company&#8217;s current and future senior debt and rank senior in right of payment to any future subordinated debt. The Notes are effectively subordinated to the Company&#8217;s current and future secured debt, including borrowings under the Company&#8217;s credit agreement, to the extent of the value of the assets securing such debt. In addition, the Notes and the guarantees are structurally subordinated to any liabilities, including trade payables, of the Company&#8217;s nonguarantor subsidiaries. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Company intends to use the net proceeds from the sale of the Notes, together with cash on hand, (i)&#160;to pay approximately $218&#160;million in connection with the exercise of certain put rights and the vesting of stock appreciation rights that were provided to certain members of the Company&#8217;s home health and hospice management team at the time of the Company&#8217;s acquisition of its home health and hospice business in 2014, (ii)&#160;to redeem $400.0&#160;million of the Company&#8217;s 5.75% Senior Notes due 2024 and (iii)&#160;to repay the outstanding borrowings under the Company&#8217;s revolving credit facility as of June&#160;30, 2019 (which were $335.0&#160;million as of such date), with the remaining net proceeds to be used for working capital and other general corporate purposes, including the payment of any additional outstanding borrowings under the revolving credit facility subsequent to June&#160;30, 2019. Pending the use of the net proceeds as described herein, the Company intends to use the net proceeds from the sale of the Notes to invest in&#160;short-term&#160;interest-bearing&#160;instruments. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Company issued the Notes under that certain indenture, dated as of December&#160;1, 2009 (the &#8220;Base Indenture&#8221;), by and between the Company and Wells Fargo Bank, National Association (as successor in interest to The Bank of Nova Scotia Trust Company of New York), as Trustee (the &#8220;Trustee&#8221;), as supplemented by an eighth supplemental indenture, dated as of September&#160;18, 2019, by and among the Company, the Guarantors and the Trustee (the &#8220;Eighth Supplemental Indenture&#8221;) and a ninth supplemental indenture, dated as of September&#160;18, 2019, by and among the Company, the Guarantors and the Trustee (the &#8220;Ninth Supplemental Indenture&#8221; and, together with the Eighth Supplemental Indenture and the Base Indenture, the &#8220;Indenture&#8221;). Interest on the Notes is payable semi-annually in arrears on February&#160;1 and August&#160;1 of each year, commencing on February&#160;1, 2020. The 2028 Notes will mature on February&#160;1, 2028, and the 2030 Notes will mature on February&#160;1, 2030. Interest on the 2028 Notes will accrue at the rate of&#160;4.500%&#160;per annum, and interest on the 2030 Notes will accrue at the rate of&#160;4.750%&#160;per annum. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">As set forth in the Eighth Supplemental Indenture, the Company may redeem some or all of the 2028 Notes (i)&#160;on or after February&#160;1, 2023, at the redemption prices specified in the Eighth Supplemental Indenture, or (ii)&#160;prior to February&#160;1, 2023, at a redemption price equal to 100% of the aggregate principal amount therefor, plus accrued and unpaid interest, if any, to the redemption date plus a &#8220;make-whole&#8221; premium. At any time prior to February&#160;1, 2023, the Company may redeem up to 35% of the aggregate principal amount of the 2028 Notes in an amount not to exceed the amount of proceeds of one or more equity offerings, at a price equal to 104.50% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date,<span style="font-style:Italic">&#160;provided</span>&#160;that at least 65% of the original aggregate principal amount of the 2028 Notes issued remains outstanding after the redemption. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">As set forth in the Ninth Supplemental Indenture, the Company may redeem some or all of the 2030 Notes (i)&#160;on or after February&#160;1, 2025, at the redemption prices specified in the Ninth Supplemental Indenture, or (ii)&#160;prior to February&#160;1, 2025, at a redemption price equal to 100% of the aggregate principal amount therefor, plus accrued and unpaid interest, if any, to the redemption date plus a &#8220;make-whole&#8221; premium. At any time prior to February&#160;1, 2025, the Company may redeem up to 35% of the aggregate principal amount of the 2030 Notes in an amount not to exceed the amount of proceeds of one or more equity offerings, at a price equal to 104.75% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date,<span style="font-style:Italic">&#160;provided</span>&#160;that at least 65% of the original aggregate principal amount of the 2030 Notes issued remains outstanding after the redemption. </p> <div></div> <p style="margin-top:0"></p>
 </div>



<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0pt;margin-top:0pt">The Indenture contains restrictive covenants that, among other things, limit the Company&#8217;s ability and the ability of certain of its subsidiaries to, among other things, incur or guarantee indebtedness; pay dividends on, or redeem or repurchase, its capital stock; make investments; and merge, consolidate or transfer all or substantially all of its assets. These covenants are subject to a number of important exceptions and qualifications, as described in the Indenture. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Wells Fargo Bank, National Association, which is the Trustee under the Indenture and paying agent and registrar for the Notes, also serves as a lender under the Company&#8217;s credit agreement. Additionally, an affiliate of Wells Fargo Bank, National Association served as an underwriter in the offering of the Notes. Wells Fargo Bank, National Association and certain of its affiliates have performed, and may in the future perform, various commercial and investment banking and financial advisory services for the Company and its affiliates, for which they have received or may in the future receive customary fees and expenses.</p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The foregoing description of the Indenture is not intended to be complete and is qualified in its entirety by reference to the full text of (i)&#160;the Base Indenture, a copy of which is filed as an exhibit to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2009 and incorporated herein by reference, (ii)&#160;the Eighth Supplemental Indenture, a copy of which is filed as Exhibit 4.2 to this Current Report on Form 8-K and incorporated herein by reference, and (iii)&#160;the Ninth Supplemental Indenture, a copy of which is filed as Exhibit 4.3 to this Current Report on Form 8-K and incorporated herein by reference. </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Item&#160;2.03. &#160;&#160;&#160;&#160;Creation of a Direct Financial Obligation or an Obligation Under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">The information included in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Item&#160;8.01. &#160;&#160;&#160;&#160;Other Events. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">The expenses relating to the offering of the Notes are estimated to be as follows: </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:68%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:80%;"></td>
<td style="width:10%;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Amount&#160;to&#160;be&#160;paid </p> </td>
<td style="vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SEC Registration Fee: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">$</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">121,200 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Accounting Fees and Expenses: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">165,000</p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Legal Fees and Expenses: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">200,000 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Printing Expenses: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">36,100 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Trustee&#8217;s Fees and Expenses: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">40,000 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Rating Agency Fees: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,400,000 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Miscellaneous expenses: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">10,000 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="font-size:0pt;page-break-inside:avoid;">
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1px solid #000000;vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1px solid #000000;vertical-align:bottom;">&#160;</td>
<td style="padding-right:2pt;vertical-align:bottom;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Total: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">$</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-weight:bold;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;1,972,300</p> </td>
<td style="vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="font-size:0pt;page-break-inside:avoid;">
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:3px double #000000;vertical-align:bottom;">&#160;</td>
<td style="border-bottom:3px double #000000;vertical-align:bottom;">&#160;</td>
<td style="padding-right:2pt;vertical-align:bottom;">&#160;</td> </tr> </table> <p style="font-family:Times New Roman;font-weight:Bold;font-style:Italic;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Forward-Looking Statements</p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">Statements contained in this Current Report on Form 8-K which are not historical facts are forward-looking statements. In addition, the Company, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and the Company undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by the Company include, but are not limited to, the Company&#8217;s ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving the Company, including any matters related to yet undiscovered issues, if any, at acquired companies; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of the Company&#8217;s information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for the Company&#8217;s services by governmental or private payors; and other factors which may be identified from time to time in the Company&#8217;s filings with the Securities and Exchange Commission and other public announcements, including the Company&#8217;s Form 10-K for the year ended December 31, 2018 and Form 10-Q for the quarters ended March 31, 2019 and June 30, 2019.</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Item&#160;9.01. &#160;&#160;&#160;&#160;Financial Statements and Exhibits. </p> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:6pt">(d)&#160;&#160;&#160;&#160;Exhibits </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:5%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="white-space:nowrap;vertical-align:bottom;text-align:CENTER;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Exhibit<br />Number </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;display:inline-block;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt"> <span style="text-decoration:underline">Description of Exhibit</span> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;4.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="http://www.sec.gov/Archives/edgar/data/785161/000078516110000011/exhibit_4-7110k.htm">Indenture dated as of December<span style="text-decoration:underline"></span>&#160;1, 2009, by and between the Company and the Trustee (incorporated herein by reference to Exhibit 4.7.1 to the Company&#8217;s Annual Report on Form 10-K for the year ended December<span style="text-decoration:underline"></span>&#160;31, 2009). </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;4.2 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex42.htm">Eighth Supplemental Indenture dated as of September&#160;18, 2019, by and among the Company, the Guarantors and the Trustee (relating to the 4.500% Notes due 2028). </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;4.3 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex43.htm">Ninth Supplemental Indenture dated as of September&#160;18, 2019, by and among the Company, the Guarantors and the Trustee (relating to the 4.750% Notes due 2030). </a> </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>



<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:7%;"></td>
<td style="width:90%;"></td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;4.4 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex42.htm">Form of 4.500% Senior Note due 2028 (included in Exhibit 4.2). </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;4.5 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex43.htm">Form of 4.750% Senior Note due 2030 (included in Exhibit 4.3). </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;5.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex51.htm">Opinion of Maynard, Cooper and Gale, P.C. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;5.2 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex52.htm">Opinion of Bradley Arant Boult Cummings LLP. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">23.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex51.htm">Consent of Maynard, Cooper and Gale, P.C. (included in Exhibit 5.1). </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">23.2 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d760186dex52.htm">Consent of Bradley Arant Boult Cummings LLP (included in Exhibit 5.2). </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File &#8211; the cover page iXBRL tags are embedded within the Inline XBRL document </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>



<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <div style="float:right;width:100%">
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:40%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:0px">
<tr>
<td style="width:12%;"></td>
<td style="width:1%;"></td>
<td style="width:87%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">ENCOMPASS HEALTH CORPORATION </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Patrick Darby </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Name: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Patrick Darby </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Title: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Executive Vice President, General Counsel and Secretary </p> </td> </tr> </table> </div> <div style="clear:both"></div> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Date: September&#160;18, 2019 </p> <div></div> <p style="margin-top:0"></p>
 </div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>d760186dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EIGHTH SUPPLEMENTAL INDENTURE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ENCOMPASS HEALTH CORPORATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4.500% SENIOR NOTES DUE 2028 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">WELLS FARGO BANK, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NATIONAL
ASSOCIATION, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Trustee </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of September&nbsp;18, 2019 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE I Establishment of New Series</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 1.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Establishment of New Series</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE II Definitions</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 2.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Definitions</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE III The Securities</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 3.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Form</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV Amendment Of Base Indenture</P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article I of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.02.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article III of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.03.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article IV of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.04.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article V of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.05.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article VI of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.06.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendments of Article VII of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.07.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XI of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.08.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XII of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.09.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XIII of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.10.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XIV of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE V Subsidiary Guarantees</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Guarantees</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.02.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Limitation on Liability</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.03.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Successors and Assigns</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.04.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>No Waiver</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.05.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Modification</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.06.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Release of Subsidiary Guarantor</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.07.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Contribution</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE VI Miscellaneous</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Integral Part</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.02.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Adoption, Ratification and Confirmation</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.03.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Counterparts</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.04.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Severability</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.05.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Governing Law</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.06.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Trustee Makes No Representation</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.07.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Damages Limitation</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.08.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>U.S.A. PATRIOT Act</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EXHIBIT A: Form of Security</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EXHIBIT B: Form of Guaranty Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EIGHTH SUPPLEMENTAL INDENTURE dated as of September&nbsp;18, 2019 (this
&#147;<U>Supplemental Indenture</U>&#148;), between ENCOMPASS HEALTH CORPORATION, a Delaware corporation (formerly known as HealthSouth Corporation, the &#147;<U>Company</U>&#148;), the SUBSIDIARY GUARANTORS (as defined herein) party hereto and
WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee (the &#147;<U>Trustee</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Company has heretofore entered into a senior indenture, dated as of December&nbsp;1, 2009 (the &#147;<U>Base Indenture</U>&#148;),
with the Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Base Indenture, as supplemented by this Supplemental Indenture, is herein called the
&#147;<U>Indenture</U>&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to Section&nbsp;3.01 of the Indenture, the form and terms of a new series of Securities
may at any time be established by a supplemental indenture executed by the Company and the Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Company proposes to
create under the Indenture a new series of Securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS additional Securities of this series and other series hereafter
established, except as may be limited in the Indenture as at the time supplemented and modified, may be issued from time to time pursuant to the Indenture as at the time supplemented and modified; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS all conditions necessary to authorize the execution and delivery of this Supplemental Indenture and to make it a valid and binding
obligation of the Company and the Subsidiary Guarantors have been done or performed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the agreements
and obligations set forth herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESTABLISHMENT OF NEW SERIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 1.01. <U>Establishment of New Series</U>. (a)&nbsp;There is hereby established a new series of Securities to be issued under the
Indenture, to be designated as the Company&#146;s 4.500% Senior Notes due 2028 (the &#147;<U>Securities</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) On the Issue
Date, the Trustee shall authenticate and deliver $500,000,000.00 of the Securities and, at any time and from time to time thereafter, the Trustee shall authenticate and deliver Additional Securities for original issue in accordance with
Section&nbsp;3.14 of the Indenture in an aggregate principal amount specified in the applicable resolution of the Board of Directors and Officers&#146; Certificate. Further, from time to time after the original issue date, Securities shall be
authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of other Securities as set forth in the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Securities shall be issued initially in the form of one or more Global Securities in substantially the form set out in Exhibit A
hereto. The Depositary with respect to the Securities shall be DTC. The Company initially appoints the Trustee to act as the Registrar and Paying Agent and to act as custodian with respect to the Global Securities. The Company has entered into a
letter of representations with the Depositary in the form provided by the Depositary and the Trustee and each agent are hereby authorized to act in accordance with such letter and applicable Depositary procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Security shall be dated the date of authentication thereof and shall bear interest as provided in the form of Security in Exhibit A
hereto. The date on which principal is payable on the Securities shall be as provided in the form of Security in Exhibit A hereto. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The record dates for the Securities and the manner of payment of principal and interest
on the Securities shall be as provided in the form of Security in Exhibit A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) If and to the extent that the provisions of the
Base Indenture are duplicative of, or in contradiction with, the provisions of this Supplemental Indenture, the provisions of this Supplemental Indenture shall govern, but solely with respect to the Securities. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.01. <U>Definitions</U>. For purposes of the Indenture, but only with respect to the Securities, and the Securities, the
following terms have the meanings indicated below. All capitalized terms used herein and not otherwise defined below shall have the meanings ascribed thereto in the Base Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Assets</U>&#148; means (1)&nbsp;any property or assets used in a Related Business; (2)&nbsp;the Capital Stock of a Person
that becomes a Restricted Subsidiary as a result of the acquisition of such Capital Stock by the Company or another Restricted Subsidiary; or (3)&nbsp;Capital Stock constituting a minority interest in any Person that at such time is a Restricted
Subsidiary; <U>provided</U>, <U>however</U>, that any such Restricted Subsidiary described in clause (2)&nbsp;or (3) above is primarily engaged in a Related Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Securities</U>&#148; means Securities issued under the terms of this Indenture subsequent to the Issue Date, and in
compliance with Sections 3.14 and 6.03, it being understood that any Securities issued in exchange for or replacement of any Security issued on the Issue Date shall not be an Additional Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Adjusted Treasury Rate</U>&#148; means, with respect to any redemption date, (1)&nbsp;the yield, under the heading which represents
the average for the immediately preceding week, appearing in the most recently published statistical release designated &#147;H.15(519)&#148; or any successor publication that is published weekly by the Board of Governors of the Federal Reserve
System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption &#147;Treasury Constant Maturities,&#148; for the maturity corresponding to the Comparable Treasury Issue (if no
maturity is within three months before or after February&nbsp;1, 2023, yields for the two published maturities most closely corresponding to the Comparable Treasury Issue shall be determined and the Adjusted Treasury Rate shall be interpolated or
extrapolated from such yields on a straight line basis, rounding to the nearest month) or (2)&nbsp;if such release (or any successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate
per year equal to the semiannual equivalent yield to maturity of the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date, in each case calculated on the third
Business Day immediately preceding the redemption date, and in each case of (1)&nbsp;and (2), plus 0.50%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; of
any specified Person means any other Person, directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, &#147;control&#148; when used with respect
to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms &#147;controlling&#148; and
&#147;controlled&#148; have meanings correlative to the foregoing. No Person (other than the Company or any Subsidiary of the Company) in whom a Receivables Entity makes an Investment in connection with a Qualified Receivables Transaction will be
deemed to be an Affiliate of the Company or any of its Subsidiaries solely by reason of such Investment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable
Premium</U>&#148; means, with respect to a Security at any redemption date, the greater of (1) 1.00% of the principal amount of such Security and (2)&nbsp;the excess of (A)&nbsp;the present value at such redemption date of (i)&nbsp;the redemption
price of such Security on February&nbsp;1, 2023 (such redemption price being set forth in paragraph 5 of such Security, exclusive of any accrued interest), plus (ii)&nbsp;all required remaining scheduled interest payments due on such Security
through February&nbsp;1, 2023 (but excluding accrued and unpaid interest to the redemption date), computed using a discount rate equal to the Adjusted Treasury Rate, over (B)&nbsp;the principal amount of such Security on such redemption date. The
Company will provide written notice to the Trustee of the Applicable Premium promptly after calculation and the Trustee will not be responsible for such calculation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Disposition</U>&#148; means any sale, lease, transfer or other disposition
(or series of related sales, leases, transfers or dispositions) by the Company or any Restricted Subsidiary, including any disposition by means of a merger, consolidation or similar transaction (each referred to for the purposes of this definition
as a &#147;<U>disposition</U>&#148;), of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any shares of Capital Stock of a Restricted Subsidiary (other than directors&#146;
qualifying shares or shares required by applicable law to be held by a Person other than the Company or a Restricted Subsidiary); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all
or substantially all the assets of any division or line of business of the Company or any Restricted Subsidiary; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) any other assets
of the Company or any Restricted Subsidiary outside of the ordinary course of business of the Company or such Restricted Subsidiary; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">other than, in the case of clauses (1), (2) and (3)&nbsp;above, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) a disposition by a Restricted Subsidiary to the Company or by the Company or a Restricted Subsidiary to a Restricted
Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) for purposes of Section&nbsp;6.06 only, a disposition that constitutes a Restricted Payment (or would
constitute a Restricted Payment but for the exclusions from the definition thereof) that is not prohibited by Section&nbsp;6.04 or that constitutes a Permitted Investment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) a disposition of all or substantially all the assets of the Company in accordance with Section&nbsp;5.01; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) a disposition of Capital Stock or other assets with a Fair Market Value of less than or equal to $10,000,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) sales of damaged, <FONT STYLE="white-space:nowrap">worn-out</FONT> or obsolete equipment or assets in the ordinary course
of business that, in the Company&#146;s reasonable judgment, are no longer either used or useful in the business of the Company or its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) the sale or discount, in each case without recourse, of accounts receivable arising in the ordinary course of business, but
only in connection with the compromise or collection thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) sales of accounts receivable and related assets of the
type specified in the definition of &#147;<U>Qualified Receivables Transaction</U>&#148; to a Receivables Entity; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H)
transfers of accounts receivable and related assets of the type specified in the definition of &#147;<U>Qualified Receivables Transaction</U>&#148; (or a fractional undivided interest therein) by a Receivables Entity in a Qualified Receivables
Transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) leases or subleases to third Persons in the ordinary course of business that do not interfere in any
material respect with the business of the Company or any of its Restricted Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) a disposition of cash or
Temporary Cash Investments; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(K) the creation of a Lien (but not the sale or other disposition of the property subject
to such Lien). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Attributable Debt</U>&#148; in respect of a Sale/Leaseback Transaction means, as at the time of determination,
the present value (discounted at the interest rate implicit in the lease, compounded annually) of the total obligations of the lessee for rental payments during the remaining term of the lease included in such Sale/Leaseback Transaction (including
any period for which such lease has been extended); <U>provided</U>, <U>however</U>, that if such Sale/Leaseback Transaction results in a Finance Lease Obligation, the amount of Indebtedness represented thereby shall be determined in accordance with
the definition of &#147;Finance Lease Obligation.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Average Life</U>&#148; means, as of the date of determination, with respect to any
Indebtedness, the quotient obtained by dividing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the sum of the products of the numbers of years from the date of determination to
the dates of each successive scheduled principal payment of or redemption or similar payment with respect to such Indebtedness multiplied by the amount of such payment by </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the sum of all such payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means each day which is not a Saturday, a Sunday or a day on which the Trustee is authorized or required by
law to close or banking institutions are not required to be open in the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Capital Markets
Indebtedness</U>&#148; means any Indebtedness: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) in the form of, or represented by, bonds (other than surety bonds, indemnity bonds,
performance bonds or bonds of a similar nature) or other securities or any Guarantee thereof; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) that is, or may be, quoted, listed
or purchased and sold on any stock exchange, automated trading system or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> or other securities market (including, without prejudice to the generality of
the foregoing, the market for securities eligible for resale pursuant to Rule 144A under the Securities Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Captive Insurance
Subsidiary</U>&#148; means HCS, Ltd., a Cayman Islands entity, and any successor to it, and any other Subsidiary formed for the purpose of facilitating self-insurance programs of the Company and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change of Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company becomes aware that any &#147;person&#148; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) is or has
become the &#147;beneficial owner&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act, except that for purposes of this clause (1)&nbsp;such person shall
be deemed to have &#147;beneficial ownership&#148; of all shares that any such person has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of more than 50% of the total
voting power of the Voting Stock of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) at any time during any period of up to 24 consecutive months, commencing on the
Issue Date, individuals who at the beginning of such period constituted the Board of Directors (together with any new directors whose election by such Board of Directors or whose nomination for election by the shareholders of the Company was
approved by a vote of a majority of the directors of the Company then still in office who were either directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to
constitute a majority of the Board of Directors then in office; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company is liquidated or dissolved or adopts a plan of
liquidation or dissolution; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the merger or consolidation of the Company with or into another Person or the merger of another Person
with or into the Company, or the sale of all or substantially all the assets of the Company (determined on a consolidated basis) to another Person, other than a transaction following which (i)&nbsp;in the case of a merger or consolidation
transaction, holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction (or other securities into which such securities are converted as part of such merger or consolidation transaction) own
directly or indirectly at least a majority of the voting power of the Voting Stock of the surviving Person in such merger or consolidation transaction immediately after such transaction and (ii)&nbsp;in the case of a sale of assets transaction, each
transferee becomes an obligor in respect of the Securities and a Subsidiary of the transferor of such assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and any
applicable Treasury Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Issue</U>&#148; means the United States Treasury
security selected by the Quotation Agent as having a maturity comparable to the remaining term of the Securities from the redemption date to February&nbsp;1, 2023, that would be utilized, at the time of selection and in accordance with customary
financial practice, in pricing new issues of corporate debt securities of a maturity most nearly equal to February&nbsp;1, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Price</U>&#148; means, with respect to any redemption date, if clause (2)&nbsp;of the Adjusted Treasury Rate is
applicable, the average of two, or if not possible, such lesser number as is obtained by the Company, Reference Treasury Dealer Quotations for such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Amortization Expense</U>&#148; means, for any Person for any period, the amortization expense of such Person and its
Restricted Subsidiaries for such period (to the extent included in the computation of Consolidated Net Income of such Person), determined on a consolidated basis in accordance with GAAP, excluding amortization expense attributable to a prepaid item
that was paid in cash in a prior period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Coverage Ratio</U>&#148; as of any date of determination means the ratio
of (a)&nbsp;the aggregate amount of EBITDA for the period of the most recent four consecutive fiscal quarters ending at least 45 days prior to the date of such determination to (b)&nbsp;Consolidated Interest Expense for such four fiscal quarters;
<U>provided</U>, <U>however</U>, that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if the Company or any Restricted Subsidiary has Incurred any Indebtedness since the beginning
of such period that remains outstanding or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio is an Incurrence of Indebtedness, or both, EBITDA and Consolidated Interest Expense for such period shall be
calculated after giving effect on a pro forma basis to such Indebtedness (and the application of the proceeds thereof) as if such Indebtedness had been Incurred on the first day of such period; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if the Company or any Restricted Subsidiary has repaid, repurchased, defeased or otherwise discharged any Indebtedness since the beginning
of such period or if any Indebtedness is to be repaid, repurchased, defeased or otherwise discharged (in each case other than Indebtedness Incurred under any revolving credit facility unless such Indebtedness has been permanently repaid and has not
been replaced) on the date of the transaction giving rise to the need to calculate the Consolidated Coverage Ratio, EBITDA and Consolidated Interest Expense for such period shall be calculated on a pro forma basis as if such discharge had occurred
on the first day of such period and as if the Company or such Restricted Subsidiary had not earned the interest income actually earned during such period in respect of cash or Temporary Cash Investments used to repay, repurchase, defease or
otherwise discharge such Indebtedness; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if since the beginning of such period the Company or any Restricted Subsidiary shall have made
any Asset Disposition, EBITDA for such period shall be reduced by an amount equal to EBITDA (if positive) directly attributable to the assets which are the subject of such Asset Disposition for such period, or increased by an amount equal to EBITDA
(if negative), directly attributable thereto for such period and Consolidated Interest Expense for such period shall be reduced by an amount equal to the Consolidated Interest Expense directly attributable to any Indebtedness of the Company or any
Restricted Subsidiary repaid, repurchased, defeased or otherwise discharged with respect to the Company and its continuing Restricted Subsidiaries in connection with such Asset Disposition for such period (or, if the Capital Stock of any Restricted
Subsidiary is sold, the Consolidated Interest Expense for such period directly attributable to the Indebtedness of such Restricted Subsidiary to the extent the Company and its continuing Restricted Subsidiaries are no longer liable for such
Indebtedness after such sale); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) if since the beginning of such period the Company or any Restricted Subsidiary (by merger or
otherwise) shall have made an Investment in any Restricted Subsidiary (or any Person that becomes a Restricted Subsidiary) or an acquisition of assets, including any acquisition of assets occurring in connection with a transaction requiring a
calculation to be made hereunder, that constitutes a hospital or other health care-related business or all or substantially all of an operating unit of a business, EBITDA and Consolidated Interest Expense for such period shall be calculated after
giving pro forma effect thereto (including the Incurrence of any Indebtedness) as if such Investment or acquisition had occurred on the first day of such period; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) if since the beginning of such period any Person (that subsequently became a Restricted
Subsidiary or was merged with or into the Company or any Restricted Subsidiary since the beginning of such period) shall have made any Asset Disposition, any Investment or acquisition of assets that would have required an adjustment pursuant to
clause (3)&nbsp;or (4) above if made by the Company or a Restricted Subsidiary during such period, EBITDA and Consolidated Interest Expense for such period shall be calculated after giving pro forma effect thereto as if such Asset Disposition,
Investment or acquisition had occurred on the first day of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this definition, whenever pro forma effect is to
be given to an acquisition of assets, the amount of income or earnings relating thereto and the amount of Consolidated Interest Expense associated with any Indebtedness Incurred in connection therewith, the pro forma calculations shall be determined
in good faith by a responsible financial or accounting Officer of the Company (and shall include any applicable Pro Forma Cost Savings). If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest on such
Indebtedness shall be calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period (taking into account any Interest Rate Agreement applicable to such Indebtedness). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Indebtedness is incurred under a revolving credit facility and is being given pro forma effect, the interest on such Indebtedness shall
be calculated based on the average daily balance of such Indebtedness for the four fiscal quarters subject to the pro forma calculation to the extent that such Indebtedness was incurred solely for working capital purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Depreciation Expense</U>&#148; means, for any Person for any period, the depreciation expense of such Person and its
Restricted Subsidiaries for such period (to the extent included in the computation of Consolidated Net Income of such Person), determined on a consolidated basis in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Income Tax Expense</U>&#148; means, for any Person for any period, the provision for taxes based on income and profits
of such Person and its Restricted Subsidiaries to the extent such provision for income taxes was deducted in computing Consolidated Net Income of such Person for such period, determined on a consolidated basis in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Interest Expense</U>&#148; means, for any period, the total interest expense of the Company and its consolidated
Restricted Subsidiaries, net of interest income of the Company and its consolidated Restricted Subsidiaries (other than interest income of any Captive Insurance Subsidiary that is a Restricted Subsidiary), <U>plus</U>, to the extent not included in
the calculation of total interest expense, and to the extent incurred by the Company or its Restricted Subsidiaries, without duplication: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) interest expense attributable to Finance Lease Obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) amortization of debt discount; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) capitalized interest; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) <FONT
STYLE="white-space:nowrap">non-cash</FONT> interest expense; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) commissions, discounts and other fees and charges owed with respect to
letters of credit and bankers&#146; acceptance financing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) net payments made or received pursuant to Hedging Obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) dividends accrued in respect of all Disqualified Stock of the Company and all Preferred Stock of any Restricted Subsidiary, in each case
held by Persons other than the Company or a Wholly Owned Subsidiary (other than dividends payable solely in Capital Stock (other than Disqualified Stock) of the Company); <U>provided</U>, <U>however</U>, that such dividends shall be multiplied by a
fraction the numerator of which is one and the denominator of which is one minus the effective combined tax rate of the issuer of such Preferred Stock (expressed as a decimal) for such period (as estimated by the chief financial officer of the
Company in good faith); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) interest accruing on any Indebtedness of any other Person to the extent such
Indebtedness is Guaranteed by (or secured by the assets of) the Company or any Restricted Subsidiary; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) the cash contributions to
any employee stock ownership plan or similar trust to the extent such contributions are used by such plan or trust to pay interest or fees to any Person (other than the Company) in connection with Indebtedness Incurred by such plan or trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Net Income</U>&#148; means, for any period, the net income of the Company and its consolidated Subsidiaries;
<U>provided</U>, <U>however</U>, that there shall not be included in such Consolidated Net Income: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any net income of any Person
(other than the Company) if such Person is not a Restricted Subsidiary, except that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) subject to the exclusion
contained in clause (4)&nbsp;below, the Company&#146;s equity in the net income of any such Person for such period shall be included in such Consolidated Net Income up to the aggregate amount of cash actually distributed by such Person during such
period to the Company or a Restricted Subsidiary as a dividend or other distribution (subject, in the case of a dividend or other distribution paid to a Restricted Subsidiary, to the limitations contained in clause (3)&nbsp;below); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the Company&#146;s equity in a net loss of any such Person for such period shall be included in determining such
Consolidated Net Income to the extent such loss has been funded with cash from the Company or a Restricted Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any net income
(or loss) of any Person acquired by the Company or a Subsidiary in a pooling of interests transaction (or any transaction accounted for in a manner similar to a pooling of interests) for any period prior to the date of such acquisition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) any net income of any Restricted Subsidiary if such Restricted Subsidiary is subject to restrictions, directly or indirectly, on the
payment of dividends or the making of distributions by such Restricted Subsidiary, directly or indirectly, to the Company, except that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) subject to the exclusion contained in clause (4)&nbsp;below, the Company&#146;s equity in the net income of any such
Restricted Subsidiary for such period shall be included in such Consolidated Net Income up to the aggregate amount of cash that could have been distributed by such Restricted Subsidiary during such period to the Company or another Restricted
Subsidiary as a dividend or other distribution (subject, in the case of a dividend or other distribution paid to another Restricted Subsidiary, to the limitation contained in this clause); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the Company&#146;s equity in a net loss of any such Restricted Subsidiary for such period shall be included in determining
such Consolidated Net Income; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) any gain (or loss) realized upon the sale or other disposition of any assets of the Company, its
consolidated Subsidiaries or any other Person (including pursuant to any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sale-and-leaseback</FONT></FONT> arrangement) which is not sold or otherwise disposed of in the ordinary
course of business and any gain (or loss) realized upon the sale or other disposition of any Capital Stock of any Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) any net
income or net losses from discontinued operations; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) extraordinary gains or losses; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) the cumulative effect of a change in accounting principles, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, for such period. Notwithstanding the foregoing, for the purposes of Section&nbsp;6.04 only, there shall be excluded from Consolidated Net Income
any repurchases, repayments or redemptions of Investments, proceeds realized on the sale of Investments or return of capital to the Company or a Restricted Subsidiary to the extent such repurchases, repayments, redemptions, proceeds or returns
increase the amount of Restricted Payments permitted under clause (a)(3)(D) or (a)(3)(E) of Section&nbsp;6.04. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Secured Debt Ratio</U>&#148; as of any date of determination, means
the ratio of (a)&nbsp;Indebtedness of the Company and its Restricted Subsidiaries, determined on a consolidated basis, secured by Liens, to (b)&nbsp;the aggregate amount of EBITDA for the period of the most recent four consecutive fiscal quarters
ending at least 45 days prior to the date of such determination, in each case with such pro forma adjustments to consolidated total Indebtedness and EBITDA as are appropriate and consistent with the pro forma adjustment provisions set forth in the
definition of &#147;Consolidated Coverage Ratio.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Tangible Assets</U>&#148; as of any date means the total
assets of the Company and its Restricted Subsidiaries (excluding any assets that would be classified as &#147;intangible assets&#148; under GAAP) on a consolidated basis at such date, as determined in accordance with GAAP, less (i)&nbsp;all <FONT
STYLE="white-space:nowrap">write-ups</FONT> subsequent to the Issue Date in the book value of any asset owned by the Company or any of its Restricted Subsidiaries and (ii)&nbsp;Investments in and assets of Unrestricted Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Total Indebtedness</U>&#148; of any Person as of any date means (a)&nbsp;all Indebtedness (including Finance Lease
Obligations but excluding (i)&nbsp;Hedging Obligations and (ii)&nbsp;to the extent they constitute Indebtedness, contingent reimbursement obligations in respect of undrawn amounts of letters of credit) minus (b)&nbsp;the aggregate amount of cash and
cash equivalents of such Person and its Subsidiaries (other than Restricted Cash and Cash Equivalents) as of such date in an amount not to exceed $100,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Corporate Trust Office</U>&#148; shall be the office of the Trustee at which this Indenture shall be principally administered, which
at the Issue Date is 150 East 42nd Street, 40th Floor, New York, New York 10017, Attn: Corporate, Trust Services, and with respect to Paying Agent and Registrar services such office shall also mean the office or agency of the Trustee located at 600
South Fourth Street, 7th Floor, Minneapolis, MN 55415, Attn: Corporate Trust Operations, or such other address as to which the Trustee may give notice to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Credit Agreement</U>&#148; means the Fourth Amended and Restated Credit Agreement dated as of September&nbsp;29, 2017, by and among
the Company, as borrower, Barclays Bank PLC, as administrative agent, and the other lenders and agents party thereto from time to time, together with the related documents thereto (including the term loans and revolving loans thereunder, any
guarantees and security documents), as amended, extended, renewed, restated, supplemented or otherwise modified (in whole or in part, and without limitation as to amount, terms, conditions, covenants and other provisions) from time to time, and any
agreement (and related document) governing Indebtedness incurred to Refinance, in whole or in part, the borrowings and commitments then outstanding or permitted to be outstanding under such Credit Agreement or a successor Credit Agreement, whether
by the same or any other lender or group of lenders (including by means of sales of debt securities to institutional investors). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Currency Agreement</U>&#148; means any foreign exchange contract, currency swap agreement or other similar agreement with respect to
currency values. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DTC</U>&#148; means The Depository Trust Company, a New York corporation, or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Designated Noncash Consideration</U>&#148; means noncash consideration received by the Company or one of its Restricted Subsidiaries
in connection with an Asset Disposition that is designated by the Company as Designated Noncash Consideration, less the amount of cash or cash equivalents received in connection with a subsequent sale of such Designated Noncash Consideration, which
cash and cash equivalents shall be considered Net Available Cash received as of such date and shall be applied pursuant to Section&nbsp;6.06. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disqualified Stock</U>&#148; means, with respect to any Person, any Capital Stock that by its terms (or by the terms of any security
into which it is convertible or for which it is exchangeable at the option of the holder) or upon the happening of any event: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) matures
or is mandatorily redeemable (other than redeemable only for Capital Stock of such Person which is not itself Disqualified Stock) pursuant to a sinking fund obligation or otherwise; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) is convertible or exchangeable at the option of the holder for Indebtedness or
Disqualified Stock; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) is mandatorily redeemable or must be purchased upon the occurrence of certain events or otherwise, in whole or
in part; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case on or prior to the date that is 91 days after the Stated Maturity of the Securities; <U>provided</U>, <U>however</U>, that any
Capital Stock that would not constitute Disqualified Stock but for provisions thereof giving holders thereof the right to require such Person to purchase or redeem such Capital Stock upon the occurrence of an &#147;asset sale&#148; or &#147;change
of control&#148; occurring prior to the date that is 91 days after the Stated Maturity of the Securities shall not constitute Disqualified Stock if the &#147;asset sale&#148; or &#147;change of control&#148; provisions applicable to such Capital
Stock are not more favorable to the holders of such Capital Stock than the terms applicable to the Securities under Sections 6.06 and 6.08. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of any Disqualified Stock that does not have a fixed redemption, repayment or repurchase price shall be calculated in accordance
with the terms of such Disqualified Stock as if such Disqualified Stock were redeemed, repaid or repurchased on any date on which the amount of such Disqualified Stock is to be determined pursuant to this Indenture; <U>provided</U>, <U>however</U>,
that if such Disqualified Stock could not be required to be redeemed, repaid or repurchased at the time of such determination, the redemption, repayment or repurchase price shall be the book value of such Disqualified Stock as reflected in the most
recent financial statements of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>EBITDA</U>&#148; of any Person for any period means Consolidated Net Income of such
Person for such period plus, without duplication, the sum for such Person of the following to the extent deducted in calculating Consolidated Net Income for such period: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Consolidated Income Tax Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Consolidated Depreciation Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Consolidated Amortization Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Consolidated Interest Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) all other <FONT STYLE="white-space:nowrap">non-cash</FONT> items or <FONT STYLE="white-space:nowrap">non-recurring</FONT> <FONT
STYLE="white-space:nowrap">non-cash</FONT> items reducing Consolidated Net Income of such Person and its Subsidiaries, determined on a consolidated basis in accordance with GAAP (including <FONT STYLE="white-space:nowrap">non-cash</FONT> charges
incurred as a result of the application of FASB Accounting Standard Codification 718, Compensation&#151;Stock Compensation); <U>provided</U> that cash expenditures made in respect of items to which the charges referred to in this clause
(5)&nbsp;relate in an aggregate amount in excess of $10,000,000 for any period of four consecutive fiscal quarters shall be deducted in determining EBITDA for the period during which such expenditures are made, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) any restructuring charges in respect of legal fees associated with the government, class-action and shareholder derivative litigation
described in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2009, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) fees, costs and expenses related to the offering of the Securities and the other Refinancing Transactions, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) any losses from discontinued operations and closed locations, and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) costs and expenses related to the settlement of the Shareholder Litigation, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case determined on a consolidated basis in accordance with GAAP, less all unusual noncash items or nonrecurring noncash items to the extent increasing
Consolidated Net Income of such Person and its Subsidiaries, determined on a consolidated basis in accordance with GAAP, in each case for such period. Notwithstanding the foregoing, the provision for taxes based on the income or profits of, and the
depreciation and amortization and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
noncash charges of, a Restricted Subsidiary shall be added to Consolidated Net Income to compute EBITDA only to the extent (and in the same proportion, including by reason of minority interests)
that the net income or loss of such Restricted Subsidiary was included in calculating Consolidated Net Income and only if a corresponding amount would be permitted at the date of determination to be dividended to the Company by such Restricted
Subsidiary without prior approval (that has not been obtained), pursuant to the terms of its charter and all agreements, instruments, judgments, decrees, orders, statutes, rules and governmental regulations applicable to such Restricted Subsidiary
or its stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Offering</U>&#148; means any public or private sale of Capital Stock (other than Disqualified Stock)
of the Company, other than public offerings with respect to the Company&#146;s common stock registered on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act and other than issuances to any Subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fair Market Value</U>&#148; means, with respect to any asset or property, the price that could be negotiated in an <FONT
STYLE="white-space:nowrap">arm&#146;s-length,</FONT> free market transaction, for cash, between a willing and able buyer and an unaffiliated willing seller, neither of whom is under undue pressure or compulsion to complete the transaction, as such
price is determined in good faith by (1)&nbsp;the Chief Financial Officer, the Treasurer or the Chief Accounting Officer of the Company (unless otherwise provided in this Indenture) for transactions valued at, or below, $10,000,000, or (2)&nbsp;the
Board of Directors of the Company (unless otherwise provided in this Indenture) for transactions valued in excess of $10,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finance Lease Obligation</U>&#148; means an obligation that is required to be classified and accounted for as a finance lease for
financial reporting purposes in accordance with GAAP, and the amount of Indebtedness represented by such obligation shall be the capitalized amount of such obligation determined in accordance with GAAP; and the Stated Maturity thereof shall be the
date of the last payment of rent or any other amount due under such lease prior to the first date upon which such lease may be terminated by the lessee without payment of a penalty. For purposes of Section&nbsp;6.09, a Finance Lease Obligation shall
be deemed to be secured by a Lien on the property being leased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guarantee</U>&#148; means any obligation, contingent or
otherwise, of any Person directly or indirectly guaranteeing any Indebtedness of any Person and any obligation, direct or indirect, contingent or otherwise, of such Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such Person (whether arising by virtue
of partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or services, to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">take-or-pay</FONT></FONT> or to maintain financial statement
conditions or otherwise); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) entered into for the purpose of assuring in any other manner the obligee of such Indebtedness of the
payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that the term
&#147;<U>Guarantee</U>&#148; shall not include endorsements for collection or deposit in the ordinary course of business. The term &#147;<U>Guarantee</U>&#148; used as a verb has a corresponding meaning. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guaranty Agreement</U>&#148; means an agreement, in substantially the form of Exhibit B hereto or another form satisfactory to the
Trustee, pursuant to which a Subsidiary Guarantor guarantees the Company&#146;s obligations with respect to the Securities on the terms provided for in this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hedging Obligations</U>&#148; of any Person means the obligations of such Person pursuant to any Interest Rate Agreement or Currency
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Incur</U>&#148; means issue, assume, Guarantee, incur or otherwise become liable for; <U>provided</U>,
<U>however</U>, that any Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) shall be deemed to be Incurred by such Person at the time it becomes a
Restricted Subsidiary. The term &#147;<U>Incurrence</U>&#148; when used as a noun shall have a correlative meaning. Solely for purposes of determining compliance with Section&nbsp;6.03: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) amortization of debt discount or the accretion of principal with respect to a noninterest bearing or other discount security; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the payment of regularly scheduled interest in the form of additional Indebtedness of
the same instrument or the payment of regularly scheduled dividends on Capital Stock in the form of additional Capital Stock of the same class and with the same terms; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the obligation to pay a premium in respect of Indebtedness arising in connection with the issuance of a notice of redemption or making of
a mandatory offer to purchase such Indebtedness </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">will not be deemed to be the Incurrence of Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, with respect to any Person on any date of determination (without duplication): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the principal in respect of (A)&nbsp;indebtedness of such Person for money borrowed and (B)&nbsp;indebtedness evidenced by notes,
debentures, bonds or other similar instruments for the payment of which such Person is responsible or liable, including, in each case, any premium on such indebtedness to the extent such premium has become due and payable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all Finance Lease Obligations of such Person and all Attributable Debt in respect of Sale/Leaseback Transactions entered into by such
Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) all obligations of such Person issued or assumed as the deferred purchase price of property, all conditional sale obligations
of such Person and all obligations of such Person under any title retention agreement (but excluding any accounts payable or other liability to trade creditors arising in the ordinary course of business); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) all obligations of such Person for the reimbursement of any obligor on any letter of credit, bankers&#146; acceptance or similar credit
transaction (other than obligations with respect to letters of credit securing obligations (other than obligations described in clauses (1)&nbsp;through (3) above) entered into in the ordinary course of business of such Person to the extent such
letters of credit are not drawn upon or, if and to the extent drawn upon, such drawing is reimbursed no later than the tenth Business Day following payment on the letter of credit); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the amount of all obligations of such Person with respect to the redemption, repayment or other repurchase of any Disqualified Stock of
such Person or, with respect to any Preferred Stock of any Subsidiary of such Person, the principal amount of such Preferred Stock to be determined in accordance with this Indenture (but excluding, in each case, any accrued dividends); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) all obligations of the type referred to in clauses (1)&nbsp;through (5) of other Persons and all dividends of other Persons for the
payment of which, in either case, such Person is responsible or liable, directly or indirectly, as obligor, guarantor or otherwise, including by means of any Guarantee; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) all obligations of the type referred to in clauses (1)&nbsp;through (6) of other Persons secured by any Lien on any property or asset of
such Person (whether or not such obligation is assumed by such Person), the amount of such obligation being deemed to be the lesser of the Fair Market Value of such property or assets and the amount of the obligation so secured; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) to the extent not otherwise included in this definition, Hedging Obligations of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, in connection with the purchase by the Company or any Restricted Subsidiary of any business, the term
&#147;Indebtedness&#148; will exclude indemnification, purchase price adjustment, holdback and contingency payment obligations to which the seller may become entitled to the extent such payment is determined by a final closing balance sheet or such
payment depends on the performance of such business after the closing; <U>provided</U>, <U>however</U>, that, at the time of closing, the amount of any such payment is not determinable and, to the extent such payment thereafter becomes fixed and
determined, the amount is paid within 60 days thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of Indebtedness of any Person at any date shall be the outstanding balance at
such date of all obligations as described above; <U>provided</U>, <U>however</U>, that in the case of Indebtedness sold at a discount, the amount of such Indebtedness at any time will be the accreted value thereof at such time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Qualified Party</U>&#148; means an investment banking firm, accounting firm or appraisal firm of national standing;
<U>provided</U>, <U>however</U>, that such firm is not an Affiliate of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Payment Date</U>&#148; means each
date specified in the Security as a fixed date on which an installment of interest is due and payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Rate
Agreement</U>&#148; means any interest rate swap agreement, interest rate cap agreement or other financial agreement or arrangement with respect to exposure to interest rates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investment</U>&#148; in any Person means any direct or indirect advance, loan (other than advances to customers in the ordinary
course of business that are recorded as accounts receivable on the balance sheet of the lender) or other extensions of credit (including by way of Guarantee or similar arrangement) or capital contribution to (by means of any transfer of cash or
other property to others or any payment for property or services for the account or use of others), or any purchase or acquisition of Capital Stock, Indebtedness or other similar instruments issued by such Person. If the Company or any Restricted
Subsidiary issues, sells or otherwise disposes of any Capital Stock of a Person that is a Restricted Subsidiary such that, after giving effect thereto, such Person is no longer a Restricted Subsidiary, any Investment by the Company or any Restricted
Subsidiary in such Person remaining after giving effect thereto will be deemed to be a new Investment at such time. The acquisition by the Company or any Restricted Subsidiary of a Person that holds an Investment in a third Person shall be deemed to
be an Investment by the Company or such Restricted Subsidiary in such third Person at such time. Except as otherwise provided for herein, the amount of an Investment shall be its Fair Market Value at the time the Investment is made and without
giving effect to subsequent changes in value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the definition of &#147;<U>Unrestricted Subsidiary</U>&#148;, the
definition of &#147;<U>Restricted Payment</U>&#148; and Section&nbsp;6.04: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &#147;<U>Investment</U>&#148; shall include the portion
(proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of any Subsidiary of the Company at the time that such Subsidiary is designated an Unrestricted Subsidiary; <U>provided</U>,
<U>however</U>, that upon a redesignation of such Subsidiary as a Restricted Subsidiary, the Company shall be deemed to continue to have a permanent &#147;Investment&#148; in an Unrestricted Subsidiary equal to an amount (if positive) equal to
(A)&nbsp;the Company&#146;s &#147;Investment&#148; in such Subsidiary at the time of such redesignation less (B)&nbsp;the portion (proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of
such Subsidiary at the time of such redesignation; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any property transferred to or from an Unrestricted Subsidiary shall be valued
at its Fair Market Value at the time of such transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issue Date</U>&#148; means September&nbsp;18, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Leverage Ratio</U>&#148; means, at any date, the ratio of (a)&nbsp;Consolidated Total Indebtedness of the Company and its Restricted
Subsidiaries on such date to (b)&nbsp;EBITDA of the Company and its Restricted Subsidiaries for the period of four consecutive fiscal quarters ending at least 45 days prior to such date, in each case with such pro forma adjustments as are
appropriate and consistent with the pro forma adjustment provisions set forth in the definition of &#147;Consolidated Coverage Ratio.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (including any conditional sale
or other title retention agreement or lease in the nature thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Moody&#146;s</U>&#148; means Moody&#146;s Investors Service,
Inc., and any successor to its rating agency business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Available Cash</U>&#148; from an Asset Disposition means cash payments received
therefrom (including any cash payments received by way of deferred payment of principal pursuant to a note or installment receivable or otherwise and proceeds from the sale or other disposition of any securities received as consideration, but only
as and when received, but excluding any other consideration received in the form of assumption by the acquiring Person of Indebtedness or other obligations relating to such properties or assets or received in any other
<FONT STYLE="white-space:nowrap">non-cash</FONT> form), in each case net of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) all legal, title and recording tax expenses, commissions
and other fees and expenses incurred (including legal, accounting and investment banking fees and commissions), and all federal, state, provincial, foreign and local taxes required to be accrued as a liability under GAAP, as a consequence of such
Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all payments made on any Indebtedness which is secured by any assets subject to such Asset Disposition, in
accordance with the terms of any Lien upon or other security agreement of any kind with respect to such assets, or which must by its terms, or in order to obtain a necessary consent to such Asset Disposition, or by applicable law, be repaid out of
the proceeds from such Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) all distributions and other payments required to be made to minority interest holders in
Restricted Subsidiaries as a result of such Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the deduction of appropriate amounts provided by the seller as a
reserve, in accordance with GAAP, against any liabilities associated with the property or other assets disposed in such Asset Disposition and retained by the Company or any Restricted Subsidiary after such Asset Disposition; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) any portion of the purchase price from an Asset Disposition placed in escrow, whether as a reserve for adjustment of the purchase price,
for satisfaction of indemnities in respect of such Asset Disposition or otherwise in connection with that Asset Disposition; <U>provided</U>, <U>however</U>, that upon the termination of that escrow, Net Available Cash shall be increased by any
portion of funds in the escrow that are released to the Company or any Restricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Cash Proceeds</U>&#148;, with
respect to any issuance or sale of Capital Stock or Indebtedness, means the cash proceeds of such issuance or sale net of attorneys&#146; fees, accountants&#146; fees, underwriters&#146; or placement agents&#146; fees, discounts or commissions and
brokerage, consultant and other fees actually incurred in connection with such issuance or sale and net of taxes paid or payable as a result thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Obligations</U>&#148; means, with respect to any Indebtedness, all obligations for principal, premium, interest, penalties, fees,
indemnifications, reimbursements, and other amounts payable pursuant to the documentation governing such Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer</U>&#148; means the Chairman of the Board of Directors, the Chief Executive Officer, the President, the Chief Financial
Officer, the Chief Accounting Officer, any Vice President, the Treasurer or the Secretary of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer&#146;s
Certificate</U>&#148; means a certificate signed by an Officer and delivered to the Trustee and &#147;<U>Officers&#146; Certificate</U>&#148; means a certificate signed by two Officers and delivered to the Trustee. Each such certificate shall
include the statements provided for in Section&nbsp;16.01 if and to the extent required by the provisions of such Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Opinion of Counsel</U>&#148; means an opinion in writing signed by legal counsel who may be an employee of or counsel to the Company
or may be other counsel who is reasonably acceptable to the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Investment</U>&#148; means an Investment by the
Company or any Restricted Subsidiary in: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company, a Restricted Subsidiary or a Person that shall, upon the making of such
Investment, become a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that the primary business of such Restricted Subsidiary is a Related Business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) another Person if, as a result of such Investment, such other Person is merged or
consolidated with or into, or transfers or conveys all or substantially all its assets to, the Company or a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that such Person&#146;s primary business is a Related Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) cash and Temporary Cash Investments; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) receivables owing to the Company or any Restricted Subsidiary if created or acquired in the ordinary course of business and payable or
dischargeable in accordance with customary trade terms; <U>provided</U>, <U>however</U>, that such trade terms may include such concessionary trade terms as the Company or any such Restricted Subsidiary deems reasonable under the circumstances; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) payroll, travel and similar advances to cover matters that are expected at the time of such advances ultimately to be treated as expenses
for accounting purposes and that are made in the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) loans or advances to officers, directors and employees
made in the ordinary course of business of the Company or such Restricted Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) stock, obligations or securities received in
settlement of debts created in the ordinary course of business and owing to the Company or any Restricted Subsidiary or in satisfaction of judgments; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) any Person to the extent such Investment represents the <FONT STYLE="white-space:nowrap">non-cash</FONT> portion of the consideration
received for (A)&nbsp;an Asset Disposition as permitted pursuant to Section&nbsp;6.06 or (B)&nbsp;a disposition of assets not constituting an Asset Disposition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) any Person where such Investment was acquired by the Company or any of its Restricted Subsidiaries (A)&nbsp;in exchange for any other
Investment or accounts receivable held by the Company or any such Restricted Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable or
(B)&nbsp;as a result of a foreclosure by the Company or any of its Restricted Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) any Person to the extent such Investments consist of prepaid expenses, negotiable instruments held for collection and lease, utility and
workers&#146; compensation, performance and other similar deposits made in the ordinary course of business by the Company or any Restricted Subsidiary; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) any Person to the extent such Investments consist of Hedging Obligations otherwise permitted under Section&nbsp;6.03; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) any Person to the extent such Investment exists on the Issue Date, and any extension, modification or renewal of any such Investments
existing on the Issue Date, but only to the extent not involving additional advances, contributions or other Investments of cash or other assets or other increases thereof (other than as a result of the accrual or accretion of interest or original
issue discount or the issuance of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-in-kind</FONT></FONT> securities, in each case, pursuant to the terms of such Investment as in effect on the Issue Date); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) Investments made by the Captive Insurance Subsidiary in the ordinary course of business and in accordance with applicable law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) a Receivables Entity, or any Investment by a Receivables Entity in any other Person in connection with a Qualified Receivables
Transaction, including Investments of funds held in accounts permitted or required by the arrangements governing such Qualified Receivables Transaction or any related Indebtedness; <U>provided</U>, <U>however</U>, that any Investment in a
Receivables Entity is in the form of a purchase money note, contribution of additional receivables or an equity interest; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) Persons
to the extent such Investments, when taken together with all other Investments made pursuant to this clause (15)&nbsp;and outstanding on the date such Investment is made, do not exceed 10% of Consolidated Tangible Assets, as determined based on the
consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means, with respect to any Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) pledges or deposits by such Person under worker&#146;s compensation laws, unemployment insurance laws or similar legislation, or good
faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person or deposits of cash or United
States government bonds to secure surety or appeal bonds to which such Person is a party, performance bonds or obligations of a like nature or deposits as security for contested taxes or import duties or for the payment of rent, in each case
Incurred in the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Liens imposed by law, such as carriers&#146;, warehousemen&#146;s and mechanics&#146;
Liens, in each case for sums not yet due or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which such Person shall then be proceeding with an appeal or
other proceedings for review and Liens arising solely by virtue of any statutory or common law provision relating to banker&#146;s Liens, rights of <FONT STYLE="white-space:nowrap">set-off</FONT> or similar rights and remedies as to deposit accounts
or other funds maintained with a creditor depository institution; <U>provided</U>, <U>however</U>, that (A)&nbsp;such deposit account is not a dedicated cash collateral account and is not subject to restrictions against access by the Company in
excess of those set forth by regulations promulgated by the Federal Reserve Board and (B)&nbsp;such deposit account is not intended by the Company or any Restricted Subsidiary to provide collateral to the depository institution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Liens for taxes, assessments or other governmental charges or claims, in each case not yet subject to penalties for <FONT
STYLE="white-space:nowrap">non-payment</FONT> or which are being contested in good faith by appropriate proceedings; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Liens in favor
of issuers of surety bonds or letters of credit issued pursuant to the request of and for the account of such Person in the ordinary course of its business; <U>provided</U>, <U>however</U>, that such letters of credit do not constitute Indebtedness;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) minor survey exceptions, minor encumbrances, easements or reservations of, or rights of others for, licenses, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real property or Liens
incidental to the conduct of the business of such Person or to the ownership of its properties which were not Incurred in connection with Indebtedness and which do not in the aggregate materially adversely affect the value of said properties or
materially impair their use in the operation of the business of such Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) Liens securing Indebtedness Incurred to finance the
construction, purchase or lease of, or repairs, improvements or additions to, property, plant or equipment of such Person; <U>provided</U>, <U>however</U>, that the Lien may not extend to any other property owned by such Person or any of its
Restricted Subsidiaries at the time the Lien is Incurred (other than assets and property affixed or appurtenant thereto), and the Indebtedness (other than any interest thereon) secured by the Lien may not be Incurred more than 180 days after the
later of the acquisition, completion of construction, repair, improvement, addition or commencement of full operation of the property subject to the Lien; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) Liens to secure Indebtedness permitted pursuant to Section&nbsp;6.03(b)(1);<I> </I><U>provided</U><I>, </I><U>however</U><I>, </I>that if
(x)&nbsp;on the date the secured Indebtedness is Incurred, and after giving pro forma effect to the Incurrence thereof, the Incurrence of such Indebtedness would result in the Consolidated Secured Debt Ratio exceeding 3.75 to 1.0, as determined
based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45&nbsp;days prior thereto, then (y)&nbsp;the total amount of Indebtedness that may be secured pursuant to this clause
(7)&nbsp;shall not exceed the greater of (i)&nbsp;the maximum amount of Indebtedness that could be Incurred on such date without such ratio being so exceeded and (ii)&nbsp;an amount equal to the maximum amount of Indebtedness that could then be
incurred pursuant to Section&nbsp;6.03(b)(1), less the amount of Indebtedness secured by Liens Incurred pursuant to clause (18)&nbsp;below and outstanding on such date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) Liens existing on the Issue Date (other than Liens referred to in the foregoing clause (7)); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) Liens on property or shares of Capital Stock of another Person at the time such other
Person becomes a Subsidiary of such Person; <U>provided</U>, <U>however</U>, that the Liens may not extend to any other property owned by such Person or any of its Restricted Subsidiaries (other than assets and property affixed or appurtenant
thereto); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) Liens on property at the time such Person or any of its Subsidiaries acquires the property, including any acquisition by
means of a merger or consolidation with or into such Person or a Subsidiary of such Person; <U>provided</U>, <U>however</U>, that the Liens may not extend to any other property owned by such Person or any of its Restricted Subsidiaries (other than
assets and property affixed or appurtenant thereto); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) Liens securing Indebtedness or other obligations of a Subsidiary of such Person
owing to such Person or a Wholly Owned Subsidiary of such Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) Liens securing Hedging Obligations so long as such Hedging
Obligations are permitted to be Incurred under this Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) any Lien on accounts receivable and related assets of the types
specified in the definition of &#147;<U>Qualified Receivables Transaction</U>&#148; incurred in connection with a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) Liens in favor of the Company or the Subsidiary Guarantors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) leases, subleases, licenses or sublicenses granted to third parties entered into in the ordinary course of business which do not
materially interfere with the conduct of the business of the Company and the Restricted Subsidiaries and which do not secure any Indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) Liens securing judgments, decrees, orders or awards for the payment of money not constituting an Event of Default in respect of which the
Company shall in good faith be prosecuting an appeal or proceedings for review, which appeal or proceedings shall not have been finally terminated, or in respect of which the period within which such appeal or proceedings may be initiated shall not
have expired; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) Liens to secure any Refinancing (or successive Refinancings) as a whole, or in part, of any Indebtedness secured by
any Lien referred to in the foregoing clause (6), (8), (9) or (10); <U>provided</U>, <U>however</U>, that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) such new
Lien shall be limited to all or part of the same property and assets that secured or, under the written agreements pursuant to which the original Lien arose, could secure the original Indebtedness (plus improvements and accessions to, such property
or proceeds or distributions thereof); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the Indebtedness secured by such Lien at such time is not increased to any
amount greater than the sum of (i)&nbsp;the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clause (6), (8), (9) or (10)&nbsp;at the time the original Lien became a Permitted Lien and (ii)&nbsp;an
amount necessary to pay any fees and expenses, including premiums, related to such refinancing, refunding, extension, renewal or replacement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18) other Liens securing Indebtedness (other than Subordinated Obligations) to the extent the Incurrence of such Indebtedness, when taken
together with all other Indebtedness secured by Liens Incurred pursuant to this clause (18)&nbsp;and outstanding on the date such other Lien is Incurred, and after giving pro forma effect to the Incurrence of such Indebtedness, would not result in
the Consolidated Secured Debt Ratio exceeding 3.75 to 1.0, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45&nbsp;days prior thereto; <U>provided</U><I>,
</I><U>however</U>, notwithstanding whether this clause (18)&nbsp;would then be available to secure Indebtedness, any Lien securing Indebtedness originally secured pursuant to this clause (18)&nbsp;may secure Refinancing Indebtedness in respect of
such Indebtedness, as long as such Lien does not extend to any property other than all or part of the same property and assets that secured or, under the written agreements pursuant to which such original Lien arose, could have secured the original
Indebtedness (plus improvements and accessions to, such property or proceeds or distributions thereof), and such Refinancing Indebtedness shall be deemed to have been secured pursuant to this clause (18); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) other Liens securing Indebtedness; provided that the aggregate principal amount of
Indebtedness secured by such Liens shall not exceed the greater of (A) $100,000,000 and (B) 3.0% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter
ending at least 45 days prior thereto (as of the date of granting such Liens and after giving pro forma effect to the Incurrence of such Indebtedness and the application of the net proceeds thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, &#147;Permitted Liens&#148; will not include any Lien described in clause (6), (9) or (10)&nbsp;above to the
extent such Lien applies to any Additional Assets acquired directly or indirectly from Net Available Cash pursuant to Section&nbsp;6.06. For purposes of this definition, the term &#147;Indebtedness&#148; shall be deemed to include interest on such
Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, corporation, partnership, limited liability company, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>principal</U>&#148; of a Security means the principal of the Security plus the premium, if any, payable on the Security which is due
or overdue or is to become due at the relevant time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pro Forma Cost Savings</U>&#148; means, with respect to any period, the
reduction in costs that were: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) directly attributable to an asset acquisition and calculated on a basis that is consistent with
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act in effect and applied as of the Issue Date, or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)
implemented by the business that was the subject of any such asset acquisition within the six months prior to or following the date of the asset acquisition and that are supportable and quantifiable by the underlying accounting records of such
business, as if, in the case of each of clause (1)&nbsp;and (2), all such reductions in costs had been effected as of the beginning of such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prospectus Supplement</U>&#148; means the Prospectus Supplement dated September&nbsp;9, 2019, and used in connection with the
offering of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Money Indebtedness</U>&#148; means Indebtedness (1)&nbsp;consisting of the deferred
purchase price of property, conditional sale obligations, obligations under any title retention agreement, other purchase money obligations and obligations in respect of industrial revenue bonds or similar Indebtedness, in each case where the
maturity of such Indebtedness does not exceed the anticipated useful life of the asset being financed, and (2)&nbsp;Incurred to finance the acquisition by the Company or a Restricted Subsidiary of such asset, including additions and improvements, in
the ordinary course of business, <U>provided</U>, <U>however</U>, that any Lien arising in connection with any such Indebtedness shall be limited to the specific asset being financed or, in the case of real property or fixtures, including additions
and improvements, the real property on which such asset is attached; <U>provided</U>, <U>further</U>, <U>however</U>, that such Indebtedness is Incurred within 180 days after such acquisition of such assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Qualified Receivables Transaction</U>&#148; means any transaction or series of transactions that may be entered into by the Company
or any of its Restricted Subsidiaries pursuant to which the Company or any of its Restricted Subsidiaries may sell, convey or otherwise transfer to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) a Receivables Entity (in the case of a transfer by the Company or any of its Restricted Subsidiaries) or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any other Person (in the case of a transfer by a Receivables Entity), </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or may grant a security interest in, any accounts receivable (whether now existing or arising in the future)
of the Company or any of its Restricted Subsidiaries, and any assets related thereto, including all collateral securing such accounts receivable, all contracts and all Guarantees or other obligations in respect of such accounts receivable, proceeds
of such accounts receivable and other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable; <U>provided</U>,
<U>however</U>, that the financing terms, covenants, termination events and other provisions thereof shall be market terms (as determined in good faith by the chief financial officer of the Company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant of a security interest in any accounts receivable of the Company or any of its Restricted Subsidiaries to secure Indebtedness
permitted pursuant to Section&nbsp;6.03(b)(1) shall not be deemed a Qualified Receivables Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Quotation Agent</U>&#148;
means the Reference Treasury Dealer selected by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Receivables Entity</U>&#148; means (a)&nbsp;a Wholly Owned
Subsidiary of the Company that is designated by the Board of Directors (as provided below) as a Receivables Entity or (b)&nbsp;another Person engaging in a Qualified Receivables Transaction with the Company, which Person engages in the business of
the financing of accounts receivable, and in either of clause (a)&nbsp;or (b): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) no portion of the Indebtedness or any other
obligations (contingent or otherwise) of such entity </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) is Guaranteed by the Company or any Subsidiary of the Company
(excluding Guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to Standard Securitization Undertakings), </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) is recourse to or obligates the Company or any Subsidiary of the Company in any way (other than pursuant to Standard
Securitization Undertakings), or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) subjects any property or asset of the Company or any Subsidiary of the Company,
directly or indirectly, contingently or otherwise, to the satisfaction thereof (other than pursuant to Standard Securitization Undertakings); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the entity is not an Affiliate of the Company or is an entity with which neither the Company nor any Subsidiary of the Company has any
material contract, agreement, arrangement or understanding other than on terms that the Company reasonably believes to be no less favorable to the Company or such Subsidiary than those that might be obtained at the time from Persons that are not
Affiliates of the Company; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) is an entity to which neither the Company nor any Subsidiary of the Company has any obligation to
maintain or preserve such entity&#146;s financial condition or cause such entity to achieve certain levels of operating results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such
designation by the Board of Directors shall be evidenced to the Trustee by filing with the Trustee a certified copy of the resolution of the Board of Directors giving effect to such designation and an Officers&#146; Certificate certifying that such
designation complied with the foregoing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer</U>&#148; means Citigroup Global Markets Inc. and
its successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer Quotations</U>&#148; means, with respect to each Reference Treasury Dealer
and any redemption date, the average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, quoted in writing to the Company by such Reference
Treasury Dealer at 5:00 p.m., New York City time, on the third Business Day immediately preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinance</U>&#148; means, in respect of any Indebtedness, to refinance, extend, renew, refund, repay, prepay, purchase, redeem,
defease or retire, or to issue other Indebtedness in exchange or replacement for, such Indebtedness. &#147;Refinanced&#148; and &#147;Refinancing&#148; shall have correlative meanings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinancing Indebtedness</U>&#148; means Indebtedness that Refinances any
Indebtedness of the Company or any Restricted Subsidiary existing on the Issue Date or Incurred in compliance with this Indenture, including Indebtedness that Refinances Refinancing Indebtedness; <U>provided</U>, <U>however</U>, that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) such Refinancing Indebtedness has a Stated Maturity no earlier than the Stated Maturity of the Indebtedness being Refinanced; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) such Refinancing Indebtedness has an Average Life at the time such Refinancing Indebtedness is Incurred that is equal to or greater than
the Average Life of the Indebtedness being Refinanced; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) such Refinancing Indebtedness has an aggregate principal amount (or if
Incurred with original issue discount, an aggregate issue price) that is equal to or less than the aggregate principal amount (or if Incurred with original issue discount, the aggregate accreted value) then outstanding (plus fees and expenses,
including any premium and defeasance costs) under the Indebtedness being Refinanced; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) if the Indebtedness being Refinanced is
subordinated in right of payment to the Securities, such Refinancing Indebtedness is subordinated in right of payment to the Securities at least to the same extent as the Indebtedness being Refinanced; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>further</U>, <U>however</U>, that Refinancing Indebtedness shall not include (A)&nbsp;Indebtedness of a Subsidiary that is not a
Subsidiary Guarantor that Refinances Indebtedness of the Company or a Subsidiary Guarantor or (B)&nbsp;Indebtedness of the Company or a Restricted Subsidiary that Refinances Indebtedness of an Unrestricted Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinancing Transactions</U>&#148; means (i)&nbsp;the initial offering of the Securities and the use of the proceeds thereof to
Refinance Indebtedness outstanding under the Credit Agreement and (ii)&nbsp;the partial redemption of the Company&#146;s 5.75% Senior Notes due 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Related Business</U>&#148; means any business in which the Company or any of the Restricted Subsidiaries was engaged on the Issue
Date and any business related, ancillary or complementary to such business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Responsible Officer</U>&#148; means any officer
within the Corporate Trust Office of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers who at the time shall
have direct responsibility for the administration of the Indenture and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of such person&#146;s knowledge of and familiarity with
the particular subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Cash and Cash Equivalents</U>&#148; means, as of any date, (a)&nbsp;the cash and cash
equivalents held by any Captive Insurance Subsidiary and committed to third-party administrators for payment of the Company&#146;s insurance claims, (b)&nbsp;the cash and cash equivalents held by Syndicated Persons to the extent that such cash and
cash equivalents are required by the owners of such Syndicated Persons to be held in separate accounts and not otherwise commingled with the assets of the Company, (c)&nbsp;the cash and cash equivalents held by any Restricted Subsidiary to the
extent that, and for so long as, such cash and cash equivalents may not be distributed to the owner or owners of the equity interests in such Restricted Subsidiary under the terms of such Restricted Subsidiary&#146;s charter or any agreement,
instrument, judgment, decree, order, statute, rule or governmental regulation applicable to such Restricted Subsidiary, and (d)&nbsp;the cash collateral deposited by the Company pursuant to Section&nbsp;2.05(c) or Section&nbsp;2.05(l) of the Credit
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Payment</U>&#148; with respect to any Person means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the declaration or payment of any dividends or any other distributions of any sort in respect of its Capital Stock (including any payment
in connection with any merger or consolidation involving such Person) or similar payment to the direct or indirect holders of its Capital Stock (other than (A)&nbsp;dividends or distributions payable solely in its Capital Stock (other than
Disqualified Stock), (B) dividends or distributions payable solely to the Company or a Restricted Subsidiary and (C)&nbsp;pro rata dividends or other distributions made by a Subsidiary that is not a Wholly Owned Subsidiary to minority stockholders
(or owners of an equivalent interest in the case of a Subsidiary that is an entity other than a corporation)); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the purchase, repurchase, redemption, defeasance or other acquisition or retirement for
value of any Capital Stock of the Company held by any Person (other than by a Restricted Subsidiary) or of any Capital Stock of a Restricted Subsidiary held by any Affiliate of the Company (other than by a Restricted Subsidiary), including in
connection with any merger or consolidation); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the purchase, repurchase, redemption, defeasance or other acquisition or retirement for
value, prior to scheduled maturity, scheduled repayment or scheduled sinking fund payment of any Subordinated Obligations of the Company or any Subsidiary Guarantor (other than (A)&nbsp;from the Company or a Restricted Subsidiary or (B)&nbsp;the
purchase, repurchase, redemption, defeasance or other acquisition or retirement of Subordinated Obligations purchased in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year
of the date of such purchase, repurchase, redemption, defeasance or other acquisition or retirement); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the making of any Investment
(other than a Permitted Investment) in any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Subsidiary</U>&#148; means any Subsidiary of the Company that is
not an Unrestricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sale/Leaseback Transaction</U>&#148; means an arrangement relating to property owned by the
Company or a Restricted Subsidiary on the Issue Date or thereafter acquired by the Company or a Restricted Subsidiary whereby the Company or a Restricted Subsidiary transfers such property to a Person and the Company or a Restricted Subsidiary
leases it from such Person, other than leases between the Company and a Restricted Subsidiary or between Restricted Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Senior Indebtedness</U>&#148; means with respect to any Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Indebtedness of such Person, whether outstanding on the Issue Date or thereafter Incurred; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all other Obligations of such Person (including interest accruing on or after the filing of any petition in bankruptcy or for
reorganization relating to such Person whether or not post-filing interest is allowed in such proceeding) in respect of Indebtedness described in clause (1)&nbsp;above </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">unless, in the case of clauses (1)&nbsp;and (2), in the instrument creating or evidencing the same or pursuant to which the same is outstanding, it is
provided that such Indebtedness or other obligations are subordinate in right of payment to the Securities or the Subsidiary Guarantee of such Person, as the case may be; <U>provided</U>, <U>however</U>, that Senior Indebtedness shall not include:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) any obligation of such Person to the Company or any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any liability for federal, state, local or other taxes owed or owing by such Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) any accounts payable or other liability to trade creditors arising in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) any Indebtedness or other Obligation of such Person which is subordinate or junior in any respect to any other Indebtedness
or other Obligation of such Person; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) that portion of any Indebtedness which at the time of Incurrence is Incurred in
violation of this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shareholder Litigation</U>&#148; means the federal securities class actions and the derivative
actions brought against the Company and/or certain of its former directors and officers and certain other parties in the United States District Court for the Northern District of Alabama and the Circuit Court in Jefferson County, Alabama relating to
financial reporting and related activity that occurred at the Company during periods ended in March 2003. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Significant Subsidiary</U>&#148; means any Restricted Subsidiary that would be a
&#147;Significant Subsidiary&#148; of the Company within the meaning of Rule <FONT STYLE="white-space:nowrap">1-02</FONT> under Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard</U><U></U><U>&nbsp;&amp; Poor&#146;s</U>&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings Services, a Standard&nbsp;&amp;
Poor&#146;s Financial Services LLC business, or any successor rating agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard Securitization Undertakings</U>&#148;
means representations, warranties, covenants and indemnities entered into by the Company or any Subsidiary of the Company that, taken as a whole, are customary in an accounts receivable transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stated Maturity</U>&#148; means, with respect to any security, the date specified in such security as the fixed date on which the
final payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision (but excluding any provision providing for the repurchase of such security at the option of the holder thereof upon the
happening of any contingency unless such contingency has occurred). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subordinated Obligation</U>&#148; means, with respect to a
Person, any Indebtedness of such Person (whether outstanding on the Issue Date or thereafter Incurred) which is subordinate or junior in right of payment to the Securities or a Subsidiary Guarantee of such Person, as the case may be, pursuant to a
written agreement to that effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary Guarantee</U>&#148; means a Guarantee by a Subsidiary Guarantor of the
Company&#146;s obligations with respect to the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary Guarantor</U>&#148; means each Subsidiary of the Company
that executes this Indenture as a guarantor on the Issue Date and each other Subsidiary of the Company that thereafter guarantees the Securities pursuant to the terms of this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Syndicated Person</U>&#148; means a Person the equity interests of which constitute Syndicated Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Syndication</U>&#148; means the sale of partnership or other equity interests (&#147;<U>Syndicated Interests</U>&#148;) in
Subsidiaries of the Company or other Persons controlled by the Company that own or operate health care facilities to (i)&nbsp;participating physicians, radiologists and other specialists, (ii)&nbsp;professional corporations and other legal entities
owned or controlled by such participating physicians, radiologists and other specialists and (iii)&nbsp;participating hospitals and other health care providers. For purposes of this definition, &#147;controlled&#148; shall have the meaning set forth
in the definition of &#147;Affiliate.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Temporary Cash Investments</U>&#148; means any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any investment in direct obligations of the United States of America or any agency thereof or obligations guaranteed by the United States
of America or any agency thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) investments in demand and time deposit accounts, certificates of deposit and money market deposits
maturing within 180 days of the date of acquisition thereof issued by a bank or trust company which is organized under the laws of the United States of America, any State thereof or any foreign country recognized by the United States of America, and
which bank or trust company has capital, surplus and undivided profits aggregating in excess of $250,000,000 (or the foreign currency equivalent thereof) or any money-market fund sponsored by a registered broker dealer or mutual fund distributor;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) repurchase obligations with a term of not more than 30 days for underlying securities of the types described in clause (1)&nbsp;above
entered into with a bank meeting the qualifications described in clause (2)&nbsp;above; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) investments in commercial paper, maturing not more than 270 days after the date of
acquisition, issued by a corporation (other than an Affiliate of the Company) organized and in existence under the laws of the United States of America or any foreign country recognized by the United States of America with a rating at the time as of
which any investment therein is made of <FONT STYLE="white-space:nowrap">&#147;P-1&#148;</FONT> (or higher) according to Moody&#146;s or <FONT STYLE="white-space:nowrap">&#147;A-1&#148;</FONT> (or higher) according to Standard and Poor&#146;s; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) investments in securities issued or fully guaranteed by any state, commonwealth or territory of the United States of America, or by any
political subdivision or taxing authority thereof, and rated at least &#147;A&#148; by Standard&nbsp;&amp; Poor&#146;s or &#147;A2&#148; by Moody&#146;s; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) eligible banker&#146;s acceptances, repurchase agreements and <FONT STYLE="white-space:nowrap">tax-exempt</FONT> municipal bonds having a
maturity of less than one year, in each case having a rating of, or evidencing the full recourse obligation of a person whose senior debt is rated, at least &#147;A&#148; by Standard&nbsp;&amp; Poor&#146;s and at least &#147;A2&#148; by
Moody&#146;s; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) investments in money market funds that invest substantially all their assets in securities of the types described
in clauses (1)&nbsp;through (6) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Uniform Commercial Code</U>&#148; means the New York Uniform Commercial Code as in effect
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Unrestricted Subsidiary</U>&#148; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any Subsidiary of the Company that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors
in the manner provided below; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any Subsidiary of an Unrestricted Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors may designate any Subsidiary of the Company (including any newly acquired or newly formed Subsidiary) to be an
Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Capital Stock or Indebtedness of, or holds any Lien on any property of, the Company or any other Subsidiary of the Company that is not a Subsidiary of the Subsidiary
to be so designated; <U>provided</U>, <U>however</U>, that either (A)&nbsp;the Subsidiary to be so designated has total assets of $1,000 or less or (B)&nbsp;if such Subsidiary has assets greater than $1,000, such designation would be permitted under
Section&nbsp;6.04. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; <U>provided</U>,
<U>however</U>, that immediately after giving effect to such designation (A)&nbsp;the Company could Incur $1.00 of additional Indebtedness under Section&nbsp;6.03(a) and (B)&nbsp;no Default shall have occurred and be continuing. Any such designation
by the Board of Directors shall be evidenced to the Trustee by promptly filing with the Trustee a copy of the resolution of the Board of Directors giving effect to such designation and an Officers&#146; Certificate certifying that such designation
complied with the foregoing provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Voting Stock</U>&#148; of a Person means all classes of Capital Stock of such Person
then outstanding and normally entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Wholly Owned Subsidiary</U>&#148; means a Restricted Subsidiary all the Capital Stock of which (other than directors&#146; qualifying
shares) is owned by the Company or one or more other Wholly Owned Subsidiaries. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
3.01. <U>Form</U>. Provisions relating to the Securities are set forth in Exhibit A hereto, which is hereby incorporated in and expressly made a part of this Supplemental Indenture. The Securities and the Trustee&#146;s certificate of authentication
thereto shall be substantially in the form of Exhibit A, which is hereby incorporated in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and expressly made a part of this Supplemental Indenture. The Securities may have notations, legends or endorsements required by law, stock exchange rule, agreements to which the Company is
subject, if any, or usage (<U>provided</U> that any such notation, legend or endorsement is in a form acceptable to the Company). Each Security shall be dated the date of its authentication. The Securities shall be issuable only in registered form
without interest coupons and only in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The terms of the Securities set forth in Exhibit A are part of the terms of this Supplemental Indenture. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT
OF BASE INDENTURE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.01. <U>Amendment of Article I of Base Indenture</U>. Section&nbsp;1.01 of the Base Indenture is hereby
amended, but only with respect to the Securities, by the deletion of the definitions of the following terms: &#147;Affiliate,&#148; &#147;Business Day,&#148; &#147;Code,&#148; &#147;Corporate Trust Office,&#148; &#147;Indebtedness,&#148;
&#147;Interest Payment Date,&#148; &#147;Mandatory Sinking Fund Payment,&#148; &#147;Officer&#146;s Certificate,&#148; &#147;Opinion of Counsel,&#148; &#147;Optional Sinking Fund Payment,&#148; &#147;Person,&#148; &#147;Responsible Officer,&#148;
&#147;Senior Indebtedness&#148; and &#147;Stated Maturity&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.02. <U>Amendment of Article III of Base Indenture</U>. Article
III of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new Section&nbsp;3.14 at the end thereof: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 3.14. <U>Issuance of Additional Securities</U>. After the Issue Date, the Company shall be entitled, subject to its compliance
with Section&nbsp;6.03, to issue Additional Securities under this Indenture, which Securities shall have identical terms as the Securities issued on the Issue Date, other than with respect to the date of issuance and issue price and first payment of
interest. All the Securities issued under this Indenture shall be treated as a single class for all purposes of this Indenture, including waivers, amendments, redemptions and offers to purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to any Additional Securities, the Company shall set forth in a resolution of the Board of Directors and an Officers&#146;
Certificate, a copy of each of which shall be delivered to the Trustee, the following information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the aggregate
principal amount of such Additional Securities to be authenticated and delivered pursuant to this Indenture and the provision of Section&nbsp;6.03 that the Company is relying on to issue such Additional Securities; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the issue price, the issue date, the CUSIP number and the ISIN of such Additional Securities; <U>provided</U>,
<U>however</U>, that no Additional Securities may be issued at a price that would cause such Additional Securities to have &#147;original issue discount&#148; within the meaning of Section&nbsp;1273 of the Code.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.03. <U>Amendment of Article IV of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Section 4.02(a) of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the words &#147;the Trustee
shall select, by lot or in such other manner as the Trustee shall deem appropriate&#148;, and replacing such deleted words with &#147;if the Securities are Global Securities, the Securities to be redeemed will be selected by the Depositary in
accordance with applicable Depositary procedures, and if the Securities to be redeemed are not Global Securities, the Trustee shall select, on a <U>pro</U> <U>rata</U> basis to the extent practicable&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Section 4.05 of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the words &#147;have a Stated
Maturity&#148; and replacing such deleted words with &#147;become due and payable&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.04. <U>Amendment of Article V of Base Indenture</U>. Article V of the Base
Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;ARTICLE V
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SUCCESSOR COMPANY </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION
5.01. <U>When Company May Merge or Transfer Assets</U>. The Company shall not consolidate with or merge with or into, or convey, transfer or lease, in one transaction or a series of transactions, directly or indirectly, all or substantially all its
assets to, any Person, unless: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the resulting, surviving or transferee Person (the &#147;<U>Successor
Company</U>&#148;) shall be a Person organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and the Successor Company (if not the Company) shall expressly assume, by a supplemental
indenture hereto, executed and delivered to the Trustee, in form satisfactory to the Trustee, all the obligations of the Company under the Securities and this Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) immediately after giving pro forma effect to such transaction (and treating any Indebtedness which becomes an obligation of
the Successor Company or any Subsidiary thereof as a result of such transaction as having been Incurred by the Successor Company or such Subsidiary at the time of such transaction), no Default shall have occurred and be continuing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) immediately after giving pro forma effect to such transaction, (A)&nbsp;the Successor Company would be able to Incur an
additional $1.00 of Indebtedness pursuant to Section&nbsp;6.03(a) or (B)&nbsp;the Consolidated Coverage Ratio for the Successor Company would be equal to or greater than such ratio for the Company and its Restricted Subsidiaries immediately prior to
such transaction; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the Company shall have delivered to the Trustee an Officers&#146; Certificate and an Opinion of
Counsel, each stating that such consolidation, merger or transfer and such supplemental indenture (if any) comply with this Indenture, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that clause (3)&nbsp;shall not be applicable to (A)&nbsp;a Restricted Subsidiary consolidating with, merging
into or transferring all or part of its properties and assets to the Company (so long as no Capital Stock of the Company is distributed to any Person) or (B)&nbsp;the Company merging with an Affiliate of the Company solely for the purpose and with
the sole effect of reincorporating the Company in another jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;5.01, the sale, lease,
conveyance, assignment, transfer or other disposition of all or substantially all of the properties and assets of one or more Subsidiaries of the Company, which properties and assets, if held by the Company instead of such Subsidiaries, would
constitute all or substantially all of the properties and assets of the Company on a consolidated basis, shall be deemed to be the transfer of all or substantially all of the properties and assets of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">The Successor Company shall be the successor to the Company and shall succeed to, and be substituted for, and may exercise every right and
power of, the Company under this Indenture, and the predecessor Company, except in the case of a lease, shall be released from the obligation to pay the principal of and interest on the Securities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.05. <U>Amendment of Article VI of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Article VI of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new Sections
6.02, 6.03, 6.04, 6.05, 6.06, 6.07, 6.08, 6.09, 6.10 and 6.11: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 6.02. <U>SEC Reports</U>. Whether or not the Company is
subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, the Company shall file with the SEC (subject to the next sentence), and provide the Trustee and Holders with, such annual and other reports as are specified in
Sections 13 and 15(d) of the Exchange Act and applicable to a U.S. corporation subject to such Sections, such reports to be so filed and provided at the times specified for the filings of such reports under such Sections and containing all the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information, audit reports and exhibits required for such reports. If, at any time, the Company is not subject to the periodic reporting requirements of the Exchange Act for any reason, the
Company shall nevertheless continue filing the reports specified in the preceding sentence with the SEC within the time periods required unless the SEC will not accept such a filing. Delivery of such reports, information and documents to the Trustee
is for informational purposes only and the Trustee&#146;s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#146;s compliance with
any of its covenants hereunder (as to which the Trustee is entitled to rely on Officer&#146;s Certificates). The Company agrees that it shall not take any action for the purpose of causing the SEC not to accept such filings. If, notwithstanding the
foregoing, the SEC will not accept such filings for any reason, the Company shall post the reports specified in the preceding sentence on its website within the time periods that would apply if the Company were required to file such reports with the
SEC. At any time that any of the Company&#146;s Subsidiaries are Unrestricted Subsidiaries, then the quarterly and annual financial information in the reports required by this paragraph shall include a reasonably detailed presentation, either on the
face of the financial statements or in the footnotes thereto, of the financial condition and results of operations of the Company and its Restricted Subsidiaries separate from the financial condition and results of operations of the Unrestricted
Subsidiaries of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">The Company also shall comply with the other provisions of Section&nbsp;314(a) of the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.03. <U>Limitation on Indebtedness</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary to, Incur,
directly or indirectly, any Indebtedness; <U>provided</U>, <U>however</U>, that the Company and the Subsidiary Guarantors shall be entitled to Incur Indebtedness if, on the date of such Incurrence and after giving effect thereto on a pro forma basis
the Consolidated Coverage Ratio exceeds 2.0 to 1.0. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing paragraph (a), the Company and the Restricted
Subsidiaries shall be entitled to Incur any or all of the following Indebtedness: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Indebtedness Incurred pursuant to
the Credit Agreement; <U>provided</U>, <U>however</U>, that, immediately after giving effect to any such Incurrence, the aggregate principal amount of all Indebtedness Incurred under this clause (1)&nbsp;and then outstanding does not exceed
$1,551,000,000 less the sum of all principal payments with respect to such Indebtedness made pursuant to Section&nbsp;6.06(a)(3)(A) and in satisfaction of Section&nbsp;6.06; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Indebtedness owed to and held by the Company or a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that (A)&nbsp;any
subsequent issuance or transfer of any Capital Stock that results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any subsequent transfer of such Indebtedness (other than to the Company or a Restricted Subsidiary) shall be
deemed, in each case, to constitute the Incurrence of such Indebtedness by the obligor thereon, (B)&nbsp;if the Company is the obligor on such Indebtedness, such Indebtedness is expressly subordinated to the prior payment in full in cash of all
obligations with respect to the Securities, and (C)&nbsp;if a Subsidiary Guarantor is the obligor on such Indebtedness, such Indebtedness is expressly subordinated to the prior payment in full in cash of all obligations of such Subsidiary Guarantor
with respect to its Subsidiary Guarantee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Securities (excluding any Additional Securities); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Indebtedness outstanding on the Issue Date (other than Indebtedness described in clause (1), (2) or (3)&nbsp;of this
Section&nbsp;6.03(b)); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) Indebtedness of a Restricted Subsidiary Incurred and outstanding on or prior to the date on
which such Subsidiary was acquired by the Company (other than Indebtedness Incurred in connection with, or to provide all or any portion of the funds or credit support utilized to consummate, the transaction or series of related transactions
pursuant to which such Subsidiary became a Subsidiary or was acquired by the Company); <U>provided</U>, <U>however</U>, that on the date of such acquisition and after giving pro forma effect thereto, the Company would have been entitled to Incur at
least $1.00 of additional Indebtedness pursuant to Section&nbsp;6.03(a); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) Refinancing Indebtedness in respect of Indebtedness Incurred pursuant to
Section&nbsp;6.03(a) or pursuant to clause (3), (4) or (5)&nbsp;or this clause (6)&nbsp;of this Section&nbsp;6.03(b); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)
Hedging Obligations directly related to Indebtedness permitted to be Incurred by the Company and its Restricted Subsidiaries pursuant to this Indenture or entered into in the ordinary course of business and not for speculative purposes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) obligations in respect of performance, bid and surety bonds and completion guarantees provided by the Company or any
Restricted Subsidiary in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) Indebtedness arising from the honoring by a bank or other
financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business; <U>provided</U>, <U>however</U>, that such Indebtedness is extinguished within three Business Days of its Incurrence;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) Indebtedness consisting of the Subsidiary Guarantee of a Subsidiary Guarantor and any Guarantee by the Company or a
Subsidiary Guarantor of Indebtedness or other obligations of the Company or any Restricted Subsidiary (other than Indebtedness Incurred pursuant to clause (5)&nbsp;of this Section&nbsp;6.03(b)) so long as the Incurrence of such Indebtedness or other
obligations by the Company or such Restricted Subsidiary is permitted under the terms of this Indenture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) (A) Purchase
Money Indebtedness, (B)&nbsp;Finance Lease Obligations and (C)&nbsp;Attributable Debt, and Refinancing Indebtedness in respect thereof, in an aggregate principal amount on the date of Incurrence that, when added to all other Indebtedness Incurred
pursuant to this clause (11)&nbsp;and then outstanding, does not exceed 15% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days
prior thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) Indebtedness Incurred by a Receivables Entity in a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) Preferred Stock issued by any Restricted Subsidiary formed to operate a single health care facility; <U>provided</U> that
the amount of such Preferred Stock, when added to the aggregate amount of all other such Preferred Stock of Restricted Subsidiaries then outstanding, does not exceed 1% of Consolidated Tangible Assets, as determined based on the consolidated balance
sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)
Indebtedness of the Company or of any of its Restricted Subsidiaries in an aggregate principal amount that, when taken together with all other Indebtedness of the Company and its Restricted Subsidiaries outstanding on the date of such Incurrence
(other than Indebtedness permitted by clauses (1)&nbsp;through (13) of this Section&nbsp;6.03(b) or by Section&nbsp;6.03(a)) does not exceed the greater of (A) $300,000,000 and (B) 7.5% of Consolidated Tangible Assets, as determined based on the
consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)
Notwithstanding the foregoing, neither the Company nor any Subsidiary Guarantor shall incur any Indebtedness pursuant to Section&nbsp;6.03(b) if the proceeds thereof are used, directly or indirectly, to Refinance any Subordinated Obligations of the
Company or any Subsidiary Guarantor unless such Indebtedness shall be subordinated to the Securities or the applicable Subsidiary Guarantee to at least the same extent as such Subordinated Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) For purposes of determining compliance with this Section&nbsp;6.03: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) all Indebtedness outstanding under the Credit Agreement on the Issue Date shall be treated as Incurred under clause (b)(1)
of this Section&nbsp;6.03; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) in the event that an item of Indebtedness (or any portion thereof) meets the criteria of
more than one of the types of Indebtedness described above, the Company, in its sole discretion, shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
classify such item of Indebtedness (or any portion thereof) at the time of Incurrence and shall only be required to include the amount and type of such Indebtedness in one of the above clauses
(<U>provided</U> that any Indebtedness originally classified as Incurred pursuant to any of clauses (b)(2) through (b)(14) of this Section&nbsp;6.03 may later be reclassified as having been Incurred pursuant to paragraph (a)&nbsp;or any other of
clauses (b)(2) through (b)(14) of this Section&nbsp;6.03 to the extent that such reclassified Indebtedness could be Incurred pursuant to paragraph (a)&nbsp;or one of clauses (b)(2) through (b)(14) of this Section&nbsp;6.03, as the case may be, if it
were Incurred at the time of such reclassification); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company shall be entitled to divide and classify an item
of Indebtedness in more than one of the types of Indebtedness described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.04. <U>Limitation on Restricted Payments</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Company shall not, and shall not permit any Restricted Subsidiary, directly or indirectly, to make a Restricted Payment if at the
time the Company or such Restricted Subsidiary makes such Restricted Payment: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) a Default shall have occurred and be
continuing (or would result therefrom); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Company is not entitled to Incur an additional $1.00 of Indebtedness
pursuant to Section&nbsp;6.03(a); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the aggregate amount of such Restricted Payment and all other Restricted Payments
since the Issue Date would exceed the sum of (without duplication): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) 50% of the Consolidated Net Income accrued during
the period (treated as one accounting period) from and including July&nbsp;1, 2006 to the end of the most recent fiscal quarter ending at least 45 days prior to the date of such Restricted Payment (or, in case such Consolidated Net Income shall be a
deficit, minus 100% of such deficit); <U>plus</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) 100% of the aggregate Net Cash Proceeds received by the Company from
the issuance or sale of its Capital Stock (other than Disqualified Stock) subsequent to the Issue Date (other than an issuance or sale to a Subsidiary of the Company and other than an issuance or sale to an employee stock ownership plan or to a
trust established by the Company or any of its Subsidiaries for the benefit of their employees) and 100% of any cash capital contribution received by the Company from its shareholders subsequent to the Issue Date; <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) the amount by which Indebtedness of the Company is reduced on the Company&#146;s balance sheet upon the conversion or
exchange subsequent to the Issue Date of any Indebtedness of the Company convertible or exchangeable for Capital Stock (other than Disqualified Stock) of the Company (less the amount of any cash, or the fair value of any other property, distributed
by the Company upon such conversion or exchange); <U>provided</U>, <U>however</U>, that the foregoing amount shall not exceed the Net Cash Proceeds received by the Company or any Restricted Subsidiary from the sale of such Indebtedness (excluding
Net Cash Proceeds from sales to a Subsidiary of the Company or to an employee stock ownership plan or to a trust established by the Company or any of its Subsidiaries for the benefit of their employees); <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) an amount equal to the net reduction in the Investments (other than Permitted Investments) made by the Company or any
Restricted Subsidiary in any Person resulting from repurchases, repayments or redemptions of such Investments by such Person, proceeds realized on the sale of such Investment and proceeds representing the return of capital (excluding dividends and
distributions), in each case received by the Company or any Restricted Subsidiary; <U>provided</U>, <U>however</U>, that the foregoing sum shall not exceed, in the case of any such Person, the amount of Investments (excluding Permitted Investments)
previously made (and treated as a Restricted Payment) by the Company or any Restricted Subsidiary in such Person; <U>plus</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) in the case of the redesignation of an Unrestricted Subsidiary as a
Restricted Subsidiary, the portion (proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of such Unrestricted Subsidiary at the time such Unrestricted Subsidiary is redesignated as a
Restricted Subsidiary, except to the extent that the Investment in such Unrestricted Subsidiary was made by the Company or a Restricted Subsidiary pursuant to Section&nbsp;6.04(b)(11) or to the extent that such Investment constituted a Permitted
Investment; <U>plus</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) $50,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The preceding provisions shall not prohibit: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any Restricted Payment made out of the Net Cash Proceeds of the substantially concurrent sale of, or made by exchange for,
Capital Stock of the Company (other than Disqualified Stock and other than Capital Stock issued or sold to a Subsidiary of the Company or an employee stock ownership plan or to a trust established by the Company or any of its Subsidiaries for the
benefit of their employees) or a substantially concurrent cash capital contribution received by the Company from its shareholders; <U>provided</U>, <U>however</U>, that (A)&nbsp;such Restricted Payment shall be excluded from the calculation of the
amount of Restricted Payments and (B)&nbsp;the Net Cash Proceeds from such sale or such cash capital contribution (to the extent so used for such Restricted Payment) shall be excluded from the calculation of amounts under Section&nbsp;6.04(a)(3)(B);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any purchase, repurchase, redemption, defeasance or other acquisition or retirement for value of Subordinated
Obligations of the Company or a Subsidiary Guarantor made by exchange for, or out of the proceeds of the substantially concurrent Incurrence of, Indebtedness of such Person that is permitted to be Incurred pursuant to Section&nbsp;6.03;
<U>provided</U>, <U>however</U>, that such purchase, repurchase, redemption, defeasance or other acquisition or retirement for value shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) dividends paid within 60 days after the date of declaration thereof if at such date of declaration such dividend would have
complied with this Section&nbsp;6.04; <U>provided</U>, <U>however</U>, that such dividend shall be included in the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) so long as no Default has occurred and is continuing, the purchase, redemption or other acquisition of shares of Capital
Stock of the Company or any of its Subsidiaries from employees, former employees, directors or former directors of the Company or any of its Subsidiaries (or permitted transferees of such employees, former employees, directors or former directors),
pursuant to the terms of the agreements (including employment agreements) or plans (or amendments thereto) approved or ratified by the Board of Directors under which such individuals purchase or sell or are granted the option to purchase or sell,
shares of such Capital Stock; <U>provided</U>, <U>however</U>, that the aggregate amount of such Restricted Payments (excluding amounts representing cancellation of Indebtedness) shall not exceed $10,000,000 in any calendar year (<U>provided</U>
that (A)&nbsp;if the Company and its Restricted Subsidiaries make less than $10,000,000 in the aggregate of such Restricted Payments in any calendar year, the unused amount for such calendar year may be carried over to the next succeeding calendar
year (but not any other calendar year thereafter) and (B)&nbsp;the amount payable in any calendar year may be increased by an amount up to the sum of (i)&nbsp;the amount of cash proceeds from the sale of Capital Stock (other than Disqualified Stock)
of the Company to employees, former employees, directors or former directors of the Company or any of its Subsidiaries, to the extent that the cash proceeds from the sale of such Capital Stock have not otherwise been applied to the payment of
Restricted Payments by virtue of Section&nbsp;6.04(a)(3)(B), plus (ii)&nbsp;the cash proceeds of key man life insurance policies received by the Company or its Restricted Subsidiaries after the Issue Date, less (iii)&nbsp;the amount of repurchases
and other acquisitions previously made with the cash proceeds described in clauses (i)&nbsp;and (ii) above); <U>provided</U> <U>further</U>, <U>however</U>, that (x)&nbsp;such repurchases and other acquisitions shall be excluded from the calculation
of the amount of Restricted Payments and (y)&nbsp;cash proceeds referred to in clause (B)(i) above used to make Restricted Payments under this Section&nbsp;6.04(b)(4) shall be excluded from the calculation of amounts under
Section&nbsp;6.04(a)(3)(B); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the declaration and payments of dividends on Disqualified Stock issued
pursuant to Section&nbsp;6.03; <U>provided</U>, <U>however</U>, in each case, that at the time of payment of such dividend, no Default shall have occurred and be continuing (or result therefrom); <U>provided</U> <U>further</U>, <U>however</U>, that
dividends referred to in this clause (5)&nbsp;shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) repurchases of Capital Stock deemed to occur upon exercise of stock options if such Capital Stock represents a portion of
the exercise price of such options; <U>provided</U>, <U>however</U>, that such Restricted Payments shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) cash payments in lieu of the issuance of fractional shares in connection with the exercise of warrants, options or other
securities convertible into or exchangeable for Capital Stock of the Company; <U>provided</U>, <U>however</U>, that any such cash payment shall not be for the purpose of evading the limitation of this Section&nbsp;6.04; <U>provided</U>
<U>further</U>, <U>however</U>, that such payments shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) in the event of a Change of Control, and if no Default shall have occurred and be continuing, the payment, purchase,
redemption, defeasance or other acquisition or retirement of Subordinated Obligations of the Company or any Subsidiary Guarantor, in each case, at a purchase price not greater than 101% of the principal amount of such Subordinated Obligations, plus
any accrued and unpaid interest thereon; <U>provided</U>, <U>however</U>, that prior to such payment, purchase, redemption, defeasance or other acquisition or retirement, the Company (or a third party to the extent permitted by this Indenture) has
made a Change of Control Offer with respect to the Securities as a result of such Change of Control and has repurchased all Securities validly tendered and not withdrawn in connection with such Change of Control Offer; <U>provided</U>
<U>further</U>, <U>however</U>, that such payments, purchases, redemptions, defeasances or other acquisitions or retirements shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) payments of intercompany subordinated Indebtedness, the Incurrence of which was permitted under Section&nbsp;6.03(b)(2);
<U>provided</U>, <U>however</U>, that no Default has occurred and is continuing or would otherwise result therefrom; <U>provided</U> <U>further</U>, <U>however</U>, that such payments shall be excluded from the calculation of the amount of
Restricted Payments; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) any Restricted Payment, so long as the Leverage Ratio is no more than 3.0 to 1.0, both as of the
date thereof and on a pro forma basis after giving effect to such Restricted Payment; <U>provided</U>, however, that (A)&nbsp;at the time of each such Restricted Payment, no Default shall have occurred and be continuing (or result therefrom) and
(B)&nbsp;such payments shall be excluded from the calculation of the amount of Restricted Payments; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) Restricted
Payments in an amount that, when taken together with all Restricted Payments made pursuant to this clause (11), does not exceed the greater of (A) $200,000,000 and (B) 5.0% of Consolidated Tangible Assets, as determined based on the consolidated
balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto; <U>provided</U>, <U>however</U>, that (I)&nbsp;at the time of each such Restricted Payment, no Default shall have occurred and be
continuing (or result therefrom) and (II)&nbsp;such payments shall be excluded from the calculation of the amount of Restricted Payments; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) any purchase or other acquisition or retirement for value of shares of Capital Stock of Encompass Health Home Health
Holdings, Inc. (f/k/a HealthSouth Home Health Holdings, Inc.) held by any Person other than the Company or any of its Subsidiaries on the Issue Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of any Restricted Payment that is not made in cash shall be determined in a manner consistent with the determination
of the amount of an Investment as set forth in the final sentence of the first paragraph of the definition of &#147;Investment&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.05. <U>Limitation on Restrictions on Distributions from Restricted
Subsidiaries</U>. The Company shall not, and shall not permit any Restricted Subsidiary to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or restriction on the ability of any Restricted Subsidiary to
(a)&nbsp;pay dividends or make any other distributions on its Capital Stock to the Company or a Restricted Subsidiary or pay any Indebtedness owed to the Company, (b)&nbsp;make any loans or advances to the Company or (c)&nbsp;transfer any of its
property or assets to the Company, except: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) with respect to clauses (a), (b) and (c), </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) any encumbrance or restriction pursuant to applicable law, rule, regulation or order or an agreement in effect at or
entered into on the Issue Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any encumbrance or restriction with respect to a Restricted Subsidiary pursuant to an
agreement relating to any Indebtedness Incurred by such Restricted Subsidiary on or prior to the date on which such Restricted Subsidiary was acquired by the Company (other than Indebtedness Incurred as consideration in, or to provide all or any
portion of the funds or credit support utilized to consummate, the transaction or series of related transactions pursuant to which such Restricted Subsidiary became a Restricted Subsidiary or was acquired by the Company) and outstanding on such
date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) any encumbrance or restriction pursuant to any amendment, modification, restatement, renewal, increase,
supplement, refunding, replacement or refinancing of an agreement referred to in clause (A)&nbsp;or (B) above; <U>provided</U>, <U>however</U>, that such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or
refinancing is no more restrictive, as reasonably determined by the Company, with respect to such encumbrances and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal, increase, supplement,
refunding, replacement or refinancing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) any encumbrance or restriction with respect to a Restricted Subsidiary imposed
pursuant to an agreement entered into for the sale or disposition of all or substantially all the Capital Stock or assets of such Restricted Subsidiary pending the closing of such sale or disposition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary
course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) any limitation or prohibition on the disposition or distribution of assets or property in joint
venture agreements, asset sale agreements, stock sale agreements and other similar agreements, which limitation or prohibition is applicable only to the assets that are the subject of such agreements; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) any encumbrance or restriction existing under or by reason of contractual requirements of a Receivables Entity in
connection with a Qualified Receivables Transaction provided that such restrictions apply only to such Receivables Entity; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) any encumbrance or restriction arising in the ordinary course of business, not relating to any Indebtedness, that does not,
individually or in the aggregate, materially detract from the value of the property or assets of the Company and its Restricted Subsidiaries, taken as whole, or adversely affect the Company&#146;s ability to make principal and interest payments on
the Securities, in each case, as determined in good faith by the Company; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) with respect to clause (c)&nbsp;only,
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) any encumbrance or restriction consisting of customary nonassignment provisions in leases governing leasehold
interests to the extent such provisions restrict the transfer of the lease or the property leased thereunder; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any encumbrance or restriction contained in Finance Lease Obligations,
any agreement governing Purchase Money Indebtedness, security agreements or mortgages securing Indebtedness of a Restricted Subsidiary to the extent such encumbrance or restriction restricts the transfer of the property subject to such Finance Lease
Obligations, Purchase Money Indebtedness, security agreements or mortgages. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.06. <U>Limitation on Sales of Assets and
Subsidiary Stock</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, consummate any Asset Disposition unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company or such Restricted Subsidiary receives consideration at the time of such Asset Disposition at least equal to
the Fair Market Value (including as to the value of all <FONT STYLE="white-space:nowrap">non-cash</FONT> consideration) of the shares and assets subject to such Asset Disposition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) at least 75% of the consideration thereof received by the Company or such Restricted Subsidiary is in the form of cash or
cash equivalents; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) an amount equal to 100% of the Net Available Cash from such Asset Disposition, other than any
Asset Disposition that constitutes a Syndication or a resyndication transaction in the ordinary course of business, is applied by the Company or such Restricted Subsidiary, as the case may be: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) to the extent the Company elects (or is required by the terms of any Indebtedness), to prepay, repay, redeem or purchase
Senior Indebtedness of the Company or a Subsidiary Guarantor or Indebtedness (other than any Disqualified Stock) of a Restricted Subsidiary that is not a Subsidiary Guarantor (in each case other than Indebtedness owed to the Company or an Affiliate
of the Company) within one year from the later of the date of such Asset Disposition or the receipt of such Net Available Cash; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) to the extent the Company elects (including with respect to the balance of such Net Available Cash after application (if
any) in accordance with clause (A)), to acquire Additional Assets within one year from the later of the date of such Asset Disposition or the receipt of such Net Available Cash; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) to the extent of the balance of such Net Available Cash after application (if any) in accordance with clauses (A)&nbsp;and
(B), to make an offer to the Holders (and to holders of other Senior Indebtedness of the Company designated by the Company) to purchase Securities (and such other Senior Indebtedness of the Company) pursuant to and subject to the conditions
contained in this Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that in connection with any prepayment, repayment or purchase of Indebtedness made to
satisfy clause (A)&nbsp;or (C) above, the Company or such Restricted Subsidiary shall permanently retire such Indebtedness and shall cause the related loan commitment (if any) to be permanently reduced in an amount equal to the principal amount so
prepaid, repaid or purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;6.06, the Company and the Restricted
Subsidiaries shall not be required to apply any Net Available Cash in accordance with this Section&nbsp;6.06 except to the extent that the aggregate Net Available Cash from all Asset Dispositions which is not applied in accordance with this
Section&nbsp;6.06 exceeds $50,000,000. Pending application of Net Available Cash pursuant to this Section&nbsp;6.06, such Net Available Cash shall be invested in Temporary Cash Investments or applied to temporarily reduce revolving credit
indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For the purposes of this Section&nbsp;6.06, the following are deemed to be cash or cash equivalents: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the assumption or discharge of any liabilities (as shown on the Company&#146;s or such Restricted Subsidiary&#146;s most
recent balance sheet or in the footnotes thereto) of the Company or such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Restricted Subsidiary (other than liabilities that are by their terms subordinated to the Securities) that are assumed by the transferee of such assets and for which the Company and all of the
Restricted Subsidiaries have been released by all creditors in writing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) securities received by the Company or any
Restricted Subsidiary from the transferee that are converted by the Company or such Restricted Subsidiary within 180 days into cash, to the extent of cash received in that conversion; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) all Temporary Cash Investments; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) any Designated Noncash Consideration having an aggregate Fair Market Value that, when taken together with all other
Designated Noncash Consideration previously received and then outstanding, does not exceed at the time of the receipt of such Designated Noncash Consideration (with the Fair Market Value of each item of Designated Noncash Consideration being
measured at the time received and without giving effect to subsequent changes in value) $30,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) In the event of an Asset
Disposition that requires the purchase of Securities (and other Senior Indebtedness of the Company) pursuant to Section&nbsp;6.06(a)(3)(C), the Company shall purchase Securities tendered pursuant to an offer by the Company for the Securities (and
such other Senior Indebtedness) (the &#147;<U>Offer</U>&#148;) at a purchase price of 100% of their principal amount (or, in the event such other Senior Indebtedness of the Company was issued with significant original issue discount, 100% of the
accreted value thereof) without premium, plus accrued but unpaid interest (or, in respect of such other Senior Indebtedness of the Company, such lesser price, if any, as may be provided for by the terms of such Senior Indebtedness) in accordance
with the procedures (including prorating in the event of oversubscription) set forth in this Indenture. If the aggregate purchase price of the securities tendered pursuant to the Offer exceeds the Net Available Cash allotted to their purchase, the
Company shall select the securities to be purchased on a <U>pro</U> <U>rata</U> basis but in round denominations, which in the case of the Securities will be denominations of $2,000 principal amount or any greater integral multiple of $1,000,
subject to applicable DTC procedures. The Company shall not be required to make such an Offer to purchase Securities (and other Senior Indebtedness of the Company) pursuant to this Section&nbsp;6.06 if the Net Available Cash available therefor is
less than $20,000,000 (which lesser amount shall be carried forward for purposes of determining whether such an offer is required with respect to the Net Available Cash from any subsequent Asset Disposition). Upon completion of such an Offer, Net
Available Cash shall be deemed to be reduced by the aggregate amount of such Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) (i) Promptly, and in any event within 10 days
after the Company becomes obligated to make an Offer, the Company shall deliver to the Trustee and send, by first-class mail (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or
regulations, send electronically) to each Holder, a written notice stating that the Holder may elect to have his Securities purchased by the Company either in whole or in part (subject to prorating as described in Section&nbsp;6.06(b) in the event
the Offer is oversubscribed) in amounts of $2,000 and any greater integral multiple of $1,000 of principal amount at the applicable purchase price. The notice shall specify a purchase date not less than 30 days nor more than 60 days after the date
of such notice (the &#147;<U>Purchase Date</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Not later than the date upon which written notice of an Offer
is delivered to the Trustee as provided below, the Company shall deliver to the Trustee an Officers&#146; Certificate as to (A)&nbsp;the amount of the Offer (the &#147;<U>Offer Amount</U>&#148;), including information as to any other Senior
Indebtedness included in the Offer for repurchase, (B)&nbsp;the allocation of the Net Available Cash from the Asset Dispositions pursuant to which such Offer is being made and (C)&nbsp;the compliance of such allocation with the provisions of
Section&nbsp;6.06(a). By 11:00 a.m. New York City time on the Purchase Date, the Company shall irrevocably deposit with the Trustee or with a Paying Agent (or, if the Company or a Wholly Owned Subsidiary is acting as Paying Agent, segregate and hold
in trust) an amount equal to the Offer Amount to be held for payment in accordance with the provisions of this Section&nbsp;6.06. Upon the expiration of the period for which the Offer remains open (the &#147;<U>Offer Period</U>&#148;), the Company
shall deliver to the Trustee for cancellation the Securities or portions thereof which have been properly tendered to and are to be accepted by the Company. The Trustee (or the Paying Agent, if not the Trustee) shall, on the Purchase Date, mail or
deliver payment (or cause the delivery of payment) to each tendering Holder in the amount of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
purchase price. In the event that the aggregate purchase price of the Securities delivered by the Company to the Trustee is less than the Offer Amount applicable to the Securities, the Trustee
shall deliver the excess to the Company immediately after the expiration of the Offer Period for application in accordance with this Section&nbsp;6.06. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Holders electing to have a Security purchased shall be required to surrender the Security, with an appropriate form duly
completed, to the Company at the address specified in the notice at least three Business Days prior to the Purchase Date. A Holder shall be entitled to withdraw its election if the Trustee or the Company receives, not later than one Business Day
prior to the Purchase Date, a telex, facsimile transmission or letter setting forth the name of such Holder, the principal amount of the Security that was delivered for purchase by such Holder and a statement that such Holder is withdrawing its
election to have such Security purchased. Holders whose Securities are purchased only in part shall be issued new Securities equal in principal amount to the unpurchased portion of the Securities surrendered. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) At the time the Company delivers Securities to the Trustee which are to be accepted for purchase, the Company shall also
deliver an Officers&#146; Certificate stating that such Securities are to be accepted by the Company pursuant to and in accordance with the terms of this Section&nbsp;6.06. A Security shall be deemed to have been accepted for purchase at the time
the Trustee, directly or through an agent, mails or delivers payment therefor to the surrendering Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The Company shall comply,
to the extent applicable, with the requirements of Section&nbsp;14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section&nbsp;6.06. To the extent that the
provisions of any securities laws or regulations conflict with provisions of this Section&nbsp;6.06, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this
Section&nbsp;6.06 by virtue of its compliance with such securities laws or regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.07. <U>Limitation on Transactions with
Affiliates</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary to, enter into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property, employee compensation arrangements or
the rendering of any service) with, or for the benefit of, any Affiliate of the Company (an &#147;<U>Affiliate Transaction</U>&#148;) unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the terms of the Affiliate Transaction are no less favorable to the Company or such Restricted Subsidiary than those that
could be obtained at the time of the Affiliate Transaction in <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> dealings with a Person who is not an Affiliate; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if such Affiliate Transaction involves an amount in excess of $50,000,000, the terms of the Affiliate Transaction are set
forth in writing and a majority of the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the Company disinterested with respect to such Affiliate Transaction have determined in good faith that the criteria set forth in clause
(1)&nbsp;are satisfied and have approved the relevant Affiliate Transaction as evidenced by a resolution of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
The provisions of Section&nbsp;6.07(a) shall not prohibit: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any Investment (other than a Permitted Investment) or other
Restricted Payment, in each case permitted to be made pursuant to Section&nbsp;6.04; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any employment or consulting
agreement, employee benefit plan, officer or director indemnification agreement or any similar arrangement entered into by the Company or any of its Restricted Subsidiaries in the ordinary course of business or approved by the Board of Directors,
and payments pursuant thereto; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) loans or advances to employees in the ordinary course of business of the
Company or its Restricted Subsidiaries, but in any event not to exceed $10,000,000 in the aggregate outstanding at any one time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the payment of reasonable fees or other reasonable compensation to, or the provision of customary benefits or
indemnification arrangements to, directors of the Company and its Restricted Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) any transaction with the
Company, a Restricted Subsidiary or any Person that would constitute an Affiliate Transaction solely because the Company or a Restricted Subsidiary owns an equity interest in or otherwise controls such Restricted Subsidiary or Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) the issuance or sale of any Capital Stock (other than Disqualified Stock) of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) any agreement as in effect on the Issue Date or any renewals or extensions of any such agreement (so long as such renewals
or extensions are not less favorable in any material respect to the Company or the Restricted Subsidiaries) and the transactions evidenced thereby; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) the provision of services to directors or officers of the Company or any of its Restricted Subsidiaries of the nature
provided by the Company or any of its Restricted Subsidiaries to customers in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)
transactions effected as a part of a Qualified Receivables Transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) any transaction entered into by a Person
prior to the time such Person becomes a Restricted Subsidiary or is merged or consolidated into the Company or a Restricted Subsidiary (provided such transaction is not entered into in contemplation of such event); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) any transaction with the Company&#146;s or any Restricted Subsidiary&#146;s customers, clients, suppliers, landlords,
lessors, or purchasers or sellers of goods or services, in each case, in the ordinary course of business and otherwise in compliance with the terms of the Indenture that are fair to the Company, or are on terms at least as favorable as would
reasonably have been entered into at such time with a Person who is not an Affiliate of the Company (as determined in good faith by the Board of Directors or senior management of the Company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.08. <U>Change of Control</U>. (a)&nbsp;Upon the occurrence of a Change of Control, each Holder shall have the right to require that
the Company purchase all or any part of such Holder&#146;s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the date of purchase plus accrued and unpaid interest, if any, to the date of purchase (subject to the
right of Holders of record on the relevant Record Date to receive interest due on the relevant Interest Payment Date), in accordance with Section&nbsp;6.08(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Within 30 days following any Change of Control, the Company shall mail (or with respect to Global Securities, to the extent permitted or
required by applicable Depositary procedures or regulations, send electronically) a notice to each Holder with a copy to the Trustee (the &#147;<U>Change of Control Offer</U>&#148;) stating: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) that a Change of Control has occurred and that such Holder has the right to require the Company to purchase such
Holder&#146;s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the date of purchase, plus accrued and unpaid interest, if any, to the date of purchase (subject to the right of Holders of record on the relevant
Record Date to receive interest on the relevant Interest Payment Date); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the circumstances and relevant facts and
financial information regarding such Change of Control; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the purchase date (which shall be no earlier than 30 days nor later
than 60 days from the date such notice is sent); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the instructions, as determined by the Company, consistent with
this Section&nbsp;6.08, that a Holder must follow in order to have its Securities purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The Company shall not be required to
make a Change of Control Offer following a Change of Control if a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Indenture applicable to a Change of
Control Offer made by the Company and purchases all Securities validly tendered and not withdrawn under such Change of Control Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)
The Company shall comply, to the extent applicable, with the requirements of Section&nbsp;14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section&nbsp;6.08. To
the extent that the provisions of any securities laws or regulations conflict with the provisions of this Section&nbsp;6.08, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its
obligations under this Section&nbsp;6.08 by virtue thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Holders electing to have a Security purchased will be required to
surrender the Security, with an appropriate form duly completed, to the Company at the address specified in the notice at least three Business Days prior to the purchase date. Holders will be entitled to withdraw their election if the Trustee or the
Company receives not later than one Business Day prior to the purchase date, a telegram, telex, facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Security which was delivered for purchase by the
Holder and a statement that such Holder is withdrawing his election to have such Security purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) On the purchase date, all
Securities purchased by the Company under this Section&nbsp;6.08 shall be delivered by the Company to the Trustee for cancellation, and the Company shall pay the purchase price plus accrued and unpaid interest, if any, to the Holders entitled
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.09. <U>Limitation on Liens</U>. The Company shall not, and shall not permit any Restricted Subsidiary to, directly or
indirectly, Incur or permit to exist any Lien (the &#147;<U>Initial Lien</U>&#148;) of any nature whatsoever on any of its properties (including Capital Stock of a Restricted Subsidiary), whether owned at the Issue Date or thereafter acquired,
securing any Indebtedness, other than Permitted Liens, without effectively providing that the Securities shall be secured equally and ratably with (or prior to) the obligations so secured for so long as such obligations are so secured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any Lien created for the benefit of the Holders pursuant to the preceding sentence shall provide by its terms that such Lien shall be
automatically and unconditionally released and discharged upon the release and discharge of the Initial Lien. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.10.
<U>Limitation on Sale/Leaseback Transactions</U>. The Company shall not, and shall not permit any Restricted Subsidiary to, enter into any Sale/Leaseback Transaction with respect to any property unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company or such Restricted Subsidiary would be entitled to (A)&nbsp;Incur Indebtedness in an amount equal to the
Attributable Debt with respect to such Sale/Leaseback Transaction pursuant to Section&nbsp;6.03 and (B)&nbsp;create a Lien on such property securing such Attributable Debt without equally and ratably securing the Securities pursuant to
Section&nbsp;6.09; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the gross proceeds received by the Company or any Restricted Subsidiary in connection with such
Sale/Leaseback Transaction are at least equal to the Fair Market Value of such property; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company applies the
proceeds of such transaction in compliance with Section&nbsp;6.06. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.11. <U>Future Guarantors</U>. (a)&nbsp;The Company shall cause each Restricted
Subsidiary that Guarantees any Indebtedness of the Company or any Subsidiary Guarantor in respect of the Credit Agreement or Capital Markets Indebtedness (or Incurs any such Indebtedness) to, at the same time, execute and deliver to the Trustee a
Guaranty Agreement pursuant to which such Restricted Subsidiary will Guarantee payment of the Securities on the same terms and conditions as those set forth in Article V of the Supplemental Indenture.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Sections 6.04 and 6.06 of the Base Indenture are hereby deleted in their entirety, but only with respect to the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Sections 6.02, 6.03, 6.05 and 6.07 of the Base Indenture are hereby amended, but only with respect to the Securities, by renumbering such
Sections 6.12, 6.13, 6.14, and 6.15, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.06. <U>Amendments of Article VII of Base Indenture</U>. (a) Section 7.01(b)
of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(b) the Company (A)&nbsp;defaults in the payment of principal of any Security when the same becomes due and payable at its Stated
Maturity, upon optional redemption, upon declaration of acceleration or otherwise or (B)&nbsp;fails to purchase Securities when required pursuant to this Indenture or the Securities;&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Section 7.01(c) the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(c) the Company fails to comply with Section&nbsp;5.01;&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Sections 7.01(d), (e) and (f)&nbsp;of the Base Indenture are hereby amended and restated, but only with respect to the Securities, to read
in their entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(d) the Company or any Subsidiary Guarantor fails to comply with any of its agreements contained in
the Securities or this Indenture (other than those referred to in (a), (b) or (c)&nbsp;above) and such failure continues for 60 days after the notice from the Trustee or the Holders specified below; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the Company, any Subsidiary Guarantor or any Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) commences a voluntary case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) consents to the entry of an order for relief against it in an involuntary case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) consents to the appointment of a Custodian of it or for any substantial part of its property; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) makes a general assignment for the benefit of its creditors; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">or takes any comparable action under any foreign laws relating to insolvency; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) is for relief against the Company, any Subsidiary Guarantor or any Significant Subsidiary in an involuntary case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) appoints a Custodian of the Company, any Subsidiary Guarantor or any Significant Subsidiary or for any substantial part of
its property; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) orders the winding up or liquidation of the Company, any Subsidiary
Guarantor or any Significant Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">or any similar relief is granted under any foreign laws and the order or decree remains unstayed
and in effect for 60 days;&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 of the Base Indenture is hereby amended, but only with respect to the Securities, by
the addition of the following new Sections 7.01(g), (h) and (i)&nbsp;as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(g) Indebtedness of the Company, any Subsidiary
Guarantor or any Significant Subsidiary is not paid within any applicable grace period after final maturity or is accelerated by the holders thereof because of a default and the total amount of such Indebtedness unpaid or accelerated exceeds
$50,000,000 or its foreign currency equivalent at the time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any judgment or decree for the payment of money in excess of $50,000,000
(or its foreign currency equivalent at the time) is entered against the Company, any Subsidiary Guarantor or any Significant Subsidiary, remains outstanding for a period of 60 consecutive days following the entry of such judgment or decree and is
not discharged, waived or effectively stayed; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any Subsidiary Guarantee ceases to be in full force and effect (other than in
accordance with the terms of such Subsidiary Guarantee) or any Subsidiary Guarantor denies or disaffirms its obligations under its Subsidiary Guarantee; or&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Section 7.01(g) of the Base Indenture is hereby amended, but only with respect to the Securities, by renumbering such section 7.01(j) and
by replacing the semi-colon at the end of such section with a period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The paragraph immediately following Section&nbsp;7.01(g) of the
Base Indenture and the last paragraph of Section&nbsp;7.01 of the Base Indenture are hereby deleted, but only with respect to the Securities, and replaced with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;The foregoing shall constitute Events of Default whatever the reason for any such Event of Default and whether such Event of Default is
voluntary or involuntary or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">However, a default under Section (d)&nbsp;of this Section&nbsp;7.01 will not constitute an Event of Default until the Trustee or the holders of
at least 25% in principal amount of the outstanding Securities notify the Company of the default and the Company does not cure such default within the time specified after receipt of such notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The term &#147;<U>Bankruptcy Law</U>&#148; means Title 11, United States Code, or any similar federal or state law for the relief of debtors.
The term &#147;<U>Custodian</U>&#148; means any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice in the form of an Officers&#146;
Certificate of any Event of Default under clause (g)&nbsp;or (i) and any event which with the giving of notice or the lapse of time or both would become an Event of Default under clause (d)&nbsp;or (h), its status and what action the Company is
taking or proposes to take with respect thereto.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Section 7.02 of the Base Indenture is hereby amended, but only with respect to
the Securities, by adding the following sentences to end of the Section: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;The holders of a majority in principal amount of the
Securities by notice to the Trustee may rescind an acceleration and its consequences if the rescission would not conflict with any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
judgment or decree and if all existing Events of Default have been cured or waived except nonpayment of principal or interest that has become due solely because of acceleration. No such
rescission shall affect any subsequent Default or impair any right consequent thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In the case of any Event of Default occurring by
reason of any willful action (or inaction) taken (or not taken) by or on behalf of the Company with the intention of avoiding payment of the premium that the Company would have had to pay if the Company then had elected to redeem the Securities
pursuant to the optional redemption provisions hereof, an equivalent premium shall also become and be immediately due and payable to the extent permitted by law upon the acceleration of the Securities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Section 7.07 the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 7.07. <U>Limitation on Suits</U>. Except to enforce the right to receive payment of principal or interest when
due, no Holder may pursue any remedy with respect to this Indenture or the Securities unless: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Holder gives to the Trustee written
notice stating that an Event of Default is continuing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the holders of at least 25% in principal amount of the outstanding Securities
make a written request to the Trustee to pursue the remedy; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) such Holder or Holders offer to the Trustee satisfactory security or
indemnity against any loss, liability or expense; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the Trustee does not comply with the request within 60 days after receipt of the
request and the offer of security or indemnity; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the holders of a majority in principal amount of the outstanding Securities do
not give the Trustee a direction inconsistent with the request during such <FONT STYLE="white-space:nowrap">60-day</FONT> period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A Holder
may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder. In the event that the definitive Securities are not issued to any beneficial owner promptly after the Registrar has
received a request from the Holder of a Global Security to issue such definitive Securities to such beneficial owner or its nominee, the Company expressly agrees and acknowledges, with respect to the right of any Holder to pursue a remedy pursuant
to this Indenture, the right of such beneficial holder of Securities to pursue such remedy with respect to the portion of the Global Security that represents such beneficial holder&#146;s Securities as if such definitive Securities had been issued.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.07. <U>Amendment of Article XI of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.03 of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Within 90 days after the occurrence thereof, and if known to the Trustee, the Trustee shall give to the Holders of the
Securities of a series notice of each Default or Event of Default with respect to the Securities of such series known to the Trustee, by transmitting such notice to Holders at their mailing addresses as the same shall then appear on the Register of
the Company (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or regulations, electronically), unless such Default shall have been cured or waived before the giving of such notice (the
term &#147;Default&#148; being hereby defined to be the events specified in Section&nbsp;7.01, which are, or after notice or lapse of time or both would become, Events of Default as defined in said Section). Except in the case of a Default or Event
of Default in payment of the principal of or interest on any of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities of such series when and as the same shall become payable, or to make any sinking fund payment as to Securities of the same series, the Trustee shall be protected in withholding such
notice, if and so long as a committee of Responsible Officers of the Trustee in good faith determines that the withholding of such notice is in the interests of the Holders of the Securities of such series.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.08. <U>Amendment of Article XII of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Article XII of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows:
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;ARTICLE XII </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Discharge
of Indenture; Defeasance </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.01. <U>Discharge of Liability on Securities; Defeasance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) When (1)&nbsp;the Company delivers to the Trustee all outstanding Securities (other than Securities replaced pursuant to
Section&nbsp;3.07) for cancellation or (2)&nbsp;all outstanding Securities have become due and payable, whether at maturity or on a redemption date as a result of the sending of a notice of redemption pursuant to Article IV hereof and the Company
irrevocably deposits with the Trustee funds in an amount sufficient, or U.S. Government Obligations the principal of and interest on which will be sufficient, or a combination thereof sufficient, to pay at maturity or upon redemption all outstanding
Securities, including interest thereon to maturity or such redemption date (other than Securities replaced pursuant to Section&nbsp;3.07), and if in either case the Company pays all other sums payable hereunder by the Company, then this Indenture
shall, subject to Section&nbsp;12.01(c), cease to be of further effect. The Trustee shall acknowledge satisfaction and discharge of this Indenture on demand of the Company accompanied by an Officers&#146; Certificate and an Opinion of Counsel, each
stating that all conditions precedent set forth herein relating to the satisfaction and discharge of this Indenture have been satisfied, and at the cost and expense of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to Sections 12.01(c) and 12.02, the Company at any time may terminate (1)&nbsp;all its obligations under the Securities and this
Indenture (&#147;legal defeasance option&#148;) or (2)&nbsp;its obligations under Sections 6.02, 6.03, 6.04, 6.05, 6.06, 6.07, 6.08, 6.09, 6.10 and 6.11 and the operation of Sections 7.01(e), 7.01(f), 7.01(g) and 7.01(h) (but, in the case of
Sections 7.01(e) and (f), with respect to Subsidiary Guarantors and Significant Subsidiaries only) and the limitations contained in Section&nbsp;5.01(a)(3) (&#147;covenant defeasance option&#148;). The Company may exercise its legal defeasance
option notwithstanding its prior exercise of its covenant defeasance option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Company exercises its legal defeasance option,
payment of the Securities may not be accelerated because of an Event of Default with respect thereto. If the Company exercises its covenant defeasance option, payment of the Securities may not be accelerated because of an Event of Default specified
in Sections 7.01(e), 7.01(f), 7.01(g) or 7.01(h) (but, in the case of Sections 7.01(e) and (f), with respect to Subsidiary Guarantors and Significant Subsidiaries only) or because of the failure of the Company to comply with Section&nbsp;5.01(a)(3).
If the Company exercises its legal defeasance option or its covenant defeasance option, each Subsidiary Guarantor, if any, shall be released from all of its obligations with respect to its Subsidiary Guarantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Upon satisfaction of the conditions set forth herein and upon request of the Company, the Trustee shall acknowledge in writing the discharge
of those obligations that the Company terminates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding clauses (a)&nbsp;and (b) above, the Company&#146;s obligations in
Sections 3.04, 3.06, 3.07 and 6.12 and in this Article XII shall survive until the Securities have been paid in full. Thereafter, the Company&#146;s obligations in Sections 11.01, 12.04 and 12.05 shall survive. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.02. <U>Conditions to Defeasance</U>. The Company may exercise its legal
defeasance option or its covenant defeasance option only if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company irrevocably deposits in trust with the
Trustee money or U.S. Government Obligations, or a combination thereof, for the payment of the principal of and interest on the Securities to redemption or maturity, as the case may be; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Company delivers to the Trustee a certificate from a nationally recognized firm of independent accountants expressing
their opinion that the payments of principal and interest when due and without reinvestment on the deposited U.S. Government Obligations plus any deposited money without investment will provide cash at such times and in such amounts as will be
sufficient to pay principal of and interest when due on all the Securities to maturity or redemption, as the case may be; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) 123 days pass after the deposit is made and during the 123 day period no Default specified in Section&nbsp;7.01(e) or
(f)&nbsp;with respect to the Company occurs which is continuing at the end of the period; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the deposit does not
constitute a default under any other agreement binding on the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the Company delivers to the Trustee an Opinion
of Counsel to the effect that the trust resulting from the deposit does not constitute, or is qualified as, a regulated investment company under the Investment Company Act of 1940; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) in the case of the legal defeasance option, the Company shall have delivered to the Trustee an Opinion of Counsel stating
that (A)&nbsp;the Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (B)&nbsp;since the date of this Indenture there has been a change in the applicable federal income tax law, in either case to the
effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders will not recognize income, gain or loss for federal income tax purposes as a result of such deposit and defeasance and will be subject to federal income tax on
the same amounts, in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) in the case of the covenant defeasance option, the Company shall have delivered to the Trustee an Opinion of Counsel to the
effect that the Holders will not recognize income, gain or loss for federal income tax purposes as a result of such covenant defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would
have been the case if such covenant defeasance had not occurred; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) the Company delivers to the Trustee an
Officers&#146; Certificate and an Opinion of Counsel, each stating that all conditions precedent to the defeasance and discharge of the Securities as contemplated by this Article XII have been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before or after a deposit, the Company may make arrangements satisfactory to the Trustee for the redemption of Securities at a future date in
accordance with Article IV. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.03. <U>Application of Trust Money</U>. The Trustee shall hold in trust money or U.S. Government
Obligations deposited with it pursuant to this Article XII. It shall apply the deposited money and the money from U.S. Government Obligations through the Paying Agent and in accordance with this Indenture to the payment of principal of and interest
on the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.04. <U>Repayment to Company</U>. The Trustee and the Paying Agent shall promptly turn over to the Company
upon request any excess money or securities held by them at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to any applicable abandoned property law, the Trustee and
the Paying Agent shall pay to the Company upon request any money held by them for the payment of principal or interest that remains unclaimed for two years, and, thereafter, Holders entitled to the money must look to the Company for payment as
general creditors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.05. <U>Indemnity for Government Obligations</U>. The Company shall pay and shall
indemnify the Trustee against any tax, fee or other charge imposed on or assessed against deposited U.S. Government Obligations or the principal and interest received on such U.S. Government Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.06. <U>Reinstatement</U>. If the Trustee or Paying Agent is unable to apply any money or U.S. Government Obligations in accordance
with this Article XII by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company&#146;s and each Subsidiary
Guarantor&#146;s obligations under this Indenture, each Subsidiary Guarantee and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this Article XII until such time as the Trustee or Paying Agent is
permitted to apply all such money or U.S. Government Obligations in accordance with this Article XII; <U>provided</U>, <U>however</U>, that, if the Company has made any payment of principal of or interest on any Securities because of the
reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or Paying Agent.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.09. <U>Amendment of Article XIII of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13.01 of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 13.01. <U>No Personal Liability</U>. No director, officer, employee, incorporator or stockholder of
the Company or any Subsidiary Guarantor shall have any liability for any obligations of the Company or any Subsidiary Guarantor under the Securities, any Subsidiary Guarantee or this Indenture or for any claim based on, in respect of, or by reason
of such obligations or their creation. By accepting a Security, each Holder shall waive and release all such liability. The waiver and release shall be part of the consideration for the issue of the Securities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.10. <U>Amendment of Article XIV of Base Indenture</U>. (a)&nbsp;Sections 14.01 and 14.02 of the Base Indenture are hereby amended
and restated, but only with respect to the Securities, to read in their entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 14.01.
<U>Without Consent of Holders</U>. The Company, the Subsidiary Guarantors and the Trustee may amend this Indenture or the Securities without notice to or consent of any Holder: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to cure any ambiguity, omission, defect or inconsistency; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) to comply with Article V; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to provide for uncertificated Securities in addition to or in place of certificated Securities; <U>provided</U>,
<U>however</U>, that the uncertificated Securities are issued in registered form for purposes of Section&nbsp;163(f) of the Code or in a manner such that the uncertificated Securities are described in Section&nbsp;163(f)(2)(B) of the Code; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to add Guarantees with respect to the Securities, including any Subsidiary Guaranties, or to secure the Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) to add to the covenants of the Company or a Subsidiary Guarantor for the benefit of the Holders or to surrender any right
or power herein conferred upon the Company or a Subsidiary Guarantor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) to make any change that does not adversely
affect the rights of any Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) to conform the text of this Indenture or the Securities to any provision of the
&#147;Description of Notes&#148; section of the Prospectus Supplement to the extent that such provision of the &#147;Description of Notes&#148; section of the Prospectus Supplement was intended to be a verbatim recitation of a provision of this
Indenture or the Securities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) to comply with any requirement of the SEC in connection with qualifying,
or maintaining the qualification of, this Indenture under the TIA; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) to make any amendment to the provisions of this
Indenture relating to the transfer and legending of Securities; <U>provided</U>, <U>however</U>, that (A)&nbsp;compliance with this Indenture as so amended would not result in Securities being transferred in violation of the Securities Act or any
other applicable securities law and (B)&nbsp;such amendment does not materially and adversely affect the rights of Holders to transfer Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">After an amendment under this Section&nbsp;14.01 becomes effective, the Company shall mail (or with respect to Global
Securities, to the extent permitted or required by applicable Depositary procedures or regulations, send electronically) to Holders a notice briefly describing such amendment. The failure to give such notice to all Holders, or any defect therein,
shall not impair or affect the validity of an amendment under this Section&nbsp;14.01. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 14.02. <U>With Consent of
Holders</U>. (a)&nbsp;The Company, the Subsidiary Guarantors and the Trustee may amend this Indenture, but only with respect to the Securities, or the Securities with the written consent of the holders of at least a majority in principal amount of
the Securities then outstanding (including consents obtained in connection with a purchase of, or tender offer or exchange for, the Securities) and any past Default or compliance with any provisions may also be waived with the consent of the holders
of at least a majority in principal amount of the Securities then outstanding. Notwithstanding the foregoing, without the consent of each Holder affected thereby, an amendment or waiver may not: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) reduce the amount of Securities whose Holders must consent to an amendment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) reduce the rate of or extend the time for payment of interest on any Security; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) reduce the principal of or change the Stated Maturity of any Security; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) (i) reduce the amount payable upon the redemption of any Security or (ii)&nbsp;change the time at which any Security may be
redeemed, in each case in accordance with Article IV; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) make any Security payable in money other than that stated in the
Security; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) impair the right of any Holder to receive payment of principal of and interest on such Holder&#146;s
Securities on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such Holder&#146;s Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) make any change in the amendment provisions that require each Holder&#146;s consent or in the waiver provisions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) make any change in the ranking or priority of any Security that would adversely affect the Securityholders; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) make any change in, or release other than in accordance with this Indenture, any Subsidiary Guarantee that would adversely
affect the Securityholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It shall not be necessary for the consent of the Holders under this Section&nbsp;14.02 to
approve the particular form of any proposed amendment, but it shall be sufficient if such consent approves the substance thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">After an amendment under this Section&nbsp;14.02 becomes effective, the
Company shall mail (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or regulations, send electronically) to Holders a notice briefly describing such amendment. The failure to give such
notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment under this Section&nbsp;14.02.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Article XIV of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new
Sections 14.07 and 14.08: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 14.07. <U>Revocation and Effect of Consents and Waivers</U>. A consent to an
amendment or a waiver by a Holder of a Security shall bind the Holder and every subsequent Holder of that Security or portion of the Security that evidences the same debt as the consenting Holder&#146;s Security, even if notation of the consent or
waiver is not made on the Security. However, any such Holder or subsequent Holder may revoke the consent or waiver as to such Holder&#146;s Security or portion of the Security if the Trustee receives the notice of revocation before the date on which
the amendment or waiver becomes effective. After an amendment or waiver becomes effective, it shall bind every Holder. An amendment or waiver becomes effective upon execution of such amendment or waiver by the Trustee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give
their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those Persons who were Holders at such
record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after such record
date. No such consent shall be valid or effective for more than 120 days after such record date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 14.08. <U>Payment
for Consent</U>. Neither the Company nor any Affiliate of the Company shall, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent,
waiver or amendment of any of the terms or provisions of this Indenture or the Securities unless such consideration is offered to all Holders and is paid to all Holders that so consent, waive or agree to amend in the time frame set forth in
solicitation documents relating to such consent, waiver or agreement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.11. <U>Amendment of Article XVI of Base
Indenture</U>. Section&nbsp;16.11 of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the first sentence of such section and replacing such deleted sentence with the following: &#147;This Indenture and the
Securities shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to applicable principles of conflicts of law to the extent that the application of the laws of another jurisdiction would be
required thereby.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.12. <U>Amendment of Base Indenture</U>. The Base Indenture is hereby amended, but only with respect to
the Securities, (a)&nbsp;by replacing cross-references to Sections and Articles therein to reflect the <FONT STYLE="white-space:nowrap">re-numbering</FONT> of such Sections and Articles as amended herein and (b)&nbsp;so that any definitions, and any
definitions included exclusively within such definitions, in the Base Indenture shall be deemed deleted or amended when all references in the Base Indenture to such definitions would be eliminated or amended as a result of the amendments effected by
this Supplemental Indenture. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSIDIARY GUARANTEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.01. <U>Guarantees</U>. (a)&nbsp;Each Subsidiary Guarantor hereby unconditionally and irrevocably guarantees, jointly and severally,
to each Holder and to the Trustee and its successors and assigns (i)&nbsp;the full and punctual payment of principal of and interest on the Securities when due, whether at maturity, by acceleration, by redemption or otherwise, and all other monetary
obligations of the Company under the Indenture and the Securities and (ii)&nbsp;the full and punctual performance within applicable grace periods of all other obligations of the Company under the Indenture and the Securities (all the foregoing being
hereinafter collectively called the &#147;<U>Guaranteed </U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Obligations</U>&#148;). Each Subsidiary Guarantor further agrees that the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice or further assent from such
Subsidiary Guarantor and that such Subsidiary Guarantor will remain bound under this Article V notwithstanding any extension or renewal of any Obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Subsidiary Guarantor waives presentation to, demand of, payment from and protest to the Company of any of the Guaranteed Obligations
and also waives notice of protest for nonpayment. Each Subsidiary Guarantor waives notice of any default under the Securities or the Guaranteed Obligations. The obligations of each Subsidiary Guarantor hereunder shall not be affected by (1)&nbsp;the
failure of any Holder or the Trustee to assert any claim or demand or to enforce any right or remedy against the Company or any other Person (including any Subsidiary Guarantor) under the Indenture, the Securities or any other agreement or
otherwise; (2)&nbsp;any extension or renewal of any thereof; (3)&nbsp;any rescission, waiver, amendment or modification of any of the terms or provisions of the Indenture, the Securities or any other agreement; (4)&nbsp;the release of any security
held by any Holder or the Trustee for the Guaranteed Obligations or any of them; (5)&nbsp;the failure of any Holder or the Trustee to exercise any right or remedy against any other guarantor of the Guaranteed Obligations; or (6)&nbsp;except as set
forth in Section&nbsp;5.06, any change in the ownership of such Subsidiary Guarantor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Subsidiary Guarantor further agrees that its
Subsidiary Guarantee herein constitutes a guarantee of payment, performance and compliance when due (and not a guarantee of collection) and waives any right to require that any resort be had by any Holder or the Trustee to any security held for
payment of the Guaranteed Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as expressly set forth in Sections 5.02, 5.05, 5.06 and 12.01(b), the obligations of
each Subsidiary Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of
setoff, counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, the obligations of each
Subsidiary Guarantor herein shall not be discharged or impaired or otherwise affected by the failure of any Holder or the Trustee to assert any claim or demand or to enforce any remedy under the Indenture, the Securities or any other agreement, by
any waiver or modification of any thereof, by any default, failure or delay, willful or otherwise, in the performance of the obligations, or by any other act or thing or omission or delay to do any other act or thing which may or might in any manner
or to any extent vary the risk of such Subsidiary Guarantor or would otherwise operate as a discharge of such Subsidiary Guarantor as a matter of law or equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Subsidiary Guarantor further agrees that its Subsidiary Guarantee herein shall continue to be effective or be reinstated, as the case
may be, if at any time payment, or any part thereof, of principal of or interest on any Obligation is rescinded or must otherwise be restored by any Holder or the Trustee upon the bankruptcy or reorganization of the Company or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the foregoing and not in limitation of any other right which any Holder or the Trustee has at law or in equity against any
Subsidiary Guarantor by virtue hereof, upon the failure of the Company to pay the principal of or interest on any Obligation when and as the same shall become due, whether at maturity, by acceleration, by redemption or otherwise, or to perform or
comply with any other Obligation, each Subsidiary Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid, in cash, to the Holders or the Trustee an amount equal to the sum of
(A)&nbsp;the unpaid amount of such Guaranteed Obligations, (B)&nbsp;accrued and unpaid interest on such Guaranteed Obligations (but only to the extent not prohibited by law) and (C)&nbsp;all other monetary Guaranteed Obligations of the Company to
the Holders and the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Each Subsidiary Guarantor agrees that it shall not be entitled to any right of subrogation in respect of
any Obligations guaranteed hereby until payment in full of all Obligations. Each Subsidiary Guarantor further agrees that, as between it, on the one hand, and the Holders and the Trustee, on the other hand, (A)&nbsp;the maturity of the Guaranteed
Obligations guaranteed hereby may be accelerated as provided in Article VII of the Indenture for the purposes of any Subsidiary Guarantee herein, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of
the Guaranteed Obligations guaranteed hereby, and (B)&nbsp;in the event of any declaration of acceleration of such Guaranteed Obligations as provided in Article VII of the Indenture, such Guaranteed Obligations (whether or not due and payable) shall
forthwith become due and payable by such Subsidiary Guarantor for the purposes of this Section&nbsp;5.01. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Each Subsidiary Guarantor also agrees to pay any and all costs and expenses (including
reasonable attorneys&#146; fees and expenses) incurred by the Trustee or any Holder in enforcing any rights under this Section&nbsp;5.01. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.02. <U>Limitation on Liability</U>. Any term or provision of the Indenture to the contrary notwithstanding, the maximum aggregate
amount of the Guaranteed Obligations guaranteed hereunder by any Subsidiary Guarantor shall not exceed the maximum amount that can be hereby guaranteed without rendering the Indenture, as it relates to such Subsidiary Guarantor, voidable under
applicable law relating to fraudulent conveyance or fraudulent transfer or similar laws affecting the rights of creditors generally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.03. <U>Successors and Assigns</U>. This Article V shall be binding upon each Subsidiary Guarantor and its successors and assigns and
shall inure to the benefit of the successors and assigns of the Trustee and the Holders and, in the event of any transfer or assignment of rights by any Holder or the Trustee, the rights and privileges conferred upon that party in the Indenture and
in the Securities shall automatically extend to and be vested in such transferee or assignee, all subject to the terms and conditions of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.04. <U>No Waiver</U>. Neither a failure nor a delay on the part of either the Trustee or the Holders in exercising any right, power
or privilege under this Article V shall operate as a waiver thereof, nor shall a single or partial exercise thereof preclude any other or further exercise of any right, power or privilege. The rights, remedies and benefits of the Trustee and the
Holders herein expressly specified are cumulative and not exclusive of any other rights, remedies or benefits which either may have under this Article V at law, in equity, by statute or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.05. <U>Modification</U>. No modification, amendment or waiver of any provision of this Article V, nor the consent to any departure
by any Subsidiary Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by the Trustee, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which
given. No notice to or demand on any Subsidiary Guarantor in any case shall entitle such Subsidiary Guarantor to any other or further notice or demand in the same, similar or other circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.06. <U>Release of Subsidiary Guarantor</U>. A Subsidiary Guarantor will be automatically released from its obligations under this
Article V: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) upon the sale or other disposition (including by way of consolidation or merger) of such Subsidiary
Guarantor, including the sale or disposition of Capital Stock of such Subsidiary Guarantor, following which such Subsidiary Guarantor is no longer a Subsidiary of the Company; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) upon the sale or disposition of all or substantially all of the assets of such Subsidiary Guarantor; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in each case other than to the Company or an Affiliate of the Company and as permitted by the Indenture and if in connection therewith the
Company provides an Officers&#146; Certificate to the Trustee to the effect that the Company shall comply with its obligations under Section&nbsp;6.06 in respect of such disposition. Upon any sale or disposition described in clause (1)&nbsp;or (2)
above, the obligor on the related Subsidiary Guarantee will be released from its obligations thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Subsidiary Guarantor also
will be automatically released from its obligations under this Article V: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) upon the designation of such Subsidiary
Guarantor as an Unrestricted Subsidiary in accordance with the terms of the Indenture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) at such time as any Guarantee
by such Subsidiary Guarantor of the obligations under the Credit Agreement and under all Capital Markets Indebtedness has been released and discharged, except a discharge or release by or as a result of payment under such Guarantee; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) if the Company exercises its legal defeasance option or its covenant
defeasance option as described in Article XII of the Indenture or if the Company&#146;s obligations under the Indenture are discharged in accordance with the terms of the Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">For avoidance of doubt, clause (b)&nbsp;above shall include a situation whereby the Guarantee of Capital Markets Indebtedness
by a Subsidiary Guarantor, including the Securities, would be released and discharged (&#147;released&#148;) immediately upon such release under the Credit Agreement but for the existence of one or more guarantees of other Capital Markets
Indebtedness the terms of which also provide that such guarantees would be released immediately upon such release under the Credit Agreement, <I>provided that</I>, in each case, all conditions precedent to such release have been satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the request of the Company, the Trustee shall execute and deliver an appropriate instrument evidencing such release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.07. <U>Contribution</U>. Each Subsidiary Guarantor that makes a payment under its Subsidiary Guarantee shall be entitled upon
payment in full of all Guaranteed Obligations under the Indenture to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor&#146;s pro rata portion of such payment based on the respective net assets
of all the Subsidiary Guarantors at the time of such payment determined in accordance with GAAP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
6.01. <U>Integral Part</U>. This Supplemental Indenture constitutes an integral part of the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.02. <U>Adoption,
Ratification and Confirmation</U>. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects hereby adopted, ratified and confirmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.03. <U>Counterparts</U>. This Supplemental Indenture may be executed in any number of counterparts, each of which when so executed
shall be deemed an original; and all such counterparts shall together constitute but one and the same instrument. Signatures of the parties hereto transmitted by facsimile or PDF may be used in lieu of the originals and shall be deemed to be their
original signatures for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.04. <U>Severability</U>. Should any provision of this Supplemental Indenture for any
reason be declared invalid or unenforceable, such decision shall not affect the validity or enforceability of any of the other provisions of this Supplemental Indenture, which other provisions shall remain in full force and effect and the
application of such invalid or unenforceable provision to persons or circumstances other than those as to which it is held invalid or unenforceable shall be valid and be enforced to the fullest extent permitted by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.05. <U>Governing Law</U>. THIS SUPPLEMENTAL INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.06. <U>Trustee Makes No Representation</U>. The Trustee makes no representation and shall not be responsible or accountable as to
the validity, execution by the other parties hereto or thereto or sufficiency of this Supplemental Indenture or of the Securities or Subsidiary Guarantees. The recitals and statements herein are deemed to be those of the Company and Subsidiary
Guarantors and not of the Trustee and the Trustee shall not be held responsible in any manner whatsoever for their correctness. The Trustee shall not be accountable for the use or application by the Company of the Securities or the proceeds thereof.
The Trustee assumes no responsibility for the accuracy or completeness of the information concerning the Company or its Affiliates or any other Person contained in the Prospectus Supplement or any related documents or for any failure by the Company
or any other Person to disclose events that may have occurred and may affect the significance or accuracy of such information, except to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the extent such information relates to the Trustee. Neither the Trustee nor any Paying Agent shall be responsible for determining whether any Asset Disposition has occurred and whether any
related offer to purchase with respect to the Securities is required. Neither the Trustee nor any Paying Agent shall be responsible for determining whether any Change of Control has occurred and whether any Change of Control Offer with respect to
the Securities is required. Neither the Trustee nor any Paying Agent shall be responsible for monitoring the credit ratings of the Company or making any request upon any rating agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.07. <U>Damages Limitation</U>. In no event shall the Trustee be responsible or liable for any special, indirect, punitive or
consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit), irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.08. <U>U.S.A. PATRIOT Act</U>. The Company and the Subsidiary Guarantors acknowledge that in accordance with Section&nbsp;326 of the
U.S.A. PATRIOT Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that
establishes a relationship or opens an account with the Trustee. The parties to this Supplemental Indenture agree that they shall provide the Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the
U.S.A. PATRIOT Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Supplemental Indenture on the date
first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ENCOMPASS HEALTH CORPORATION, as Issuer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Patrick Darby</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Patrick Darby</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.500% Senior Notes due 2028] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">GUARANTORS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health C Corp Sub Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Central Arkansas Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Jonesboro Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Columbia, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Concord, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Dothan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Florence, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Manati, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Panama City, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of San Juan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Tyler Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Yuma Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of City View, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of San Antonio, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of Texarkana, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of The Woodlands, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">HealthSouth Rehabilitation Hospital of Austin, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehab Concepts Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Reliant Blocker Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Western Neuro Care, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.500% Senior Notes due 2028] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Tustin, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Western Neuro Care, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">HealthSouth Rehabilitation Hospital of North Houston, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">HealthSouth North Houston GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.500% Senior Notes due 2028] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Continental Medical Systems, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings Subsidiary, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Alabama Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Arizona Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Arkansas Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Boise Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Bryan Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health California Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Colorado Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Deaconess Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Fairlawn Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health GKBJH Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Gulfport Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Iowa Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Johnson City Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Joint Ventures Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Kansas Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Kentucky Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Littleton Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Lubbock Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Martin County Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Maryland Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Massachusetts Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Midland Odessa Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Myrtle Beach Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Nevada Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health New Mexico Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health North Houston GP, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Ohio Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Owned Hospitals Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Pennsylvania Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Properties, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Albuquerque, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bakersfield, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bluffton, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Braintree, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Charleston, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cincinnati, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dayton, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of East Valley, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Erie, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fort Smith, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Franklin, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Gadsden, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Harmarville, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Henderson, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Kingsport, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Lakeview, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Largo, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Las Vegas, LLC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.500% Senior Notes due 2028] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Littleton, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Miami, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Middletown, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Modesto, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of New England, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Newnan, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Ocala, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Petersburg, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Reading, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sarasota, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Scottsdale, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Shelby County, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sunrise, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tallahassee, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Toms River, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Utah, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Vineland, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of York, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Institute of Tucson, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Savannah Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Sea Pines Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Sewickley Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health South Carolina Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health South Dakota Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Support Companies, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Texas Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Tucson Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Tulsa Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Utah Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Virginia Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Walton Rehabilitation Hospital, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health West Tennessee Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health West Virginia Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Westerville Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Winston-Salem Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Abilene, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Arlington, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Austin, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Cypress, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Dallas, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Humble, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Pearland, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Plano, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Richardson, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Round Rock, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Sugar Land, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of the <FONT STYLE="white-space:nowrap">Mid-Cities,</FONT> LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital The Vintage, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Fort Worth, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Print Promotions Group, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Rebound, LLC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.500% Senior Notes due 2028] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital Corporation of America, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital of North Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital of Plano, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.500% Senior Notes due 2028] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">WELLS FARGO BANK, NATIONAL<BR>ASSOCIATION, as Trustee</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stefan Victory</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stefan Victory</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.500% Senior Notes due 2028] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF FACE OF SECURITY] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Global Securities Legend] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS
SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#147;DTC&#148;), NEW YORK, NEW YORK OR A NOMINEE OF DTC, WHICH MAY BE
TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE
IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE
LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#146;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS
SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Definitive Securities Legend] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>4.500% Senior Note Due 2028 </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">NO.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">CUSIP No. 29261A AA8</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">ISIN No. US29261AAA88</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION, a Delaware corporation, promises to pay to Cede&nbsp;&amp; Co., or registered
assigns, the principal sum of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dollars on February&nbsp;1, 2028. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;1 and August 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: January&nbsp;15 and July 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Security are set forth on the other side of this Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date of authentication: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WELLS FARGO BANK, NATIONAL
ASSOCIATION, as Trustee </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF REVERSE SIDE OF SECURITY] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>4.500% Senior Note Due 2028 </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Interest</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred
to, being herein called the &#147;<U>Company</U>&#148;), promises to pay interest on the principal amount of this Security at the rate per annum shown above. The Company shall pay interest semiannually on February&nbsp;1 and August&nbsp;1 of each
year, commencing February&nbsp;1, 2020. Interest on the Securities will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from September&nbsp;18, 2019. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. The Company shall pay interest on overdue principal at the rate borne by this Security plus 1.0% per annum, and it shall pay interest on
overdue installments of interest at the same rate to the extent lawful. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Method of Payment</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall pay interest on the Securities (except defaulted interest) to the Persons who are registered holders of Securities at the
close of business on the January&nbsp;15 or July&nbsp;15 next preceding the Interest Payment Date even if Securities are canceled after the Record Date and on or before the Interest Payment Date. Holders must surrender Securities to a Paying Agent
to collect principal payments. The Company shall pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts. Payments in respect of the Securities represented by a
Global Security (including principal and interest) will be made by wire transfer of immediately available funds to the accounts specified by the Depositary. The Company shall make all payments in respect of a certificated Security (including
principal and interest) by mailing a check to the registered address of each Holder thereof; <U>provided</U>, <U>however</U>, that payments on a certificated Security will be made by wire transfer to a U.S. dollar account maintained by the payee
with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such account no later than 30 days immediately preceding the relevant due date for
payment (or such other date as the Trustee may accept in its discretion). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Paying Agent and Registrar</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, Wells Fargo Bank, National Association, a national banking association (the &#147;<U>Trustee</U>&#148;), will act as Paying Agent
and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act as Paying
Agent, Registrar or <FONT STYLE="white-space:nowrap">co-Registrar.</FONT> The transferor of any Security shall provide or cause to be provided to the Trustee all information necessary to allow the Trustee to comply with any applicable tax reporting
obligations, including without limitation any cost basis reporting obligations under Section&nbsp;6045 of the Code. In connection with any proposed exchange of a certificated Security for a Global Security, there shall be provided to the Trustee all
information necessary to allow the Trustee to comply with any applicable tax reporting obligations, including without limitation any cost basis reporting obligations under Section&nbsp;6045 of the Code. The Trustee may rely on information provided
to it by other Persons and shall have no responsibility to verify or ensure the accuracy of such information. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Indenture</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Securities under the eighth supplemental indenture (the &#147;<U>Supplemental Indenture</U>&#148;), dated as of
September&nbsp;18, 2019, to the indenture dated as of December&nbsp;1, 2009 (together with the Supplemental Indenture, the &#147;<U>Indenture</U>&#148;), among the Company, the Subsidiary Guarantors and the Trustee. The terms of the Securities
include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. &#167;&#167; 77aaa-77bbbb) (the &#147;<U>Act</U>&#148;). Terms defined in the Indenture and not defined herein have
the meanings ascribed thereto in the Indenture. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and the Act for a statement of those terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities are general unsecured obligations of the Company. The Company shall be
entitled, subject to its compliance with Section&nbsp;6.03 of the Indenture, to issue Additional Securities pursuant to Section&nbsp;3.14 of the Indenture. The Securities issued on the Issue Date, and any Additional Securities, will be treated as a
single class for all purposes under the Indenture. The Indenture contains covenants that limit the ability of the Company and its subsidiaries to incur additional indebtedness; pay dividends or distributions on, or redeem or repurchase capital
stock; make investments; issue or sell capital stock of subsidiaries; engage in transactions with affiliates; create liens on assets; transfer or sell assets; guarantee indebtedness; restrict dividends or other payments of subsidiaries; consolidate,
merge or transfer all or substantially all of its assets; and engage in sale/leaseback transactions. These covenants are subject to important exceptions and qualifications. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Optional Redemption</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth below, the Company shall not be entitled to redeem the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On and after February&nbsp;1, 2023, the Company shall be entitled at its option to redeem all or a portion of the Securities upon not less
than 30 nor more than 60 days&#146; notice, at the redemption prices (expressed in percentages of principal amount on the redemption date), plus accrued interest to the redemption date (subject to the right of Holders of record on the relevant
Record Date to receive interest due on the relevant Interest Payment Date), if redeemed during the <FONT STYLE="white-space:nowrap">12-month</FONT> period commencing on February&nbsp;1 of the years set forth below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Redemption&nbsp;Price</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102.250</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101.125</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.000</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, prior to February&nbsp;1, 2023, the Company shall be entitled at its option on one or more occasions to redeem
Securities (which includes Additional Securities, if any) in an aggregate principal amount not to exceed 35% of the aggregate principal amount of the Securities (which includes Additional Securities, if any) originally issued at a redemption price
(expressed as a percentage of principal amount) of 104.50%, plus accrued and unpaid interest to the redemption date, with the net cash proceeds from one or more Equity Offerings; <U>provided</U>, <U>however</U>, that (1)&nbsp;at least 65% of such
aggregate principal amount of Securities (which includes Additional Securities, if any) remains outstanding immediately after the occurrence of each such redemption (other than Securities held, directly or indirectly, by the Company or its
Affiliates); and (2)&nbsp;each such redemption occurs within 90 days after the date of the related Equity Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to
February&nbsp;1, 2023, the Company shall be entitled at its option to redeem all or a portion of the Securities at a redemption price equal to 100% of the principal amount of the Securities plus the Applicable Premium as of, and accrued and unpaid
interest to, the redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notice of Redemption</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption will be mailed (or with respect to Global Securities, to the extent permitted or required by applicable DTC procedures or
regulations, send electronically) at least 30 days but not more than 60 days before the redemption date to each Holder of Securities to be redeemed at his registered address. Securities in denominations larger than $2,000 principal amount may be
redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Securities (or portions thereof) to be redeemed on the redemption date is deposited with the Paying Agent on or
before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Securities (or such portions thereof) called for redemption. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Put Provisions</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon a Change of Control, any Holder will have the right to cause the Company to repurchase all or any part of the Securities of such Holder at
a repurchase price equal to 101% of the principal amount of the Securities to be repurchased plus accrued interest to the date of repurchase (subject to the right of Holders of record on the relevant Record Date to receive interest due on the
related Interest Payment Date) as provided in, and subject to the terms of, the Indenture. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Guarantee</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payment by the Company of the principal of and interest on the Securities is fully and unconditionally guaranteed on a joint and several
senior unsecured basis by each of the Subsidiary Guarantors to the extent set forth in the Indenture. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Denominations; Transfer; Exchange</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities are in registered form without coupons in denominations of $2,000 principal amount and any greater integral multiple of $1,000.
A Holder may transfer or exchange Securities in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Securities selected for redemption (except, in the case of a Security to be redeemed in part, the portion of the Security not to be redeemed) or any
Securities for a period of 15 days before a selection of Securities to be redeemed or 15 days before an Interest Payment Date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Persons Deemed Owners</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in paragraph 2 hereof, the registered Holder of this Security may be treated as the owner of it for all purposes. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Unclaimed Money</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If money for the payment of principal or interest on any Securities remains unclaimed for two years, the Trustee or Paying Agent shall pay the
money back to the Company at its request at the end of the two years after such principal or interest has become due or payable, unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must
look only to the Company as general creditors and not to the Trustee for payment. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Discharge and Defeasance</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time shall be entitled to terminate some or all of its obligations under the Securities and
the Indenture if the Company irrevocably deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Securities to redemption or maturity, as the case may be. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Amendment, Waiver</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (a)&nbsp;the Indenture and the Securities may be amended with the written consent of
the holders of at least a majority in principal amount outstanding of the Securities and (b)&nbsp;any default or noncompliance with any provision may be waived with the written consent of the holders of a majority in principal amount outstanding of
the Securities. Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company, the Subsidiary Guarantors and the Trustee shall be entitled to amend the Indenture or the Securities to cure any
ambiguity, omission, defect or inconsistency, or to comply with Article V of the Indenture, or to provide for uncertificated Securities in addition to or in place of certificated Securities, or to add guarantees with respect to the Securities,
including Subsidiary Guarantees, or to add additional covenants or surrender rights and powers conferred on the Company or the Subsidiary Guarantors, or to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conform the text of the Indenture or the Securities to any provision of the &#147;Description of Notes&#148; section of the Prospectus Supplement under certain circumstances, or to comply with
any requirement of the SEC in connection with qualifying the Indenture under the Act, or to make any change that does not adversely affect the rights of any Securityholder, or to make amendments to provisions of the Indenture relating to the form,
authentication, transfer and legending of the Securities. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Defaults and Remedies</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Indenture, Events of Default include (a)&nbsp;default for 30 days in payment of interest on the Securities; (b)&nbsp;default in
payment of principal on the Securities at maturity, upon redemption pursuant to paragraph 5 of the Securities, upon acceleration or otherwise, or failure by the Company to redeem or purchase Securities when required; (c)&nbsp;failure by the Company
or any Subsidiary Guarantor to comply with other agreements in the Indenture or the Securities, in certain cases subject to notice and lapse of time; (d)&nbsp;certain accelerations (including failure to pay within any grace period after final
maturity) of other Indebtedness of the Company, any Subsidiary Guarantor or any Significant Subsidiary if the amount accelerated (or so unpaid) exceeds $50&nbsp;million; (e)&nbsp;certain events of bankruptcy or insolvency with respect to the
Company, a Subsidiary Guarantor or any Significant Subsidiary; (f)&nbsp;certain judgments or decrees for the payment of money in excess of $50&nbsp;million against the Company, a Subsidiary Guarantor or any Significant Subsidiary; and
(g)&nbsp;certain defaults with respect to Subsidiary Guarantees. If an Event of Default occurs and is continuing, the Trustee or the holders of at least 25% in principal amount of the Securities may declare all the Securities to be due and payable
immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Securities being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securityholders may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Securities unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Securities may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Securityholders notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding notice is in the interest of the Holders. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Trustee Dealings with the Company</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the Act, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Securities and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any
Paying Agent, Registrar, <FONT STYLE="white-space:nowrap">co-Registrar</FONT> or <FONT STYLE="white-space:nowrap">co-Paying</FONT> Agent may do the same with like rights. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>No Recourse Against Others</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or any Subsidiary Guarantor shall not have any liability for any
obligations of the Company or any Subsidiary Guarantor under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security, each Securityholder waives and
releases all such liability. The waiver and release are part of the consideration for the issue of the Securities. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authentication</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Security shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the other side of this Security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Abbreviations</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Securityholder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by
the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>CUSIP Numbers</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers
to be printed on the Securities and has directed the Trustee to use CUSIP numbers in notices of redemption as a convenience to Securityholders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as
contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE
PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will furnish to any Securityholder upon written request and without charge to the Securityholder a copy of the Indenture which has in it the text of the form of this Security. Requests may be made to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assign this Security, fill in the form below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I or we
assign and transfer this Security to </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(Print or type assignee&#146;s name, address and zip code) </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(Insert assignee&#146;s Social
Security or Tax I.D. No.)&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> agent to transfer this
Security on the books of the Company. The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DATE: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YOUR SIGNATURE:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the other side of this Security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[TO BE ATTACHED TO GLOBAL SECURITIES] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following increases or decreases in this Global Security have been made: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Date of Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount&nbsp;of&nbsp;decrease<BR>in Principal amount<BR>of this Global<BR>Security</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount&nbsp;of&nbsp;increase<BR>in&nbsp;Principal&nbsp;amount<BR>of this Global<BR>Security</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal&nbsp;amount&nbsp;of<BR>this&nbsp;Global&nbsp;Security<BR>following such<BR>decrease&nbsp;or&nbsp;increase</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Signature of<BR>authorized&nbsp;officer&nbsp;of<BR>Trustee&nbsp;or&nbsp;Securities<BR>Custodian</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OPTION OF HOLDER TO ELECT PURCHASE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you want to elect to have this Security purchased by the Company pursuant to Section&nbsp;6.06 or 6.08 of the Indenture, check the box:
&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you want to elect to have only part of this Security purchased by the Company pursuant to Section&nbsp;6.06 or 6.08 of the
Indenture, state the amount in principal amount: $ </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Your</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Signature:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">(Sign exactly as your name appears on the other side of this Security.)</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature&nbsp;Guarantee:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(Signature must be guaranteed)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signatures must be guaranteed by an &#147;eligible guarantor institution&#148; meeting the requirements of the Registrar,
which requirements include membership or participation in the Security Transfer Agent Medallion Program (&#147;<U>STAMP</U>&#148;) or such other &#147;signature guarantee program&#148; as may be determined by the Registrar in addition to, or in
substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF GUARANTY AGREEMENT] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">GUARANTY AGREEMENT (this &#147;<U>Guaranty Agreement</U>&#148;) dated as of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; among [GUARANTOR] (the
&#147;<U>New Guarantor</U>&#148;), a subsidiary of ENCOMPASS HEALTH CORPORATION (or its successor), a Delaware corporation (the &#147;<U>Company</U>&#148;), the subsidiary guarantors party to the Indenture (defined below) (the &#147;<U>Subsidiary
Guarantors</U>&#148;), in favor of WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee under the Indenture (the &#147;<U>Trustee</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H : </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS
the Company and the Subsidiary Guarantors (the &#147;<U>Existing Guarantors</U>&#148;) have heretofore executed and delivered to the Trustee an eighth supplemental indenture (the &#147;<U>Eighth Supplemental Indenture</U>&#148;) dated as of
September&nbsp;18, 2019, to the indenture (together with the Eighth Supplemental Indenture, the &#147;<U>Indenture</U>&#148;) dated as of December&nbsp;1, 2009, providing for the issuance of the Company&#146;s 4.500% Senior Notes due 2028 (the
&#147;<U>Securities</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS Section&nbsp;6.11 of the Indenture provides that under certain circumstances the Company is
required to cause the New Guarantor to execute and deliver to the Trustee an agreement pursuant to which the New Guarantor shall unconditionally guarantee all the Company&#146;s obligations under the Securities pursuant to a Subsidiary Guarantee on
the terms and conditions set forth herein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the New Guarantor and the Company mutually covenant and agree for the equal and ratable benefit of the holders of the Securities as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Agreement to Guarantee</U>. The New Guarantor hereby agrees, jointly and severally with all Existing Guarantors, to unconditionally
guarantee the Company&#146;s obligations under the Securities on the terms and subject to the conditions set forth in Article V of the Eighth Supplemental Indenture and to be bound by all other applicable provisions of the Indenture and the
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Ratification of Indenture; Supplemental Indentures and Guaranty Agreements Part of Indenture</U>. Except as expressly
amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Guaranty Agreement shall form a part of the Indenture for all purposes, and
every holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Governing Law</U>. <B>THIS
GUARANTY AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION
WOULD BE REQUIRED THEREBY.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Trustee Makes No Representation</U>. The Trustee makes no representation and shall not be
responsible or accountable as to the validity, execution by the parties hereto or thereto or sufficiency of this Guaranty Agreement or the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Counterparts</U>. The parties may sign any number of copies of this Guaranty Agreement. Each signed copy shall be an original, but all
of them together represent the same agreement. Signatures of the parties hereto transmitted by facsimile or PDF may be used in lieu of the originals and shall be deemed to be their original signatures for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Effect of Headings</U>. The Section headings herein are for convenience only and shall not affect the construction thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Guaranty Agreement to be duly
executed as of the date first above written. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[NEW GUARANTOR], </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">by </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Name: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">by </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>d760186dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NINTH SUPPLEMENTAL INDENTURE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ENCOMPASS HEALTH CORPORATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4.750% SENIOR NOTES DUE 2030 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">WELLS FARGO BANK, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NATIONAL
ASSOCIATION, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Trustee </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of September&nbsp;18, 2019 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE I Establishment of New Series</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 1.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Establishment of New Series</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE II Definitions</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 2.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Definitions</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE III The Securities</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 3.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Form</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE IV Amendment Of Base Indenture</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article I of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.02.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article III of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.03.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article IV of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.04.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article V of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.05.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article VI of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.06.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendments of Article VII of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.07.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XI of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.08.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XII of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.09.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XIII of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 4.10.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Amendment of Article XIV of Base Indenture</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE V Subsidiary Guarantees</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Guarantees</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.02.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Limitation on Liability</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.03.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Successors and Assigns</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.04.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>No Waiver</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.05.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Modification</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.06.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Release of Subsidiary Guarantor</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 5.07.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Contribution</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE VI Miscellaneous</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.01.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Integral Part</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.02.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Adoption, Ratification and Confirmation</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.03.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Counterparts</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.04.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Severability</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.05.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Governing Law</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.06.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Trustee Makes No Representation</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.07.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>Damages Limitation</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECTION 6.08.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>U.S.A. PATRIOT Act</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EXHIBIT A: Form of Security</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EXHIBIT B: Form of Guaranty Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NINTH SUPPLEMENTAL INDENTURE dated as of September&nbsp;18, 2019 (this &#147;<U>Supplemental
Indenture</U>&#148;), between ENCOMPASS HEALTH CORPORATION, a Delaware corporation (formerly known as HealthSouth Corporation, the &#147;<U>Company</U>&#148;), the SUBSIDIARY GUARANTORS (as defined herein) party hereto and WELLS FARGO BANK, NATIONAL
ASSOCIATION, as trustee (the &#147;<U>Trustee</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Company has heretofore entered into a senior indenture, dated as of December&nbsp;1, 2009 (the &#147;<U>Base Indenture</U>&#148;),
with the Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Base Indenture, as supplemented by this Supplemental Indenture, is herein called the
&#147;<U>Indenture</U>&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to Section&nbsp;3.01 of the Indenture, the form and terms of a new series of Securities
may at any time be established by a supplemental indenture executed by the Company and the Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Company proposes to
create under the Indenture a new series of Securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS additional Securities of this series and other series hereafter
established, except as may be limited in the Indenture as at the time supplemented and modified, may be issued from time to time pursuant to the Indenture as at the time supplemented and modified; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS all conditions necessary to authorize the execution and delivery of this Supplemental Indenture and to make it a valid and binding
obligation of the Company and the Subsidiary Guarantors have been done or performed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the agreements
and obligations set forth herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESTABLISHMENT OF NEW SERIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 1.01. <U>Establishment of New Series</U>. (a)&nbsp;There is hereby established a new series of Securities to be issued under the
Indenture, to be designated as the Company&#146;s 4.750% Senior Notes due 2030 (the &#147;<U>Securities</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) On the Issue
Date, the Trustee shall authenticate and deliver $500,000,000.00 of the Securities and, at any time and from time to time thereafter, the Trustee shall authenticate and deliver Additional Securities for original issue in accordance with
Section&nbsp;3.14 of the Indenture in an aggregate principal amount specified in the applicable resolution of the Board of Directors and Officers&#146; Certificate. Further, from time to time after the original issue date, Securities shall be
authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of other Securities as set forth in the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Securities shall be issued initially in the form of one or more Global Securities in substantially the form set out in Exhibit A
hereto. The Depositary with respect to the Securities shall be DTC. The Company initially appoints the Trustee to act as the Registrar and Paying Agent and to act as custodian with respect to the Global Securities. The Company has entered into a
letter of representations with the Depositary in the form provided by the Depositary and the Trustee and each agent are hereby authorized to act in accordance with such letter and applicable Depositary procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Security shall be dated the date of authentication thereof and shall bear interest as provided in the form of Security in Exhibit A
hereto. The date on which principal is payable on the Securities shall be as provided in the form of Security in Exhibit A hereto. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The record dates for the Securities and the manner of payment of principal and interest
on the Securities shall be as provided in the form of Security in Exhibit A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) If and to the extent that the provisions of the
Base Indenture are duplicative of, or in contradiction with, the provisions of this Supplemental Indenture, the provisions of this Supplemental Indenture shall govern, but solely with respect to the Securities. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.01. <U>Definitions</U>. For purposes of the Indenture, but only with respect to the Securities, and the Securities, the
following terms have the meanings indicated below. All capitalized terms used herein and not otherwise defined below shall have the meanings ascribed thereto in the Base Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Assets</U>&#148; means (1)&nbsp;any property or assets used in a Related Business; (2)&nbsp;the Capital Stock of a Person
that becomes a Restricted Subsidiary as a result of the acquisition of such Capital Stock by the Company or another Restricted Subsidiary; or (3)&nbsp;Capital Stock constituting a minority interest in any Person that at such time is a Restricted
Subsidiary; <U>provided</U>, <U>however</U>, that any such Restricted Subsidiary described in clause (2)&nbsp;or (3) above is primarily engaged in a Related Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Securities</U>&#148; means Securities issued under the terms of this Indenture subsequent to the Issue Date, and in
compliance with Sections 3.14 and 6.03, it being understood that any Securities issued in exchange for or replacement of any Security issued on the Issue Date shall not be an Additional Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Adjusted Treasury Rate</U>&#148; means, with respect to any redemption date, (1)&nbsp;the yield, under the heading which represents
the average for the immediately preceding week, appearing in the most recently published statistical release designated &#147;H.15(519)&#148; or any successor publication that is published weekly by the Board of Governors of the Federal Reserve
System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption &#147;Treasury Constant Maturities,&#148; for the maturity corresponding to the Comparable Treasury Issue (if no
maturity is within three months before or after February&nbsp;1, 2025, yields for the two published maturities most closely corresponding to the Comparable Treasury Issue shall be determined and the Adjusted Treasury Rate shall be interpolated or
extrapolated from such yields on a straight line basis, rounding to the nearest month) or (2)&nbsp;if such release (or any successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate
per year equal to the semiannual equivalent yield to maturity of the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date, in each case calculated on the third
Business Day immediately preceding the redemption date, and in each case of (1)&nbsp;and (2), plus 0.50%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; of
any specified Person means any other Person, directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, &#147;control&#148; when used with respect
to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms &#147;controlling&#148; and
&#147;controlled&#148; have meanings correlative to the foregoing. No Person (other than the Company or any Subsidiary of the Company) in whom a Receivables Entity makes an Investment in connection with a Qualified Receivables Transaction will be
deemed to be an Affiliate of the Company or any of its Subsidiaries solely by reason of such Investment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable
Premium</U>&#148; means, with respect to a Security at any redemption date, the greater of (1) 1.00% of the principal amount of such Security and (2)&nbsp;the excess of (A)&nbsp;the present value at such redemption date of (i)&nbsp;the redemption
price of such Security on February&nbsp;1, 2025 (such redemption price being set forth in paragraph 5 of such Security, exclusive of any accrued interest), plus (ii)&nbsp;all required remaining scheduled interest payments due on such Security
through February&nbsp;1, 2025 (but excluding accrued and unpaid interest to the redemption date), computed using a discount rate equal to the Adjusted Treasury Rate, over (B)&nbsp;the principal amount of such Security on such redemption date. The
Company will provide written notice to the Trustee of the Applicable Premium promptly after calculation and the Trustee will not be responsible for such calculation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Disposition</U>&#148; means any sale, lease, transfer or other disposition
(or series of related sales, leases, transfers or dispositions) by the Company or any Restricted Subsidiary, including any disposition by means of a merger, consolidation or similar transaction (each referred to for the purposes of this definition
as a &#147;<U>disposition</U>&#148;), of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any shares of Capital Stock of a Restricted Subsidiary (other than directors&#146;
qualifying shares or shares required by applicable law to be held by a Person other than the Company or a Restricted Subsidiary); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all
or substantially all the assets of any division or line of business of the Company or any Restricted Subsidiary; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) any other assets
of the Company or any Restricted Subsidiary outside of the ordinary course of business of the Company or such Restricted Subsidiary; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">other than, in the case of clauses (1), (2) and (3)&nbsp;above, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) a disposition by a Restricted Subsidiary to the Company or by the Company or a Restricted Subsidiary to a Restricted
Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) for purposes of Section&nbsp;6.06 only, a disposition that constitutes a Restricted Payment (or would
constitute a Restricted Payment but for the exclusions from the definition thereof) that is not prohibited by Section&nbsp;6.04 or that constitutes a Permitted Investment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) a disposition of all or substantially all the assets of the Company in accordance with Section&nbsp;5.01; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) a disposition of Capital Stock or other assets with a Fair Market Value of less than or equal to $10,000,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) sales of damaged, <FONT STYLE="white-space:nowrap">worn-out</FONT> or obsolete equipment or assets in the ordinary course
of business that, in the Company&#146;s reasonable judgment, are no longer either used or useful in the business of the Company or its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) the sale or discount, in each case without recourse, of accounts receivable arising in the ordinary course of business, but
only in connection with the compromise or collection thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) sales of accounts receivable and related assets of the
type specified in the definition of &#147;<U>Qualified Receivables Transaction</U>&#148; to a Receivables Entity; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H)
transfers of accounts receivable and related assets of the type specified in the definition of &#147;<U>Qualified Receivables Transaction</U>&#148; (or a fractional undivided interest therein) by a Receivables Entity in a Qualified Receivables
Transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) leases or subleases to third Persons in the ordinary course of business that do not interfere in any
material respect with the business of the Company or any of its Restricted Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) a disposition of cash or
Temporary Cash Investments; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(K) the creation of a Lien (but not the sale or other disposition of the property subject
to such Lien). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Attributable Debt</U>&#148; in respect of a Sale/Leaseback Transaction means, as at the time of determination,
the present value (discounted at the interest rate implicit in the lease, compounded annually) of the total obligations of the lessee for rental payments during the remaining term of the lease included in such Sale/Leaseback Transaction (including
any period for which such lease has been extended); <U>provided</U>, <U>however</U>, that if such Sale/Leaseback Transaction results in a Finance Lease Obligation, the amount of Indebtedness represented thereby shall be determined in accordance with
the definition of &#147;Finance Lease Obligation.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Average Life</U>&#148; means, as of the date of determination, with respect to any
Indebtedness, the quotient obtained by dividing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the sum of the products of the numbers of years from the date of determination to
the dates of each successive scheduled principal payment of or redemption or similar payment with respect to such Indebtedness multiplied by the amount of such payment by </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the sum of all such payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means each day which is not a Saturday, a Sunday or a day on which the Trustee is authorized or required by
law to close or banking institutions are not required to be open in the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Capital Markets
Indebtedness</U>&#148; means any Indebtedness: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) in the form of, or represented by, bonds (other than surety bonds, indemnity bonds,
performance bonds or bonds of a similar nature) or other securities or any Guarantee thereof; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) that is, or may be, quoted, listed
or purchased and sold on any stock exchange, automated trading system or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> or other securities market (including, without prejudice to the generality of
the foregoing, the market for securities eligible for resale pursuant to Rule 144A under the Securities Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Captive Insurance
Subsidiary</U>&#148; means HCS, Ltd., a Cayman Islands entity, and any successor to it, and any other Subsidiary formed for the purpose of facilitating self-insurance programs of the Company and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change of Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company becomes aware that any &#147;person&#148; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) is or has
become the &#147;beneficial owner&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act, except that for purposes of this clause (1)&nbsp;such person shall
be deemed to have &#147;beneficial ownership&#148; of all shares that any such person has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of more than 50% of the total
voting power of the Voting Stock of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) at any time during any period of up to 24 consecutive months, commencing on the
Issue Date, individuals who at the beginning of such period constituted the Board of Directors (together with any new directors whose election by such Board of Directors or whose nomination for election by the shareholders of the Company was
approved by a vote of a majority of the directors of the Company then still in office who were either directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to
constitute a majority of the Board of Directors then in office; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company is liquidated or dissolved or adopts a plan of
liquidation or dissolution; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the merger or consolidation of the Company with or into another Person or the merger of another Person
with or into the Company, or the sale of all or substantially all the assets of the Company (determined on a consolidated basis) to another Person, other than a transaction following which (i)&nbsp;in the case of a merger or consolidation
transaction, holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction (or other securities into which such securities are converted as part of such merger or consolidation transaction) own
directly or indirectly at least a majority of the voting power of the Voting Stock of the surviving Person in such merger or consolidation transaction immediately after such transaction and (ii)&nbsp;in the case of a sale of assets transaction, each
transferee becomes an obligor in respect of the Securities and a Subsidiary of the transferor of such assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and any
applicable Treasury Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Issue</U>&#148; means the United States Treasury
security selected by the Quotation Agent as having a maturity comparable to the remaining term of the Securities from the redemption date to February&nbsp;1, 2025, that would be utilized, at the time of selection and in accordance with customary
financial practice, in pricing new issues of corporate debt securities of a maturity most nearly equal to February&nbsp;1, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Price</U>&#148; means, with respect to any redemption date, if clause (2)&nbsp;of the Adjusted Treasury Rate is
applicable, the average of two, or if not possible, such lesser number as is obtained by the Company, Reference Treasury Dealer Quotations for such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Amortization Expense</U>&#148; means, for any Person for any period, the amortization expense of such Person and its
Restricted Subsidiaries for such period (to the extent included in the computation of Consolidated Net Income of such Person), determined on a consolidated basis in accordance with GAAP, excluding amortization expense attributable to a prepaid item
that was paid in cash in a prior period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Coverage Ratio</U>&#148; as of any date of determination means the ratio
of (a)&nbsp;the aggregate amount of EBITDA for the period of the most recent four consecutive fiscal quarters ending at least 45 days prior to the date of such determination to (b)&nbsp;Consolidated Interest Expense for such four fiscal quarters;
<U>provided</U>, <U>however</U>, that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if the Company or any Restricted Subsidiary has Incurred any Indebtedness since the beginning
of such period that remains outstanding or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio is an Incurrence of Indebtedness, or both, EBITDA and Consolidated Interest Expense for such period shall be
calculated after giving effect on a pro forma basis to such Indebtedness (and the application of the proceeds thereof) as if such Indebtedness had been Incurred on the first day of such period; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if the Company or any Restricted Subsidiary has repaid, repurchased, defeased or otherwise discharged any Indebtedness since the beginning
of such period or if any Indebtedness is to be repaid, repurchased, defeased or otherwise discharged (in each case other than Indebtedness Incurred under any revolving credit facility unless such Indebtedness has been permanently repaid and has not
been replaced) on the date of the transaction giving rise to the need to calculate the Consolidated Coverage Ratio, EBITDA and Consolidated Interest Expense for such period shall be calculated on a pro forma basis as if such discharge had occurred
on the first day of such period and as if the Company or such Restricted Subsidiary had not earned the interest income actually earned during such period in respect of cash or Temporary Cash Investments used to repay, repurchase, defease or
otherwise discharge such Indebtedness; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if since the beginning of such period the Company or any Restricted Subsidiary shall have made
any Asset Disposition, EBITDA for such period shall be reduced by an amount equal to EBITDA (if positive) directly attributable to the assets which are the subject of such Asset Disposition for such period, or increased by an amount equal to EBITDA
(if negative), directly attributable thereto for such period and Consolidated Interest Expense for such period shall be reduced by an amount equal to the Consolidated Interest Expense directly attributable to any Indebtedness of the Company or any
Restricted Subsidiary repaid, repurchased, defeased or otherwise discharged with respect to the Company and its continuing Restricted Subsidiaries in connection with such Asset Disposition for such period (or, if the Capital Stock of any Restricted
Subsidiary is sold, the Consolidated Interest Expense for such period directly attributable to the Indebtedness of such Restricted Subsidiary to the extent the Company and its continuing Restricted Subsidiaries are no longer liable for such
Indebtedness after such sale); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) if since the beginning of such period the Company or any Restricted Subsidiary (by merger or
otherwise) shall have made an Investment in any Restricted Subsidiary (or any Person that becomes a Restricted Subsidiary) or an acquisition of assets, including any acquisition of assets occurring in connection with a transaction requiring a
calculation to be made hereunder, that constitutes a hospital or other health care-related business or all or substantially all of an operating unit of a business, EBITDA and Consolidated Interest Expense for such period shall be calculated after
giving pro forma effect thereto (including the Incurrence of any Indebtedness) as if such Investment or acquisition had occurred on the first day of such period; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) if since the beginning of such period any Person (that subsequently became a Restricted
Subsidiary or was merged with or into the Company or any Restricted Subsidiary since the beginning of such period) shall have made any Asset Disposition, any Investment or acquisition of assets that would have required an adjustment pursuant to
clause (3)&nbsp;or (4) above if made by the Company or a Restricted Subsidiary during such period, EBITDA and Consolidated Interest Expense for such period shall be calculated after giving pro forma effect thereto as if such Asset Disposition,
Investment or acquisition had occurred on the first day of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this definition, whenever pro forma effect is to
be given to an acquisition of assets, the amount of income or earnings relating thereto and the amount of Consolidated Interest Expense associated with any Indebtedness Incurred in connection therewith, the pro forma calculations shall be determined
in good faith by a responsible financial or accounting Officer of the Company (and shall include any applicable Pro Forma Cost Savings). If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest on such
Indebtedness shall be calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period (taking into account any Interest Rate Agreement applicable to such Indebtedness). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Indebtedness is incurred under a revolving credit facility and is being given pro forma effect, the interest on such Indebtedness shall
be calculated based on the average daily balance of such Indebtedness for the four fiscal quarters subject to the pro forma calculation to the extent that such Indebtedness was incurred solely for working capital purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Depreciation Expense</U>&#148; means, for any Person for any period, the depreciation expense of such Person and its
Restricted Subsidiaries for such period (to the extent included in the computation of Consolidated Net Income of such Person), determined on a consolidated basis in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Income Tax Expense</U>&#148; means, for any Person for any period, the provision for taxes based on income and profits
of such Person and its Restricted Subsidiaries to the extent such provision for income taxes was deducted in computing Consolidated Net Income of such Person for such period, determined on a consolidated basis in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Interest Expense</U>&#148; means, for any period, the total interest expense of the Company and its consolidated
Restricted Subsidiaries, net of interest income of the Company and its consolidated Restricted Subsidiaries (other than interest income of any Captive Insurance Subsidiary that is a Restricted Subsidiary), <U>plus</U>, to the extent not included in
the calculation of total interest expense, and to the extent incurred by the Company or its Restricted Subsidiaries, without duplication: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) interest expense attributable to Finance Lease Obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) amortization of debt discount; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) capitalized interest; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) <FONT
STYLE="white-space:nowrap">non-cash</FONT> interest expense; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) commissions, discounts and other fees and charges owed with respect to
letters of credit and bankers&#146; acceptance financing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) net payments made or received pursuant to Hedging Obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) dividends accrued in respect of all Disqualified Stock of the Company and all Preferred Stock of any Restricted Subsidiary, in each case
held by Persons other than the Company or a Wholly Owned Subsidiary (other than dividends payable solely in Capital Stock (other than Disqualified Stock) of the Company); <U>provided</U>, <U>however</U>, that such dividends shall be multiplied by a
fraction the numerator of which is one and the denominator of which is one minus the effective combined tax rate of the issuer of such Preferred Stock (expressed as a decimal) for such period (as estimated by the chief financial officer of the
Company in good faith); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) interest accruing on any Indebtedness of any other Person to the extent such
Indebtedness is Guaranteed by (or secured by the assets of) the Company or any Restricted Subsidiary; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) the cash contributions to
any employee stock ownership plan or similar trust to the extent such contributions are used by such plan or trust to pay interest or fees to any Person (other than the Company) in connection with Indebtedness Incurred by such plan or trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Net Income</U>&#148; means, for any period, the net income of the Company and its consolidated Subsidiaries;
<U>provided</U>, <U>however</U>, that there shall not be included in such Consolidated Net Income: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any net income of any Person
(other than the Company) if such Person is not a Restricted Subsidiary, except that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) subject to the exclusion
contained in clause (4)&nbsp;below, the Company&#146;s equity in the net income of any such Person for such period shall be included in such Consolidated Net Income up to the aggregate amount of cash actually distributed by such Person during such
period to the Company or a Restricted Subsidiary as a dividend or other distribution (subject, in the case of a dividend or other distribution paid to a Restricted Subsidiary, to the limitations contained in clause (3)&nbsp;below); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the Company&#146;s equity in a net loss of any such Person for such period shall be included in determining such
Consolidated Net Income to the extent such loss has been funded with cash from the Company or a Restricted Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any net income
(or loss) of any Person acquired by the Company or a Subsidiary in a pooling of interests transaction (or any transaction accounted for in a manner similar to a pooling of interests) for any period prior to the date of such acquisition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) any net income of any Restricted Subsidiary if such Restricted Subsidiary is subject to restrictions, directly or indirectly, on the
payment of dividends or the making of distributions by such Restricted Subsidiary, directly or indirectly, to the Company, except that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) subject to the exclusion contained in clause (4)&nbsp;below, the Company&#146;s equity in the net income of any such
Restricted Subsidiary for such period shall be included in such Consolidated Net Income up to the aggregate amount of cash that could have been distributed by such Restricted Subsidiary during such period to the Company or another Restricted
Subsidiary as a dividend or other distribution (subject, in the case of a dividend or other distribution paid to another Restricted Subsidiary, to the limitation contained in this clause); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the Company&#146;s equity in a net loss of any such Restricted Subsidiary for such period shall be included in determining
such Consolidated Net Income; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) any gain (or loss) realized upon the sale or other disposition of any assets of the Company, its
consolidated Subsidiaries or any other Person (including pursuant to any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sale-and-leaseback</FONT></FONT> arrangement) which is not sold or otherwise disposed of in the ordinary
course of business and any gain (or loss) realized upon the sale or other disposition of any Capital Stock of any Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) any net
income or net losses from discontinued operations; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) extraordinary gains or losses; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) the cumulative effect of a change in accounting principles, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, for such period. Notwithstanding the foregoing, for the purposes of Section&nbsp;6.04 only, there shall be excluded from Consolidated Net Income
any repurchases, repayments or redemptions of Investments, proceeds realized on the sale of Investments or return of capital to the Company or a Restricted Subsidiary to the extent such repurchases, repayments, redemptions, proceeds or returns
increase the amount of Restricted Payments permitted under clause (a)(3)(D) or (a)(3)(E) of Section&nbsp;6.04. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Secured Debt Ratio</U>&#148; as of any date of determination, means
the ratio of (a)&nbsp;Indebtedness of the Company and its Restricted Subsidiaries, determined on a consolidated basis, secured by Liens, to (b)&nbsp;the aggregate amount of EBITDA for the period of the most recent four consecutive fiscal quarters
ending at least 45 days prior to the date of such determination, in each case with such pro forma adjustments to consolidated total Indebtedness and EBITDA as are appropriate and consistent with the pro forma adjustment provisions set forth in the
definition of &#147;Consolidated Coverage Ratio.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Tangible Assets</U>&#148; as of any date means the total
assets of the Company and its Restricted Subsidiaries (excluding any assets that would be classified as &#147;intangible assets&#148; under GAAP) on a consolidated basis at such date, as determined in accordance with GAAP, less (i)&nbsp;all <FONT
STYLE="white-space:nowrap">write-ups</FONT> subsequent to the Issue Date in the book value of any asset owned by the Company or any of its Restricted Subsidiaries and (ii)&nbsp;Investments in and assets of Unrestricted Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Total Indebtedness</U>&#148; of any Person as of any date means (a)&nbsp;all Indebtedness (including Finance Lease
Obligations but excluding (i)&nbsp;Hedging Obligations and (ii)&nbsp;to the extent they constitute Indebtedness, contingent reimbursement obligations in respect of undrawn amounts of letters of credit) minus (b)&nbsp;the aggregate amount of cash and
cash equivalents of such Person and its Subsidiaries (other than Restricted Cash and Cash Equivalents) as of such date in an amount not to exceed $100,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Corporate Trust Office</U>&#148; shall be the office of the Trustee at which this Indenture shall be principally administered, which
at the Issue Date is 150 East 42nd Street, 40th Floor, New York, New York 10017, Attn: Corporate, Trust Services, and with respect to Paying Agent and Registrar services such office shall also mean the office or agency of the Trustee located at 600
South Fourth Street, 7th Floor, Minneapolis, MN 55415, Attn: Corporate Trust Operations, or such other address as to which the Trustee may give notice to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Credit Agreement</U>&#148; means the Fourth Amended and Restated Credit Agreement dated as of September&nbsp;29, 2017, by and among
the Company, as borrower, Barclays Bank PLC, as administrative agent, and the other lenders and agents party thereto from time to time, together with the related documents thereto (including the term loans and revolving loans thereunder, any
guarantees and security documents), as amended, extended, renewed, restated, supplemented or otherwise modified (in whole or in part, and without limitation as to amount, terms, conditions, covenants and other provisions) from time to time, and any
agreement (and related document) governing Indebtedness incurred to Refinance, in whole or in part, the borrowings and commitments then outstanding or permitted to be outstanding under such Credit Agreement or a successor Credit Agreement, whether
by the same or any other lender or group of lenders (including by means of sales of debt securities to institutional investors). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Currency Agreement</U>&#148; means any foreign exchange contract, currency swap agreement or other similar agreement with respect to
currency values. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DTC</U>&#148; means The Depository Trust Company, a New York corporation, or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Designated Noncash Consideration</U>&#148; means noncash consideration received by the Company or one of its Restricted Subsidiaries
in connection with an Asset Disposition that is designated by the Company as Designated Noncash Consideration, less the amount of cash or cash equivalents received in connection with a subsequent sale of such Designated Noncash Consideration, which
cash and cash equivalents shall be considered Net Available Cash received as of such date and shall be applied pursuant to Section&nbsp;6.06. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disqualified Stock</U>&#148; means, with respect to any Person, any Capital Stock that by its terms (or by the terms of any security
into which it is convertible or for which it is exchangeable at the option of the holder) or upon the happening of any event: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) matures
or is mandatorily redeemable (other than redeemable only for Capital Stock of such Person which is not itself Disqualified Stock) pursuant to a sinking fund obligation or otherwise; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) is convertible or exchangeable at the option of the holder for Indebtedness or
Disqualified Stock; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) is mandatorily redeemable or must be purchased upon the occurrence of certain events or otherwise, in whole or
in part; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case on or prior to the date that is 91 days after the Stated Maturity of the Securities; <U>provided</U>, <U>however</U>, that any
Capital Stock that would not constitute Disqualified Stock but for provisions thereof giving holders thereof the right to require such Person to purchase or redeem such Capital Stock upon the occurrence of an &#147;asset sale&#148; or &#147;change
of control&#148; occurring prior to the date that is 91 days after the Stated Maturity of the Securities shall not constitute Disqualified Stock if the &#147;asset sale&#148; or &#147;change of control&#148; provisions applicable to such Capital
Stock are not more favorable to the holders of such Capital Stock than the terms applicable to the Securities under Sections 6.06 and 6.08. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of any Disqualified Stock that does not have a fixed redemption, repayment or repurchase price shall be calculated in accordance
with the terms of such Disqualified Stock as if such Disqualified Stock were redeemed, repaid or repurchased on any date on which the amount of such Disqualified Stock is to be determined pursuant to this Indenture; <U>provided</U>, <U>however</U>,
that if such Disqualified Stock could not be required to be redeemed, repaid or repurchased at the time of such determination, the redemption, repayment or repurchase price shall be the book value of such Disqualified Stock as reflected in the most
recent financial statements of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>EBITDA</U>&#148; of any Person for any period means Consolidated Net Income of such
Person for such period plus, without duplication, the sum for such Person of the following to the extent deducted in calculating Consolidated Net Income for such period: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Consolidated Income Tax Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Consolidated Depreciation Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Consolidated Amortization Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Consolidated Interest Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) all other <FONT STYLE="white-space:nowrap">non-cash</FONT> items or <FONT STYLE="white-space:nowrap">non-recurring</FONT> <FONT
STYLE="white-space:nowrap">non-cash</FONT> items reducing Consolidated Net Income of such Person and its Subsidiaries, determined on a consolidated basis in accordance with GAAP (including <FONT STYLE="white-space:nowrap">non-cash</FONT> charges
incurred as a result of the application of FASB Accounting Standard Codification 718, Compensation&#151;Stock Compensation); <U>provided</U> that cash expenditures made in respect of items to which the charges referred to in this clause
(5)&nbsp;relate in an aggregate amount in excess of $10,000,000 for any period of four consecutive fiscal quarters shall be deducted in determining EBITDA for the period during which such expenditures are made, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) any restructuring charges in respect of legal fees associated with the government, class-action and shareholder derivative litigation
described in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2009, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) fees, costs and expenses related to the offering of the Securities and the other Refinancing Transactions, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) any losses from discontinued operations and closed locations, and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) costs and expenses related to the settlement of the Shareholder Litigation, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case determined on a consolidated basis in accordance with GAAP, less all unusual noncash items or nonrecurring noncash items to the extent increasing
Consolidated Net Income of such Person and its Subsidiaries, determined on a consolidated basis in accordance with GAAP, in each case for such period. Notwithstanding the foregoing, the provision for taxes based on the income or profits of, and the
depreciation and amortization and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
noncash charges of, a Restricted Subsidiary shall be added to Consolidated Net Income to compute EBITDA only to the extent (and in the same proportion, including by reason of minority interests)
that the net income or loss of such Restricted Subsidiary was included in calculating Consolidated Net Income and only if a corresponding amount would be permitted at the date of determination to be dividended to the Company by such Restricted
Subsidiary without prior approval (that has not been obtained), pursuant to the terms of its charter and all agreements, instruments, judgments, decrees, orders, statutes, rules and governmental regulations applicable to such Restricted Subsidiary
or its stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Offering</U>&#148; means any public or private sale of Capital Stock (other than Disqualified Stock)
of the Company, other than public offerings with respect to the Company&#146;s common stock registered on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act and other than issuances to any Subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fair Market Value</U>&#148; means, with respect to any asset or property, the price that could be negotiated in an <FONT
STYLE="white-space:nowrap">arm&#146;s-length,</FONT> free market transaction, for cash, between a willing and able buyer and an unaffiliated willing seller, neither of whom is under undue pressure or compulsion to complete the transaction, as such
price is determined in good faith by (1)&nbsp;the Chief Financial Officer, the Treasurer or the Chief Accounting Officer of the Company (unless otherwise provided in this Indenture) for transactions valued at, or below, $10,000,000, or (2)&nbsp;the
Board of Directors of the Company (unless otherwise provided in this Indenture) for transactions valued in excess of $10,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finance Lease Obligation</U>&#148; means an obligation that is required to be classified and accounted for as a finance lease for
financial reporting purposes in accordance with GAAP, and the amount of Indebtedness represented by such obligation shall be the capitalized amount of such obligation determined in accordance with GAAP; and the Stated Maturity thereof shall be the
date of the last payment of rent or any other amount due under such lease prior to the first date upon which such lease may be terminated by the lessee without payment of a penalty. For purposes of Section&nbsp;6.09, a Finance Lease Obligation shall
be deemed to be secured by a Lien on the property being leased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guarantee</U>&#148; means any obligation, contingent or
otherwise, of any Person directly or indirectly guaranteeing any Indebtedness of any Person and any obligation, direct or indirect, contingent or otherwise, of such Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such Person (whether arising by virtue
of partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or services, to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">take-or-pay</FONT></FONT> or to maintain financial statement
conditions or otherwise); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) entered into for the purpose of assuring in any other manner the obligee of such Indebtedness of the
payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that the term
&#147;<U>Guarantee</U>&#148; shall not include endorsements for collection or deposit in the ordinary course of business. The term &#147;<U>Guarantee</U>&#148; used as a verb has a corresponding meaning. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guaranty Agreement</U>&#148; means an agreement, in substantially the form of Exhibit B hereto or another form satisfactory to the
Trustee, pursuant to which a Subsidiary Guarantor guarantees the Company&#146;s obligations with respect to the Securities on the terms provided for in this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hedging Obligations</U>&#148; of any Person means the obligations of such Person pursuant to any Interest Rate Agreement or Currency
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Incur</U>&#148; means issue, assume, Guarantee, incur or otherwise become liable for; <U>provided</U>,
<U>however</U>, that any Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) shall be deemed to be Incurred by such Person at the time it becomes a
Restricted Subsidiary. The term &#147;<U>Incurrence</U>&#148; when used as a noun shall have a correlative meaning. Solely for purposes of determining compliance with Section&nbsp;6.03: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) amortization of debt discount or the accretion of principal with respect to a noninterest bearing or other discount security; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the payment of regularly scheduled interest in the form of additional Indebtedness of
the same instrument or the payment of regularly scheduled dividends on Capital Stock in the form of additional Capital Stock of the same class and with the same terms; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the obligation to pay a premium in respect of Indebtedness arising in connection with the issuance of a notice of redemption or making of
a mandatory offer to purchase such Indebtedness </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">will not be deemed to be the Incurrence of Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, with respect to any Person on any date of determination (without duplication): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the principal in respect of (A)&nbsp;indebtedness of such Person for money borrowed and (B)&nbsp;indebtedness evidenced by notes,
debentures, bonds or other similar instruments for the payment of which such Person is responsible or liable, including, in each case, any premium on such indebtedness to the extent such premium has become due and payable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all Finance Lease Obligations of such Person and all Attributable Debt in respect of Sale/Leaseback Transactions entered into by such
Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) all obligations of such Person issued or assumed as the deferred purchase price of property, all conditional sale obligations
of such Person and all obligations of such Person under any title retention agreement (but excluding any accounts payable or other liability to trade creditors arising in the ordinary course of business); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) all obligations of such Person for the reimbursement of any obligor on any letter of credit, bankers&#146; acceptance or similar credit
transaction (other than obligations with respect to letters of credit securing obligations (other than obligations described in clauses (1)&nbsp;through (3) above) entered into in the ordinary course of business of such Person to the extent such
letters of credit are not drawn upon or, if and to the extent drawn upon, such drawing is reimbursed no later than the tenth Business Day following payment on the letter of credit); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the amount of all obligations of such Person with respect to the redemption, repayment or other repurchase of any Disqualified Stock of
such Person or, with respect to any Preferred Stock of any Subsidiary of such Person, the principal amount of such Preferred Stock to be determined in accordance with this Indenture (but excluding, in each case, any accrued dividends); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) all obligations of the type referred to in clauses (1)&nbsp;through (5) of other Persons and all dividends of other Persons for the
payment of which, in either case, such Person is responsible or liable, directly or indirectly, as obligor, guarantor or otherwise, including by means of any Guarantee; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) all obligations of the type referred to in clauses (1)&nbsp;through (6) of other Persons secured by any Lien on any property or asset of
such Person (whether or not such obligation is assumed by such Person), the amount of such obligation being deemed to be the lesser of the Fair Market Value of such property or assets and the amount of the obligation so secured; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) to the extent not otherwise included in this definition, Hedging Obligations of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, in connection with the purchase by the Company or any Restricted Subsidiary of any business, the term
&#147;Indebtedness&#148; will exclude indemnification, purchase price adjustment, holdback and contingency payment obligations to which the seller may become entitled to the extent such payment is determined by a final closing balance sheet or such
payment depends on the performance of such business after the closing; <U>provided</U>, <U>however</U>, that, at the time of closing, the amount of any such payment is not determinable and, to the extent such payment thereafter becomes fixed and
determined, the amount is paid within 60 days thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of Indebtedness of any Person at any date shall be the outstanding balance at
such date of all obligations as described above; <U>provided</U>, <U>however</U>, that in the case of Indebtedness sold at a discount, the amount of such Indebtedness at any time will be the accreted value thereof at such time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Qualified Party</U>&#148; means an investment banking firm, accounting firm or appraisal firm of national standing;
<U>provided</U>, <U>however</U>, that such firm is not an Affiliate of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Payment Date</U>&#148; means each
date specified in the Security as a fixed date on which an installment of interest is due and payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Rate
Agreement</U>&#148; means any interest rate swap agreement, interest rate cap agreement or other financial agreement or arrangement with respect to exposure to interest rates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investment</U>&#148; in any Person means any direct or indirect advance, loan (other than advances to customers in the ordinary
course of business that are recorded as accounts receivable on the balance sheet of the lender) or other extensions of credit (including by way of Guarantee or similar arrangement) or capital contribution to (by means of any transfer of cash or
other property to others or any payment for property or services for the account or use of others), or any purchase or acquisition of Capital Stock, Indebtedness or other similar instruments issued by such Person. If the Company or any Restricted
Subsidiary issues, sells or otherwise disposes of any Capital Stock of a Person that is a Restricted Subsidiary such that, after giving effect thereto, such Person is no longer a Restricted Subsidiary, any Investment by the Company or any Restricted
Subsidiary in such Person remaining after giving effect thereto will be deemed to be a new Investment at such time. The acquisition by the Company or any Restricted Subsidiary of a Person that holds an Investment in a third Person shall be deemed to
be an Investment by the Company or such Restricted Subsidiary in such third Person at such time. Except as otherwise provided for herein, the amount of an Investment shall be its Fair Market Value at the time the Investment is made and without
giving effect to subsequent changes in value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the definition of &#147;<U>Unrestricted Subsidiary</U>&#148;, the
definition of &#147;<U>Restricted Payment</U>&#148; and Section&nbsp;6.04: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &#147;<U>Investment</U>&#148; shall include the portion
(proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of any Subsidiary of the Company at the time that such Subsidiary is designated an Unrestricted Subsidiary; <U>provided</U>,
<U>however</U>, that upon a redesignation of such Subsidiary as a Restricted Subsidiary, the Company shall be deemed to continue to have a permanent &#147;Investment&#148; in an Unrestricted Subsidiary equal to an amount (if positive) equal to
(A)&nbsp;the Company&#146;s &#147;Investment&#148; in such Subsidiary at the time of such redesignation less (B)&nbsp;the portion (proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of
such Subsidiary at the time of such redesignation; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any property transferred to or from an Unrestricted Subsidiary shall be valued
at its Fair Market Value at the time of such transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issue Date</U>&#148; means September&nbsp;18, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Leverage Ratio</U>&#148; means, at any date, the ratio of (a)&nbsp;Consolidated Total Indebtedness of the Company and its Restricted
Subsidiaries on such date to (b)&nbsp;EBITDA of the Company and its Restricted Subsidiaries for the period of four consecutive fiscal quarters ending at least 45 days prior to such date, in each case with such pro forma adjustments as are
appropriate and consistent with the pro forma adjustment provisions set forth in the definition of &#147;Consolidated Coverage Ratio.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (including any conditional sale
or other title retention agreement or lease in the nature thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Moody&#146;s</U>&#148; means Moody&#146;s Investors Service,
Inc., and any successor to its rating agency business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Available Cash</U>&#148; from an Asset Disposition means cash payments received
therefrom (including any cash payments received by way of deferred payment of principal pursuant to a note or installment receivable or otherwise and proceeds from the sale or other disposition of any securities received as consideration, but only
as and when received, but excluding any other consideration received in the form of assumption by the acquiring Person of Indebtedness or other obligations relating to such properties or assets or received in any other
<FONT STYLE="white-space:nowrap">non-cash</FONT> form), in each case net of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) all legal, title and recording tax expenses, commissions
and other fees and expenses incurred (including legal, accounting and investment banking fees and commissions), and all federal, state, provincial, foreign and local taxes required to be accrued as a liability under GAAP, as a consequence of such
Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all payments made on any Indebtedness which is secured by any assets subject to such Asset Disposition, in
accordance with the terms of any Lien upon or other security agreement of any kind with respect to such assets, or which must by its terms, or in order to obtain a necessary consent to such Asset Disposition, or by applicable law, be repaid out of
the proceeds from such Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) all distributions and other payments required to be made to minority interest holders in
Restricted Subsidiaries as a result of such Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the deduction of appropriate amounts provided by the seller as a
reserve, in accordance with GAAP, against any liabilities associated with the property or other assets disposed in such Asset Disposition and retained by the Company or any Restricted Subsidiary after such Asset Disposition; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) any portion of the purchase price from an Asset Disposition placed in escrow, whether as a reserve for adjustment of the purchase price,
for satisfaction of indemnities in respect of such Asset Disposition or otherwise in connection with that Asset Disposition; <U>provided</U>, <U>however</U>, that upon the termination of that escrow, Net Available Cash shall be increased by any
portion of funds in the escrow that are released to the Company or any Restricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Cash Proceeds</U>&#148;, with
respect to any issuance or sale of Capital Stock or Indebtedness, means the cash proceeds of such issuance or sale net of attorneys&#146; fees, accountants&#146; fees, underwriters&#146; or placement agents&#146; fees, discounts or commissions and
brokerage, consultant and other fees actually incurred in connection with such issuance or sale and net of taxes paid or payable as a result thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Obligations</U>&#148; means, with respect to any Indebtedness, all obligations for principal, premium, interest, penalties, fees,
indemnifications, reimbursements, and other amounts payable pursuant to the documentation governing such Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer</U>&#148; means the Chairman of the Board of Directors, the Chief Executive Officer, the President, the Chief Financial
Officer, the Chief Accounting Officer, any Vice President, the Treasurer or the Secretary of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer&#146;s
Certificate</U>&#148; means a certificate signed by an Officer and delivered to the Trustee and &#147;<U>Officers&#146; Certificate</U>&#148; means a certificate signed by two Officers and delivered to the Trustee. Each such certificate shall
include the statements provided for in Section&nbsp;16.01 if and to the extent required by the provisions of such Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Opinion of Counsel</U>&#148; means an opinion in writing signed by legal counsel who may be an employee of or counsel to the Company
or may be other counsel who is reasonably acceptable to the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Investment</U>&#148; means an Investment by the
Company or any Restricted Subsidiary in: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company, a Restricted Subsidiary or a Person that shall, upon the making of such
Investment, become a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that the primary business of such Restricted Subsidiary is a Related Business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) another Person if, as a result of such Investment, such other Person is merged or
consolidated with or into, or transfers or conveys all or substantially all its assets to, the Company or a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that such Person&#146;s primary business is a Related Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) cash and Temporary Cash Investments; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) receivables owing to the Company or any Restricted Subsidiary if created or acquired in the ordinary course of business and payable or
dischargeable in accordance with customary trade terms; <U>provided</U>, <U>however</U>, that such trade terms may include such concessionary trade terms as the Company or any such Restricted Subsidiary deems reasonable under the circumstances; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) payroll, travel and similar advances to cover matters that are expected at the time of such advances ultimately to be treated as expenses
for accounting purposes and that are made in the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) loans or advances to officers, directors and employees
made in the ordinary course of business of the Company or such Restricted Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) stock, obligations or securities received in
settlement of debts created in the ordinary course of business and owing to the Company or any Restricted Subsidiary or in satisfaction of judgments; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) any Person to the extent such Investment represents the <FONT STYLE="white-space:nowrap">non-cash</FONT> portion of the consideration
received for (A)&nbsp;an Asset Disposition as permitted pursuant to Section&nbsp;6.06 or (B)&nbsp;a disposition of assets not constituting an Asset Disposition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) any Person where such Investment was acquired by the Company or any of its Restricted Subsidiaries (A)&nbsp;in exchange for any other
Investment or accounts receivable held by the Company or any such Restricted Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable or
(B)&nbsp;as a result of a foreclosure by the Company or any of its Restricted Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) any Person to the extent such Investments consist of prepaid expenses, negotiable instruments held for collection and lease, utility and
workers&#146; compensation, performance and other similar deposits made in the ordinary course of business by the Company or any Restricted Subsidiary; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) any Person to the extent such Investments consist of Hedging Obligations otherwise permitted under Section&nbsp;6.03; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) any Person to the extent such Investment exists on the Issue Date, and any extension, modification or renewal of any such Investments
existing on the Issue Date, but only to the extent not involving additional advances, contributions or other Investments of cash or other assets or other increases thereof (other than as a result of the accrual or accretion of interest or original
issue discount or the issuance of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-in-kind</FONT></FONT> securities, in each case, pursuant to the terms of such Investment as in effect on the Issue Date); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) Investments made by the Captive Insurance Subsidiary in the ordinary course of business and in accordance with applicable law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) a Receivables Entity, or any Investment by a Receivables Entity in any other Person in connection with a Qualified Receivables
Transaction, including Investments of funds held in accounts permitted or required by the arrangements governing such Qualified Receivables Transaction or any related Indebtedness; <U>provided</U>, <U>however</U>, that any Investment in a
Receivables Entity is in the form of a purchase money note, contribution of additional receivables or an equity interest; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) Persons
to the extent such Investments, when taken together with all other Investments made pursuant to this clause (15)&nbsp;and outstanding on the date such Investment is made, do not exceed 10% of Consolidated Tangible Assets, as determined based on the
consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means, with respect to any Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) pledges or deposits by such Person under worker&#146;s compensation laws, unemployment insurance laws or similar legislation, or good
faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person or deposits of cash or United
States government bonds to secure surety or appeal bonds to which such Person is a party, performance bonds or obligations of a like nature or deposits as security for contested taxes or import duties or for the payment of rent, in each case
Incurred in the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Liens imposed by law, such as carriers&#146;, warehousemen&#146;s and mechanics&#146;
Liens, in each case for sums not yet due or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which such Person shall then be proceeding with an appeal or
other proceedings for review and Liens arising solely by virtue of any statutory or common law provision relating to banker&#146;s Liens, rights of <FONT STYLE="white-space:nowrap">set-off</FONT> or similar rights and remedies as to deposit accounts
or other funds maintained with a creditor depository institution; <U>provided</U>, <U>however</U>, that (A)&nbsp;such deposit account is not a dedicated cash collateral account and is not subject to restrictions against access by the Company in
excess of those set forth by regulations promulgated by the Federal Reserve Board and (B)&nbsp;such deposit account is not intended by the Company or any Restricted Subsidiary to provide collateral to the depository institution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Liens for taxes, assessments or other governmental charges or claims, in each case not yet subject to penalties for <FONT
STYLE="white-space:nowrap">non-payment</FONT> or which are being contested in good faith by appropriate proceedings; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Liens in favor
of issuers of surety bonds or letters of credit issued pursuant to the request of and for the account of such Person in the ordinary course of its business; <U>provided</U>, <U>however</U>, that such letters of credit do not constitute Indebtedness;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) minor survey exceptions, minor encumbrances, easements or reservations of, or rights of others for, licenses, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real property or Liens
incidental to the conduct of the business of such Person or to the ownership of its properties which were not Incurred in connection with Indebtedness and which do not in the aggregate materially adversely affect the value of said properties or
materially impair their use in the operation of the business of such Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) Liens securing Indebtedness Incurred to finance the
construction, purchase or lease of, or repairs, improvements or additions to, property, plant or equipment of such Person; <U>provided</U>, <U>however</U>, that the Lien may not extend to any other property owned by such Person or any of its
Restricted Subsidiaries at the time the Lien is Incurred (other than assets and property affixed or appurtenant thereto), and the Indebtedness (other than any interest thereon) secured by the Lien may not be Incurred more than 180 days after the
later of the acquisition, completion of construction, repair, improvement, addition or commencement of full operation of the property subject to the Lien; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) Liens to secure Indebtedness permitted pursuant to Section&nbsp;6.03(b)(1);<I> </I><U>provided</U><I>, </I><U>however</U><I>, </I>that if
(x)&nbsp;on the date the secured Indebtedness is Incurred, and after giving pro forma effect to the Incurrence thereof, the Incurrence of such Indebtedness would result in the Consolidated Secured Debt Ratio exceeding 3.75 to 1.0, as determined
based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45&nbsp;days prior thereto, then (y)&nbsp;the total amount of Indebtedness that may be secured pursuant to this clause
(7)&nbsp;shall not exceed the greater of (i)&nbsp;the maximum amount of Indebtedness that could be Incurred on such date without such ratio being so exceeded and (ii)&nbsp;an amount equal to the maximum amount of Indebtedness that could then be
incurred pursuant to Section&nbsp;6.03(b)(1), less the amount of Indebtedness secured by Liens Incurred pursuant to clause (18)&nbsp;below and outstanding on such date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) Liens existing on the Issue Date (other than Liens referred to in the foregoing clause (7)); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) Liens on property or shares of Capital Stock of another Person at the time such other
Person becomes a Subsidiary of such Person; <U>provided</U>, <U>however</U>, that the Liens may not extend to any other property owned by such Person or any of its Restricted Subsidiaries (other than assets and property affixed or appurtenant
thereto); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) Liens on property at the time such Person or any of its Subsidiaries acquires the property, including any acquisition by
means of a merger or consolidation with or into such Person or a Subsidiary of such Person; <U>provided</U>, <U>however</U>, that the Liens may not extend to any other property owned by such Person or any of its Restricted Subsidiaries (other than
assets and property affixed or appurtenant thereto); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) Liens securing Indebtedness or other obligations of a Subsidiary of such Person
owing to such Person or a Wholly Owned Subsidiary of such Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) Liens securing Hedging Obligations so long as such Hedging
Obligations are permitted to be Incurred under this Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) any Lien on accounts receivable and related assets of the types
specified in the definition of &#147;<U>Qualified Receivables Transaction</U>&#148; incurred in connection with a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) Liens in favor of the Company or the Subsidiary Guarantors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) leases, subleases, licenses or sublicenses granted to third parties entered into in the ordinary course of business which do not
materially interfere with the conduct of the business of the Company and the Restricted Subsidiaries and which do not secure any Indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) Liens securing judgments, decrees, orders or awards for the payment of money not constituting an Event of Default in respect of which the
Company shall in good faith be prosecuting an appeal or proceedings for review, which appeal or proceedings shall not have been finally terminated, or in respect of which the period within which such appeal or proceedings may be initiated shall not
have expired; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) Liens to secure any Refinancing (or successive Refinancings) as a whole, or in part, of any Indebtedness secured by
any Lien referred to in the foregoing clause (6), (8), (9) or (10); <U>provided</U>, <U>however</U>, that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) such new
Lien shall be limited to all or part of the same property and assets that secured or, under the written agreements pursuant to which the original Lien arose, could secure the original Indebtedness (plus improvements and accessions to, such property
or proceeds or distributions thereof); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the Indebtedness secured by such Lien at such time is not increased to any
amount greater than the sum of (i)&nbsp;the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clause (6), (8), (9) or (10)&nbsp;at the time the original Lien became a Permitted Lien and (ii)&nbsp;an
amount necessary to pay any fees and expenses, including premiums, related to such refinancing, refunding, extension, renewal or replacement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18) other Liens securing Indebtedness (other than Subordinated Obligations) to the extent the Incurrence of such Indebtedness, when taken
together with all other Indebtedness secured by Liens Incurred pursuant to this clause (18)&nbsp;and outstanding on the date such other Lien is Incurred, and after giving pro forma effect to the Incurrence of such Indebtedness, would not result in
the Consolidated Secured Debt Ratio exceeding 3.75 to 1.0, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45&nbsp;days prior thereto; <U>provided</U><I>,
</I><U>however</U>, notwithstanding whether this clause (18)&nbsp;would then be available to secure Indebtedness, any Lien securing Indebtedness originally secured pursuant to this clause (18)&nbsp;may secure Refinancing Indebtedness in respect of
such Indebtedness, as long as such Lien does not extend to any property other than all or part of the same property and assets that secured or, under the written agreements pursuant to which such original Lien arose, could have secured the original
Indebtedness (plus improvements and accessions to, such property or proceeds or distributions thereof), and such Refinancing Indebtedness shall be deemed to have been secured pursuant to this clause (18); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) other Liens securing Indebtedness; provided that the aggregate principal amount of
Indebtedness secured by such Liens shall not exceed the greater of (A) $100,000,000 and (B) 3.0% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter
ending at least 45 days prior thereto (as of the date of granting such Liens and after giving pro forma effect to the Incurrence of such Indebtedness and the application of the net proceeds thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, &#147;Permitted Liens&#148; will not include any Lien described in clause (6), (9) or (10)&nbsp;above to the
extent such Lien applies to any Additional Assets acquired directly or indirectly from Net Available Cash pursuant to Section&nbsp;6.06. For purposes of this definition, the term &#147;Indebtedness&#148; shall be deemed to include interest on such
Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, corporation, partnership, limited liability company, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>principal</U>&#148; of a Security means the principal of the Security plus the premium, if any, payable on the Security which is due
or overdue or is to become due at the relevant time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pro Forma Cost Savings</U>&#148; means, with respect to any period, the
reduction in costs that were: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) directly attributable to an asset acquisition and calculated on a basis that is consistent with
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act in effect and applied as of the Issue Date, or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)
implemented by the business that was the subject of any such asset acquisition within the six months prior to or following the date of the asset acquisition and that are supportable and quantifiable by the underlying accounting records of such
business, as if, in the case of each of clause (1)&nbsp;and (2), all such reductions in costs had been effected as of the beginning of such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prospectus Supplement</U>&#148; means the Prospectus Supplement dated September&nbsp;9, 2019, and used in connection with the
offering of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Money Indebtedness</U>&#148; means Indebtedness (1)&nbsp;consisting of the deferred
purchase price of property, conditional sale obligations, obligations under any title retention agreement, other purchase money obligations and obligations in respect of industrial revenue bonds or similar Indebtedness, in each case where the
maturity of such Indebtedness does not exceed the anticipated useful life of the asset being financed, and (2)&nbsp;Incurred to finance the acquisition by the Company or a Restricted Subsidiary of such asset, including additions and improvements, in
the ordinary course of business, <U>provided</U>, <U>however</U>, that any Lien arising in connection with any such Indebtedness shall be limited to the specific asset being financed or, in the case of real property or fixtures, including additions
and improvements, the real property on which such asset is attached; <U>provided</U>, <U>further</U>, <U>however</U>, that such Indebtedness is Incurred within 180 days after such acquisition of such assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Qualified Receivables Transaction</U>&#148; means any transaction or series of transactions that may be entered into by the Company
or any of its Restricted Subsidiaries pursuant to which the Company or any of its Restricted Subsidiaries may sell, convey or otherwise transfer to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) a Receivables Entity (in the case of a transfer by the Company or any of its Restricted Subsidiaries) or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any other Person (in the case of a transfer by a Receivables Entity), </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or may grant a security interest in, any accounts receivable (whether now existing or arising in the future)
of the Company or any of its Restricted Subsidiaries, and any assets related thereto, including all collateral securing such accounts receivable, all contracts and all Guarantees or other obligations in respect of such accounts receivable, proceeds
of such accounts receivable and other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable; <U>provided</U>,
<U>however</U>, that the financing terms, covenants, termination events and other provisions thereof shall be market terms (as determined in good faith by the chief financial officer of the Company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant of a security interest in any accounts receivable of the Company or any of its Restricted Subsidiaries to secure Indebtedness
permitted pursuant to Section&nbsp;6.03(b)(1) shall not be deemed a Qualified Receivables Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Quotation Agent</U>&#148;
means the Reference Treasury Dealer selected by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Receivables Entity</U>&#148; means (a)&nbsp;a Wholly Owned
Subsidiary of the Company that is designated by the Board of Directors (as provided below) as a Receivables Entity or (b)&nbsp;another Person engaging in a Qualified Receivables Transaction with the Company, which Person engages in the business of
the financing of accounts receivable, and in either of clause (a)&nbsp;or (b): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) no portion of the Indebtedness or any other
obligations (contingent or otherwise) of such entity </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) is Guaranteed by the Company or any Subsidiary of the Company
(excluding Guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to Standard Securitization Undertakings), </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) is recourse to or obligates the Company or any Subsidiary of the Company in any way (other than pursuant to Standard
Securitization Undertakings), or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) subjects any property or asset of the Company or any Subsidiary of the Company,
directly or indirectly, contingently or otherwise, to the satisfaction thereof (other than pursuant to Standard Securitization Undertakings); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the entity is not an Affiliate of the Company or is an entity with which neither the Company nor any Subsidiary of the Company has any
material contract, agreement, arrangement or understanding other than on terms that the Company reasonably believes to be no less favorable to the Company or such Subsidiary than those that might be obtained at the time from Persons that are not
Affiliates of the Company; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) is an entity to which neither the Company nor any Subsidiary of the Company has any obligation to
maintain or preserve such entity&#146;s financial condition or cause such entity to achieve certain levels of operating results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such
designation by the Board of Directors shall be evidenced to the Trustee by filing with the Trustee a certified copy of the resolution of the Board of Directors giving effect to such designation and an Officers&#146; Certificate certifying that such
designation complied with the foregoing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer</U>&#148; means Citigroup Global Markets Inc. and
its successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer Quotations</U>&#148; means, with respect to each Reference Treasury Dealer
and any redemption date, the average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, quoted in writing to the Company by such Reference
Treasury Dealer at 5:00 p.m., New York City time, on the third Business Day immediately preceding such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinance</U>&#148; means, in respect of any Indebtedness, to refinance, extend, renew, refund, repay, prepay, purchase, redeem,
defease or retire, or to issue other Indebtedness in exchange or replacement for, such Indebtedness. &#147;Refinanced&#148; and &#147;Refinancing&#148; shall have correlative meanings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinancing Indebtedness</U>&#148; means Indebtedness that Refinances any
Indebtedness of the Company or any Restricted Subsidiary existing on the Issue Date or Incurred in compliance with this Indenture, including Indebtedness that Refinances Refinancing Indebtedness; <U>provided</U>, <U>however</U>, that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) such Refinancing Indebtedness has a Stated Maturity no earlier than the Stated Maturity of the Indebtedness being Refinanced; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) such Refinancing Indebtedness has an Average Life at the time such Refinancing Indebtedness is Incurred that is equal to or greater than
the Average Life of the Indebtedness being Refinanced; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) such Refinancing Indebtedness has an aggregate principal amount (or if
Incurred with original issue discount, an aggregate issue price) that is equal to or less than the aggregate principal amount (or if Incurred with original issue discount, the aggregate accreted value) then outstanding (plus fees and expenses,
including any premium and defeasance costs) under the Indebtedness being Refinanced; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) if the Indebtedness being Refinanced is
subordinated in right of payment to the Securities, such Refinancing Indebtedness is subordinated in right of payment to the Securities at least to the same extent as the Indebtedness being Refinanced; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>further</U>, <U>however</U>, that Refinancing Indebtedness shall not include (A)&nbsp;Indebtedness of a Subsidiary that is not a
Subsidiary Guarantor that Refinances Indebtedness of the Company or a Subsidiary Guarantor or (B)&nbsp;Indebtedness of the Company or a Restricted Subsidiary that Refinances Indebtedness of an Unrestricted Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinancing Transactions</U>&#148; means (i)&nbsp;the initial offering of the Securities and the use of the proceeds thereof to
Refinance Indebtedness outstanding under the Credit Agreement and (ii)&nbsp;the partial redemption of the Company&#146;s 5.75% Senior Notes due 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Related Business</U>&#148; means any business in which the Company or any of the Restricted Subsidiaries was engaged on the Issue
Date and any business related, ancillary or complementary to such business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Responsible Officer</U>&#148; means any officer
within the Corporate Trust Office of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers who at the time shall
have direct responsibility for the administration of the Indenture and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of such person&#146;s knowledge of and familiarity with
the particular subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Cash and Cash Equivalents</U>&#148; means, as of any date, (a)&nbsp;the cash and cash
equivalents held by any Captive Insurance Subsidiary and committed to third-party administrators for payment of the Company&#146;s insurance claims, (b)&nbsp;the cash and cash equivalents held by Syndicated Persons to the extent that such cash and
cash equivalents are required by the owners of such Syndicated Persons to be held in separate accounts and not otherwise commingled with the assets of the Company, (c)&nbsp;the cash and cash equivalents held by any Restricted Subsidiary to the
extent that, and for so long as, such cash and cash equivalents may not be distributed to the owner or owners of the equity interests in such Restricted Subsidiary under the terms of such Restricted Subsidiary&#146;s charter or any agreement,
instrument, judgment, decree, order, statute, rule or governmental regulation applicable to such Restricted Subsidiary, and (d)&nbsp;the cash collateral deposited by the Company pursuant to Section&nbsp;2.05(c) or Section&nbsp;2.05(l) of the Credit
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Payment</U>&#148; with respect to any Person means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the declaration or payment of any dividends or any other distributions of any sort in respect of its Capital Stock (including any payment
in connection with any merger or consolidation involving such Person) or similar payment to the direct or indirect holders of its Capital Stock (other than (A)&nbsp;dividends or distributions payable solely in its Capital Stock (other than
Disqualified Stock), (B) dividends or distributions payable solely to the Company or a Restricted Subsidiary and (C)&nbsp;pro rata dividends or other distributions made by a Subsidiary that is not a Wholly Owned Subsidiary to minority stockholders
(or owners of an equivalent interest in the case of a Subsidiary that is an entity other than a corporation)); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the purchase, repurchase, redemption, defeasance or other acquisition or retirement for
value of any Capital Stock of the Company held by any Person (other than by a Restricted Subsidiary) or of any Capital Stock of a Restricted Subsidiary held by any Affiliate of the Company (other than by a Restricted Subsidiary), including in
connection with any merger or consolidation); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the purchase, repurchase, redemption, defeasance or other acquisition or retirement for
value, prior to scheduled maturity, scheduled repayment or scheduled sinking fund payment of any Subordinated Obligations of the Company or any Subsidiary Guarantor (other than (A)&nbsp;from the Company or a Restricted Subsidiary or (B)&nbsp;the
purchase, repurchase, redemption, defeasance or other acquisition or retirement of Subordinated Obligations purchased in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year
of the date of such purchase, repurchase, redemption, defeasance or other acquisition or retirement); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the making of any Investment
(other than a Permitted Investment) in any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Subsidiary</U>&#148; means any Subsidiary of the Company that is
not an Unrestricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sale/Leaseback Transaction</U>&#148; means an arrangement relating to property owned by the
Company or a Restricted Subsidiary on the Issue Date or thereafter acquired by the Company or a Restricted Subsidiary whereby the Company or a Restricted Subsidiary transfers such property to a Person and the Company or a Restricted Subsidiary
leases it from such Person, other than leases between the Company and a Restricted Subsidiary or between Restricted Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Senior Indebtedness</U>&#148; means with respect to any Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Indebtedness of such Person, whether outstanding on the Issue Date or thereafter Incurred; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) all other Obligations of such Person (including interest accruing on or after the filing of any petition in bankruptcy or for
reorganization relating to such Person whether or not post-filing interest is allowed in such proceeding) in respect of Indebtedness described in clause (1)&nbsp;above </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">unless, in the case of clauses (1)&nbsp;and (2), in the instrument creating or evidencing the same or pursuant to which the same is outstanding, it is
provided that such Indebtedness or other obligations are subordinate in right of payment to the Securities or the Subsidiary Guarantee of such Person, as the case may be; <U>provided</U>, <U>however</U>, that Senior Indebtedness shall not include:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) any obligation of such Person to the Company or any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any liability for federal, state, local or other taxes owed or owing by such Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) any accounts payable or other liability to trade creditors arising in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) any Indebtedness or other Obligation of such Person which is subordinate or junior in any respect to any other Indebtedness
or other Obligation of such Person; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) that portion of any Indebtedness which at the time of Incurrence is Incurred in
violation of this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shareholder Litigation</U>&#148; means the federal securities class actions and the derivative
actions brought against the Company and/or certain of its former directors and officers and certain other parties in the United States District Court for the Northern District of Alabama and the Circuit Court in Jefferson County, Alabama relating to
financial reporting and related activity that occurred at the Company during periods ended in March 2003. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Significant Subsidiary</U>&#148; means any Restricted Subsidiary that would be a
&#147;Significant Subsidiary&#148; of the Company within the meaning of Rule <FONT STYLE="white-space:nowrap">1-02</FONT> under Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard</U><U></U><U>&nbsp;&amp; Poor&#146;s</U>&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings Services, a Standard&nbsp;&amp;
Poor&#146;s Financial Services LLC business, or any successor rating agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard Securitization Undertakings</U>&#148;
means representations, warranties, covenants and indemnities entered into by the Company or any Subsidiary of the Company that, taken as a whole, are customary in an accounts receivable transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stated Maturity</U>&#148; means, with respect to any security, the date specified in such security as the fixed date on which the
final payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision (but excluding any provision providing for the repurchase of such security at the option of the holder thereof upon the
happening of any contingency unless such contingency has occurred). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subordinated Obligation</U>&#148; means, with respect to a
Person, any Indebtedness of such Person (whether outstanding on the Issue Date or thereafter Incurred) which is subordinate or junior in right of payment to the Securities or a Subsidiary Guarantee of such Person, as the case may be, pursuant to a
written agreement to that effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary Guarantee</U>&#148; means a Guarantee by a Subsidiary Guarantor of the
Company&#146;s obligations with respect to the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary Guarantor</U>&#148; means each Subsidiary of the Company
that executes this Indenture as a guarantor on the Issue Date and each other Subsidiary of the Company that thereafter guarantees the Securities pursuant to the terms of this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Syndicated Person</U>&#148; means a Person the equity interests of which constitute Syndicated Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Syndication</U>&#148; means the sale of partnership or other equity interests (&#147;<U>Syndicated Interests</U>&#148;) in
Subsidiaries of the Company or other Persons controlled by the Company that own or operate health care facilities to (i)&nbsp;participating physicians, radiologists and other specialists, (ii)&nbsp;professional corporations and other legal entities
owned or controlled by such participating physicians, radiologists and other specialists and (iii)&nbsp;participating hospitals and other health care providers. For purposes of this definition, &#147;controlled&#148; shall have the meaning set forth
in the definition of &#147;Affiliate.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Temporary Cash Investments</U>&#148; means any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any investment in direct obligations of the United States of America or any agency thereof or obligations guaranteed by the United States
of America or any agency thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) investments in demand and time deposit accounts, certificates of deposit and money market deposits
maturing within 180 days of the date of acquisition thereof issued by a bank or trust company which is organized under the laws of the United States of America, any State thereof or any foreign country recognized by the United States of America, and
which bank or trust company has capital, surplus and undivided profits aggregating in excess of $250,000,000 (or the foreign currency equivalent thereof) or any money-market fund sponsored by a registered broker dealer or mutual fund distributor;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) repurchase obligations with a term of not more than 30 days for underlying securities of the types described in clause (1)&nbsp;above
entered into with a bank meeting the qualifications described in clause (2)&nbsp;above; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) investments in commercial paper, maturing not more than 270 days after the date of
acquisition, issued by a corporation (other than an Affiliate of the Company) organized and in existence under the laws of the United States of America or any foreign country recognized by the United States of America with a rating at the time as of
which any investment therein is made of <FONT STYLE="white-space:nowrap">&#147;P-1&#148;</FONT> (or higher) according to Moody&#146;s or <FONT STYLE="white-space:nowrap">&#147;A-1&#148;</FONT> (or higher) according to Standard and Poor&#146;s; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) investments in securities issued or fully guaranteed by any state, commonwealth or territory of the United States of America, or by any
political subdivision or taxing authority thereof, and rated at least &#147;A&#148; by Standard&nbsp;&amp; Poor&#146;s or &#147;A2&#148; by Moody&#146;s; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) eligible banker&#146;s acceptances, repurchase agreements and <FONT STYLE="white-space:nowrap">tax-exempt</FONT> municipal bonds having a
maturity of less than one year, in each case having a rating of, or evidencing the full recourse obligation of a person whose senior debt is rated, at least &#147;A&#148; by Standard&nbsp;&amp; Poor&#146;s and at least &#147;A2&#148; by
Moody&#146;s; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) investments in money market funds that invest substantially all their assets in securities of the types described
in clauses (1)&nbsp;through (6) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Uniform Commercial Code</U>&#148; means the New York Uniform Commercial Code as in effect
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Unrestricted Subsidiary</U>&#148; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any Subsidiary of the Company that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors
in the manner provided below; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any Subsidiary of an Unrestricted Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors may designate any Subsidiary of the Company (including any newly acquired or newly formed Subsidiary) to be an
Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Capital Stock or Indebtedness of, or holds any Lien on any property of, the Company or any other Subsidiary of the Company that is not a Subsidiary of the Subsidiary
to be so designated; <U>provided</U>, <U>however</U>, that either (A)&nbsp;the Subsidiary to be so designated has total assets of $1,000 or less or (B)&nbsp;if such Subsidiary has assets greater than $1,000, such designation would be permitted under
Section&nbsp;6.04. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; <U>provided</U>,
<U>however</U>, that immediately after giving effect to such designation (A)&nbsp;the Company could Incur $1.00 of additional Indebtedness under Section&nbsp;6.03(a) and (B)&nbsp;no Default shall have occurred and be continuing. Any such designation
by the Board of Directors shall be evidenced to the Trustee by promptly filing with the Trustee a copy of the resolution of the Board of Directors giving effect to such designation and an Officers&#146; Certificate certifying that such designation
complied with the foregoing provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Voting Stock</U>&#148; of a Person means all classes of Capital Stock of such Person
then outstanding and normally entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Wholly Owned Subsidiary</U>&#148; means a Restricted Subsidiary all the Capital Stock of which (other than directors&#146; qualifying
shares) is owned by the Company or one or more other Wholly Owned Subsidiaries. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
3.01. <U>Form</U>. Provisions relating to the Securities are set forth in Exhibit A hereto, which is hereby incorporated in and expressly made a part of this Supplemental Indenture. The Securities and the Trustee&#146;s certificate of authentication
thereto shall be substantially in the form of Exhibit A, which is hereby incorporated in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and expressly made a part of this Supplemental Indenture. The Securities may have notations, legends or endorsements required by law, stock exchange rule, agreements to which the Company is
subject, if any, or usage (<U>provided</U> that any such notation, legend or endorsement is in a form acceptable to the Company). Each Security shall be dated the date of its authentication. The Securities shall be issuable only in registered form
without interest coupons and only in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The terms of the Securities set forth in Exhibit A are part of the terms of this Supplemental Indenture. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT
OF BASE INDENTURE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.01. <U>Amendment of Article I of Base Indenture</U>. Section&nbsp;1.01 of the Base Indenture is hereby
amended, but only with respect to the Securities, by the deletion of the definitions of the following terms: &#147;Affiliate,&#148; &#147;Business Day,&#148; &#147;Code,&#148; &#147;Corporate Trust Office,&#148; &#147;Indebtedness,&#148;
&#147;Interest Payment Date,&#148; &#147;Mandatory Sinking Fund Payment,&#148; &#147;Officer&#146;s Certificate,&#148; &#147;Opinion of Counsel,&#148; &#147;Optional Sinking Fund Payment,&#148; &#147;Person,&#148; &#147;Responsible Officer,&#148;
&#147;Senior Indebtedness&#148; and &#147;Stated Maturity&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.02. <U>Amendment of Article III of Base Indenture</U>. Article
III of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new Section&nbsp;3.14 at the end thereof: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 3.14. <U>Issuance of Additional Securities</U>. After the Issue Date, the Company shall be entitled, subject to its compliance
with Section&nbsp;6.03, to issue Additional Securities under this Indenture, which Securities shall have identical terms as the Securities issued on the Issue Date, other than with respect to the date of issuance and issue price and first payment of
interest. All the Securities issued under this Indenture shall be treated as a single class for all purposes of this Indenture, including waivers, amendments, redemptions and offers to purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to any Additional Securities, the Company shall set forth in a resolution of the Board of Directors and an Officers&#146;
Certificate, a copy of each of which shall be delivered to the Trustee, the following information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the aggregate
principal amount of such Additional Securities to be authenticated and delivered pursuant to this Indenture and the provision of Section&nbsp;6.03 that the Company is relying on to issue such Additional Securities; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the issue price, the issue date, the CUSIP number and the ISIN of such Additional Securities; <U>provided</U>,
<U>however</U>, that no Additional Securities may be issued at a price that would cause such Additional Securities to have &#147;original issue discount&#148; within the meaning of Section&nbsp;1273 of the Code.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.03. <U>Amendment of Article IV of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Section 4.02(a) of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the words &#147;the Trustee
shall select, by lot or in such other manner as the Trustee shall deem appropriate&#148;, and replacing such deleted words with &#147;if the Securities are Global Securities, the Securities to be redeemed will be selected by the Depositary in
accordance with applicable Depositary procedures, and if the Securities to be redeemed are not Global Securities, the Trustee shall select, on a <U>pro</U> <U>rata</U> basis to the extent practicable&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Section 4.05 of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the words &#147;have a Stated
Maturity&#148; and replacing such deleted words with &#147;become due and payable&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.04. <U>Amendment of Article V of Base Indenture</U>. Article V of the Base
Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;ARTICLE V
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SUCCESSOR COMPANY </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION
5.01. <U>When Company May Merge or Transfer Assets</U>. The Company shall not consolidate with or merge with or into, or convey, transfer or lease, in one transaction or a series of transactions, directly or indirectly, all or substantially all its
assets to, any Person, unless: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the resulting, surviving or transferee Person (the &#147;<U>Successor
Company</U>&#148;) shall be a Person organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and the Successor Company (if not the Company) shall expressly assume, by a supplemental
indenture hereto, executed and delivered to the Trustee, in form satisfactory to the Trustee, all the obligations of the Company under the Securities and this Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) immediately after giving pro forma effect to such transaction (and treating any Indebtedness which becomes an obligation of
the Successor Company or any Subsidiary thereof as a result of such transaction as having been Incurred by the Successor Company or such Subsidiary at the time of such transaction), no Default shall have occurred and be continuing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) immediately after giving pro forma effect to such transaction, (A)&nbsp;the Successor Company would be able to Incur an
additional $1.00 of Indebtedness pursuant to Section&nbsp;6.03(a) or (B)&nbsp;the Consolidated Coverage Ratio for the Successor Company would be equal to or greater than such ratio for the Company and its Restricted Subsidiaries immediately prior to
such transaction; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the Company shall have delivered to the Trustee an Officers&#146; Certificate and an Opinion of
Counsel, each stating that such consolidation, merger or transfer and such supplemental indenture (if any) comply with this Indenture, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that clause (3)&nbsp;shall not be applicable to (A)&nbsp;a Restricted Subsidiary consolidating with, merging
into or transferring all or part of its properties and assets to the Company (so long as no Capital Stock of the Company is distributed to any Person) or (B)&nbsp;the Company merging with an Affiliate of the Company solely for the purpose and with
the sole effect of reincorporating the Company in another jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;5.01, the sale, lease,
conveyance, assignment, transfer or other disposition of all or substantially all of the properties and assets of one or more Subsidiaries of the Company, which properties and assets, if held by the Company instead of such Subsidiaries, would
constitute all or substantially all of the properties and assets of the Company on a consolidated basis, shall be deemed to be the transfer of all or substantially all of the properties and assets of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">The Successor Company shall be the successor to the Company and shall succeed to, and be substituted for, and may exercise every right and
power of, the Company under this Indenture, and the predecessor Company, except in the case of a lease, shall be released from the obligation to pay the principal of and interest on the Securities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.05. <U>Amendment of Article VI of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Article VI of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new Sections
6.02, 6.03, 6.04, 6.05, 6.06, 6.07, 6.08, 6.09, 6.10 and 6.11: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 6.02. <U>SEC Reports</U>. Whether or not the Company is
subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, the Company shall file with the SEC (subject to the next sentence), and provide the Trustee and Holders with, such annual and other reports as are specified in
Sections 13 and 15(d) of the Exchange Act and applicable to a U.S. corporation subject to such Sections, such reports to be so filed and provided at the times specified for the filings of such reports under such Sections and containing all the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information, audit reports and exhibits required for such reports. If, at any time, the Company is not subject to the periodic reporting requirements of the Exchange Act for any reason, the
Company shall nevertheless continue filing the reports specified in the preceding sentence with the SEC within the time periods required unless the SEC will not accept such a filing. Delivery of such reports, information and documents to the Trustee
is for informational purposes only and the Trustee&#146;s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#146;s compliance with
any of its covenants hereunder (as to which the Trustee is entitled to rely on Officer&#146;s Certificates). The Company agrees that it shall not take any action for the purpose of causing the SEC not to accept such filings. If, notwithstanding the
foregoing, the SEC will not accept such filings for any reason, the Company shall post the reports specified in the preceding sentence on its website within the time periods that would apply if the Company were required to file such reports with the
SEC. At any time that any of the Company&#146;s Subsidiaries are Unrestricted Subsidiaries, then the quarterly and annual financial information in the reports required by this paragraph shall include a reasonably detailed presentation, either on the
face of the financial statements or in the footnotes thereto, of the financial condition and results of operations of the Company and its Restricted Subsidiaries separate from the financial condition and results of operations of the Unrestricted
Subsidiaries of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">The Company also shall comply with the other provisions of Section&nbsp;314(a) of the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.03. <U>Limitation on Indebtedness</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary to, Incur,
directly or indirectly, any Indebtedness; <U>provided</U>, <U>however</U>, that the Company and the Subsidiary Guarantors shall be entitled to Incur Indebtedness if, on the date of such Incurrence and after giving effect thereto on a pro forma basis
the Consolidated Coverage Ratio exceeds 2.0 to 1.0. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing paragraph (a), the Company and the Restricted
Subsidiaries shall be entitled to Incur any or all of the following Indebtedness: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Indebtedness Incurred pursuant to
the Credit Agreement; <U>provided</U>, <U>however</U>, that, immediately after giving effect to any such Incurrence, the aggregate principal amount of all Indebtedness Incurred under this clause (1)&nbsp;and then outstanding does not exceed
$1,551,000,000 less the sum of all principal payments with respect to such Indebtedness made pursuant to Section&nbsp;6.06(a)(3)(A) and in satisfaction of Section&nbsp;6.06; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Indebtedness owed to and held by the Company or a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that (A)&nbsp;any
subsequent issuance or transfer of any Capital Stock that results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any subsequent transfer of such Indebtedness (other than to the Company or a Restricted Subsidiary) shall be
deemed, in each case, to constitute the Incurrence of such Indebtedness by the obligor thereon, (B)&nbsp;if the Company is the obligor on such Indebtedness, such Indebtedness is expressly subordinated to the prior payment in full in cash of all
obligations with respect to the Securities, and (C)&nbsp;if a Subsidiary Guarantor is the obligor on such Indebtedness, such Indebtedness is expressly subordinated to the prior payment in full in cash of all obligations of such Subsidiary Guarantor
with respect to its Subsidiary Guarantee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Securities (excluding any Additional Securities); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Indebtedness outstanding on the Issue Date (other than Indebtedness described in clause (1), (2) or (3)&nbsp;of this
Section&nbsp;6.03(b)); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) Indebtedness of a Restricted Subsidiary Incurred and outstanding on or prior to the date on
which such Subsidiary was acquired by the Company (other than Indebtedness Incurred in connection with, or to provide all or any portion of the funds or credit support utilized to consummate, the transaction or series of related transactions
pursuant to which such Subsidiary became a Subsidiary or was acquired by the Company); <U>provided</U>, <U>however</U>, that on the date of such acquisition and after giving pro forma effect thereto, the Company would have been entitled to Incur at
least $1.00 of additional Indebtedness pursuant to Section&nbsp;6.03(a); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) Refinancing Indebtedness in respect of Indebtedness Incurred pursuant to
Section&nbsp;6.03(a) or pursuant to clause (3), (4) or (5)&nbsp;or this clause (6)&nbsp;of this Section&nbsp;6.03(b); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)
Hedging Obligations directly related to Indebtedness permitted to be Incurred by the Company and its Restricted Subsidiaries pursuant to this Indenture or entered into in the ordinary course of business and not for speculative purposes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) obligations in respect of performance, bid and surety bonds and completion guarantees provided by the Company or any
Restricted Subsidiary in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) Indebtedness arising from the honoring by a bank or other
financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business; <U>provided</U>, <U>however</U>, that such Indebtedness is extinguished within three Business Days of its Incurrence;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) Indebtedness consisting of the Subsidiary Guarantee of a Subsidiary Guarantor and any Guarantee by the Company or a
Subsidiary Guarantor of Indebtedness or other obligations of the Company or any Restricted Subsidiary (other than Indebtedness Incurred pursuant to clause (5)&nbsp;of this Section&nbsp;6.03(b)) so long as the Incurrence of such Indebtedness or other
obligations by the Company or such Restricted Subsidiary is permitted under the terms of this Indenture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) (A) Purchase
Money Indebtedness, (B)&nbsp;Finance Lease Obligations and (C)&nbsp;Attributable Debt, and Refinancing Indebtedness in respect thereof, in an aggregate principal amount on the date of Incurrence that, when added to all other Indebtedness Incurred
pursuant to this clause (11)&nbsp;and then outstanding, does not exceed 15% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days
prior thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) Indebtedness Incurred by a Receivables Entity in a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) Preferred Stock issued by any Restricted Subsidiary formed to operate a single health care facility; <U>provided</U> that
the amount of such Preferred Stock, when added to the aggregate amount of all other such Preferred Stock of Restricted Subsidiaries then outstanding, does not exceed 1% of Consolidated Tangible Assets, as determined based on the consolidated balance
sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)
Indebtedness of the Company or of any of its Restricted Subsidiaries in an aggregate principal amount that, when taken together with all other Indebtedness of the Company and its Restricted Subsidiaries outstanding on the date of such Incurrence
(other than Indebtedness permitted by clauses (1)&nbsp;through (13) of this Section&nbsp;6.03(b) or by Section&nbsp;6.03(a)) does not exceed the greater of (A) $300,000,000 and (B) 7.5% of Consolidated Tangible Assets, as determined based on the
consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)
Notwithstanding the foregoing, neither the Company nor any Subsidiary Guarantor shall incur any Indebtedness pursuant to Section&nbsp;6.03(b) if the proceeds thereof are used, directly or indirectly, to Refinance any Subordinated Obligations of the
Company or any Subsidiary Guarantor unless such Indebtedness shall be subordinated to the Securities or the applicable Subsidiary Guarantee to at least the same extent as such Subordinated Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) For purposes of determining compliance with this Section&nbsp;6.03: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) all Indebtedness outstanding under the Credit Agreement on the Issue Date shall be treated as Incurred under clause (b)(1)
of this Section&nbsp;6.03; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) in the event that an item of Indebtedness (or any portion thereof) meets the criteria of
more than one of the types of Indebtedness described above, the Company, in its sole discretion, shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
classify such item of Indebtedness (or any portion thereof) at the time of Incurrence and shall only be required to include the amount and type of such Indebtedness in one of the above clauses
(<U>provided</U> that any Indebtedness originally classified as Incurred pursuant to any of clauses (b)(2) through (b)(14) of this Section&nbsp;6.03 may later be reclassified as having been Incurred pursuant to paragraph (a)&nbsp;or any other of
clauses (b)(2) through (b)(14) of this Section&nbsp;6.03 to the extent that such reclassified Indebtedness could be Incurred pursuant to paragraph (a)&nbsp;or one of clauses (b)(2) through (b)(14) of this Section&nbsp;6.03, as the case may be, if it
were Incurred at the time of such reclassification); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company shall be entitled to divide and classify an item
of Indebtedness in more than one of the types of Indebtedness described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.04. <U>Limitation on Restricted Payments</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Company shall not, and shall not permit any Restricted Subsidiary, directly or indirectly, to make a Restricted Payment if at the
time the Company or such Restricted Subsidiary makes such Restricted Payment: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) a Default shall have occurred and be
continuing (or would result therefrom); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Company is not entitled to Incur an additional $1.00 of Indebtedness
pursuant to Section&nbsp;6.03(a); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the aggregate amount of such Restricted Payment and all other Restricted Payments
since the Issue Date would exceed the sum of (without duplication): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) 50% of the Consolidated Net Income accrued during
the period (treated as one accounting period) from and including July&nbsp;1, 2006 to the end of the most recent fiscal quarter ending at least 45 days prior to the date of such Restricted Payment (or, in case such Consolidated Net Income shall be a
deficit, minus 100% of such deficit); <U>plus</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) 100% of the aggregate Net Cash Proceeds received by the Company from
the issuance or sale of its Capital Stock (other than Disqualified Stock) subsequent to the Issue Date (other than an issuance or sale to a Subsidiary of the Company and other than an issuance or sale to an employee stock ownership plan or to a
trust established by the Company or any of its Subsidiaries for the benefit of their employees) and 100% of any cash capital contribution received by the Company from its shareholders subsequent to the Issue Date; <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) the amount by which Indebtedness of the Company is reduced on the Company&#146;s balance sheet upon the conversion or
exchange subsequent to the Issue Date of any Indebtedness of the Company convertible or exchangeable for Capital Stock (other than Disqualified Stock) of the Company (less the amount of any cash, or the fair value of any other property, distributed
by the Company upon such conversion or exchange); <U>provided</U>, <U>however</U>, that the foregoing amount shall not exceed the Net Cash Proceeds received by the Company or any Restricted Subsidiary from the sale of such Indebtedness (excluding
Net Cash Proceeds from sales to a Subsidiary of the Company or to an employee stock ownership plan or to a trust established by the Company or any of its Subsidiaries for the benefit of their employees); <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) an amount equal to the net reduction in the Investments (other than Permitted Investments) made by the Company or any
Restricted Subsidiary in any Person resulting from repurchases, repayments or redemptions of such Investments by such Person, proceeds realized on the sale of such Investment and proceeds representing the return of capital (excluding dividends and
distributions), in each case received by the Company or any Restricted Subsidiary; <U>provided</U>, <U>however</U>, that the foregoing sum shall not exceed, in the case of any such Person, the amount of Investments (excluding Permitted Investments)
previously made (and treated as a Restricted Payment) by the Company or any Restricted Subsidiary in such Person; <U>plus</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) in the case of the redesignation of an Unrestricted Subsidiary as a
Restricted Subsidiary, the portion (proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of such Unrestricted Subsidiary at the time such Unrestricted Subsidiary is redesignated as a
Restricted Subsidiary, except to the extent that the Investment in such Unrestricted Subsidiary was made by the Company or a Restricted Subsidiary pursuant to Section&nbsp;6.04(b)(11) or to the extent that such Investment constituted a Permitted
Investment; <U>plus</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) $50,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The preceding provisions shall not prohibit: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any Restricted Payment made out of the Net Cash Proceeds of the substantially concurrent sale of, or made by exchange for,
Capital Stock of the Company (other than Disqualified Stock and other than Capital Stock issued or sold to a Subsidiary of the Company or an employee stock ownership plan or to a trust established by the Company or any of its Subsidiaries for the
benefit of their employees) or a substantially concurrent cash capital contribution received by the Company from its shareholders; <U>provided</U>, <U>however</U>, that (A)&nbsp;such Restricted Payment shall be excluded from the calculation of the
amount of Restricted Payments and (B)&nbsp;the Net Cash Proceeds from such sale or such cash capital contribution (to the extent so used for such Restricted Payment) shall be excluded from the calculation of amounts under Section&nbsp;6.04(a)(3)(B);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any purchase, repurchase, redemption, defeasance or other acquisition or retirement for value of Subordinated
Obligations of the Company or a Subsidiary Guarantor made by exchange for, or out of the proceeds of the substantially concurrent Incurrence of, Indebtedness of such Person that is permitted to be Incurred pursuant to Section&nbsp;6.03;
<U>provided</U>, <U>however</U>, that such purchase, repurchase, redemption, defeasance or other acquisition or retirement for value shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) dividends paid within 60 days after the date of declaration thereof if at such date of declaration such dividend would have
complied with this Section&nbsp;6.04; <U>provided</U>, <U>however</U>, that such dividend shall be included in the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) so long as no Default has occurred and is continuing, the purchase, redemption or other acquisition of shares of Capital
Stock of the Company or any of its Subsidiaries from employees, former employees, directors or former directors of the Company or any of its Subsidiaries (or permitted transferees of such employees, former employees, directors or former directors),
pursuant to the terms of the agreements (including employment agreements) or plans (or amendments thereto) approved or ratified by the Board of Directors under which such individuals purchase or sell or are granted the option to purchase or sell,
shares of such Capital Stock; <U>provided</U>, <U>however</U>, that the aggregate amount of such Restricted Payments (excluding amounts representing cancellation of Indebtedness) shall not exceed $10,000,000 in any calendar year (<U>provided</U>
that (A)&nbsp;if the Company and its Restricted Subsidiaries make less than $10,000,000 in the aggregate of such Restricted Payments in any calendar year, the unused amount for such calendar year may be carried over to the next succeeding calendar
year (but not any other calendar year thereafter) and (B)&nbsp;the amount payable in any calendar year may be increased by an amount up to the sum of (i)&nbsp;the amount of cash proceeds from the sale of Capital Stock (other than Disqualified Stock)
of the Company to employees, former employees, directors or former directors of the Company or any of its Subsidiaries, to the extent that the cash proceeds from the sale of such Capital Stock have not otherwise been applied to the payment of
Restricted Payments by virtue of Section&nbsp;6.04(a)(3)(B), plus (ii)&nbsp;the cash proceeds of key man life insurance policies received by the Company or its Restricted Subsidiaries after the Issue Date, less (iii)&nbsp;the amount of repurchases
and other acquisitions previously made with the cash proceeds described in clauses (i)&nbsp;and (ii) above); <U>provided</U> <U>further</U>, <U>however</U>, that (x)&nbsp;such repurchases and other acquisitions shall be excluded from the calculation
of the amount of Restricted Payments and (y)&nbsp;cash proceeds referred to in clause (B)(i) above used to make Restricted Payments under this Section&nbsp;6.04(b)(4) shall be excluded from the calculation of amounts under
Section&nbsp;6.04(a)(3)(B); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the declaration and payments of dividends on Disqualified Stock issued
pursuant to Section&nbsp;6.03; <U>provided</U>, <U>however</U>, in each case, that at the time of payment of such dividend, no Default shall have occurred and be continuing (or result therefrom); <U>provided</U> <U>further</U>, <U>however</U>, that
dividends referred to in this clause (5)&nbsp;shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) repurchases of Capital Stock deemed to occur upon exercise of stock options if such Capital Stock represents a portion of
the exercise price of such options; <U>provided</U>, <U>however</U>, that such Restricted Payments shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) cash payments in lieu of the issuance of fractional shares in connection with the exercise of warrants, options or other
securities convertible into or exchangeable for Capital Stock of the Company; <U>provided</U>, <U>however</U>, that any such cash payment shall not be for the purpose of evading the limitation of this Section&nbsp;6.04; <U>provided</U>
<U>further</U>, <U>however</U>, that such payments shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) in the event of a Change of Control, and if no Default shall have occurred and be continuing, the payment, purchase,
redemption, defeasance or other acquisition or retirement of Subordinated Obligations of the Company or any Subsidiary Guarantor, in each case, at a purchase price not greater than 101% of the principal amount of such Subordinated Obligations, plus
any accrued and unpaid interest thereon; <U>provided</U>, <U>however</U>, that prior to such payment, purchase, redemption, defeasance or other acquisition or retirement, the Company (or a third party to the extent permitted by this Indenture) has
made a Change of Control Offer with respect to the Securities as a result of such Change of Control and has repurchased all Securities validly tendered and not withdrawn in connection with such Change of Control Offer; <U>provided</U>
<U>further</U>, <U>however</U>, that such payments, purchases, redemptions, defeasances or other acquisitions or retirements shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) payments of intercompany subordinated Indebtedness, the Incurrence of which was permitted under Section&nbsp;6.03(b)(2);
<U>provided</U>, <U>however</U>, that no Default has occurred and is continuing or would otherwise result therefrom; <U>provided</U> <U>further</U>, <U>however</U>, that such payments shall be excluded from the calculation of the amount of
Restricted Payments; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) any Restricted Payment, so long as the Leverage Ratio is no more than 3.0 to 1.0, both as of the
date thereof and on a pro forma basis after giving effect to such Restricted Payment; <U>provided</U>, however, that (A)&nbsp;at the time of each such Restricted Payment, no Default shall have occurred and be continuing (or result therefrom) and
(B)&nbsp;such payments shall be excluded from the calculation of the amount of Restricted Payments; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) Restricted
Payments in an amount that, when taken together with all Restricted Payments made pursuant to this clause (11), does not exceed the greater of (A) $200,000,000 and (B) 5.0% of Consolidated Tangible Assets, as determined based on the consolidated
balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto; <U>provided</U>, <U>however</U>, that (I)&nbsp;at the time of each such Restricted Payment, no Default shall have occurred and be
continuing (or result therefrom) and (II)&nbsp;such payments shall be excluded from the calculation of the amount of Restricted Payments; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) any purchase or other acquisition or retirement for value of shares of Capital Stock of Encompass Health Home Health
Holdings, Inc. (f/k/a HealthSouth Home Health Holdings, Inc.) held by any Person other than the Company or any of its Subsidiaries on the Issue Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of any Restricted Payment that is not made in cash shall be determined in a manner consistent with the determination
of the amount of an Investment as set forth in the final sentence of the first paragraph of the definition of &#147;Investment&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.05. <U>Limitation on Restrictions on Distributions from Restricted
Subsidiaries</U>. The Company shall not, and shall not permit any Restricted Subsidiary to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or restriction on the ability of any Restricted Subsidiary to
(a)&nbsp;pay dividends or make any other distributions on its Capital Stock to the Company or a Restricted Subsidiary or pay any Indebtedness owed to the Company, (b)&nbsp;make any loans or advances to the Company or (c)&nbsp;transfer any of its
property or assets to the Company, except: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) with respect to clauses (a), (b) and (c), </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) any encumbrance or restriction pursuant to applicable law, rule, regulation or order or an agreement in effect at or
entered into on the Issue Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any encumbrance or restriction with respect to a Restricted Subsidiary pursuant to an
agreement relating to any Indebtedness Incurred by such Restricted Subsidiary on or prior to the date on which such Restricted Subsidiary was acquired by the Company (other than Indebtedness Incurred as consideration in, or to provide all or any
portion of the funds or credit support utilized to consummate, the transaction or series of related transactions pursuant to which such Restricted Subsidiary became a Restricted Subsidiary or was acquired by the Company) and outstanding on such
date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) any encumbrance or restriction pursuant to any amendment, modification, restatement, renewal, increase,
supplement, refunding, replacement or refinancing of an agreement referred to in clause (A)&nbsp;or (B) above; <U>provided</U>, <U>however</U>, that such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or
refinancing is no more restrictive, as reasonably determined by the Company, with respect to such encumbrances and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal, increase, supplement,
refunding, replacement or refinancing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) any encumbrance or restriction with respect to a Restricted Subsidiary imposed
pursuant to an agreement entered into for the sale or disposition of all or substantially all the Capital Stock or assets of such Restricted Subsidiary pending the closing of such sale or disposition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary
course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) any limitation or prohibition on the disposition or distribution of assets or property in joint
venture agreements, asset sale agreements, stock sale agreements and other similar agreements, which limitation or prohibition is applicable only to the assets that are the subject of such agreements; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) any encumbrance or restriction existing under or by reason of contractual requirements of a Receivables Entity in
connection with a Qualified Receivables Transaction provided that such restrictions apply only to such Receivables Entity; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) any encumbrance or restriction arising in the ordinary course of business, not relating to any Indebtedness, that does not,
individually or in the aggregate, materially detract from the value of the property or assets of the Company and its Restricted Subsidiaries, taken as whole, or adversely affect the Company&#146;s ability to make principal and interest payments on
the Securities, in each case, as determined in good faith by the Company; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) with respect to clause (c)&nbsp;only,
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) any encumbrance or restriction consisting of customary nonassignment provisions in leases governing leasehold
interests to the extent such provisions restrict the transfer of the lease or the property leased thereunder; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any encumbrance or restriction contained in Finance Lease Obligations,
any agreement governing Purchase Money Indebtedness, security agreements or mortgages securing Indebtedness of a Restricted Subsidiary to the extent such encumbrance or restriction restricts the transfer of the property subject to such Finance Lease
Obligations, Purchase Money Indebtedness, security agreements or mortgages. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.06. <U>Limitation on Sales of Assets and
Subsidiary Stock</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, consummate any Asset Disposition unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company or such Restricted Subsidiary receives consideration at the time of such Asset Disposition at least equal to
the Fair Market Value (including as to the value of all <FONT STYLE="white-space:nowrap">non-cash</FONT> consideration) of the shares and assets subject to such Asset Disposition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) at least 75% of the consideration thereof received by the Company or such Restricted Subsidiary is in the form of cash or
cash equivalents; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) an amount equal to 100% of the Net Available Cash from such Asset Disposition, other than any
Asset Disposition that constitutes a Syndication or a resyndication transaction in the ordinary course of business, is applied by the Company or such Restricted Subsidiary, as the case may be: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) to the extent the Company elects (or is required by the terms of any Indebtedness), to prepay, repay, redeem or purchase
Senior Indebtedness of the Company or a Subsidiary Guarantor or Indebtedness (other than any Disqualified Stock) of a Restricted Subsidiary that is not a Subsidiary Guarantor (in each case other than Indebtedness owed to the Company or an Affiliate
of the Company) within one year from the later of the date of such Asset Disposition or the receipt of such Net Available Cash; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) to the extent the Company elects (including with respect to the balance of such Net Available Cash after application (if
any) in accordance with clause (A)), to acquire Additional Assets within one year from the later of the date of such Asset Disposition or the receipt of such Net Available Cash; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) to the extent of the balance of such Net Available Cash after application (if any) in accordance with clauses (A)&nbsp;and
(B), to make an offer to the Holders (and to holders of other Senior Indebtedness of the Company designated by the Company) to purchase Securities (and such other Senior Indebtedness of the Company) pursuant to and subject to the conditions
contained in this Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that in connection with any prepayment, repayment or purchase of Indebtedness made to
satisfy clause (A)&nbsp;or (C) above, the Company or such Restricted Subsidiary shall permanently retire such Indebtedness and shall cause the related loan commitment (if any) to be permanently reduced in an amount equal to the principal amount so
prepaid, repaid or purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Section&nbsp;6.06, the Company and the Restricted
Subsidiaries shall not be required to apply any Net Available Cash in accordance with this Section&nbsp;6.06 except to the extent that the aggregate Net Available Cash from all Asset Dispositions which is not applied in accordance with this
Section&nbsp;6.06 exceeds $50,000,000. Pending application of Net Available Cash pursuant to this Section&nbsp;6.06, such Net Available Cash shall be invested in Temporary Cash Investments or applied to temporarily reduce revolving credit
indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For the purposes of this Section&nbsp;6.06, the following are deemed to be cash or cash equivalents: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the assumption or discharge of any liabilities (as shown on the Company&#146;s or such Restricted Subsidiary&#146;s most
recent balance sheet or in the footnotes thereto) of the Company or such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Restricted Subsidiary (other than liabilities that are by their terms subordinated to the Securities) that are assumed by the transferee of such assets and for which the Company and all of the
Restricted Subsidiaries have been released by all creditors in writing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) securities received by the Company or any
Restricted Subsidiary from the transferee that are converted by the Company or such Restricted Subsidiary within 180 days into cash, to the extent of cash received in that conversion; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) all Temporary Cash Investments; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) any Designated Noncash Consideration having an aggregate Fair Market Value that, when taken together with all other
Designated Noncash Consideration previously received and then outstanding, does not exceed at the time of the receipt of such Designated Noncash Consideration (with the Fair Market Value of each item of Designated Noncash Consideration being
measured at the time received and without giving effect to subsequent changes in value) $30,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) In the event of an Asset
Disposition that requires the purchase of Securities (and other Senior Indebtedness of the Company) pursuant to Section&nbsp;6.06(a)(3)(C), the Company shall purchase Securities tendered pursuant to an offer by the Company for the Securities (and
such other Senior Indebtedness) (the &#147;<U>Offer</U>&#148;) at a purchase price of 100% of their principal amount (or, in the event such other Senior Indebtedness of the Company was issued with significant original issue discount, 100% of the
accreted value thereof) without premium, plus accrued but unpaid interest (or, in respect of such other Senior Indebtedness of the Company, such lesser price, if any, as may be provided for by the terms of such Senior Indebtedness) in accordance
with the procedures (including prorating in the event of oversubscription) set forth in this Indenture. If the aggregate purchase price of the securities tendered pursuant to the Offer exceeds the Net Available Cash allotted to their purchase, the
Company shall select the securities to be purchased on a <U>pro</U> <U>rata</U> basis but in round denominations, which in the case of the Securities will be denominations of $2,000 principal amount or any greater integral multiple of $1,000,
subject to applicable DTC procedures. The Company shall not be required to make such an Offer to purchase Securities (and other Senior Indebtedness of the Company) pursuant to this Section&nbsp;6.06 if the Net Available Cash available therefor is
less than $20,000,000 (which lesser amount shall be carried forward for purposes of determining whether such an offer is required with respect to the Net Available Cash from any subsequent Asset Disposition). Upon completion of such an Offer, Net
Available Cash shall be deemed to be reduced by the aggregate amount of such Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) (i) Promptly, and in any event within 10 days
after the Company becomes obligated to make an Offer, the Company shall deliver to the Trustee and send, by first-class mail (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or
regulations, send electronically) to each Holder, a written notice stating that the Holder may elect to have his Securities purchased by the Company either in whole or in part (subject to prorating as described in Section&nbsp;6.06(b) in the event
the Offer is oversubscribed) in amounts of $2,000 and any greater integral multiple of $1,000 of principal amount at the applicable purchase price. The notice shall specify a purchase date not less than 30 days nor more than 60 days after the date
of such notice (the &#147;<U>Purchase Date</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Not later than the date upon which written notice of an Offer
is delivered to the Trustee as provided below, the Company shall deliver to the Trustee an Officers&#146; Certificate as to (A)&nbsp;the amount of the Offer (the &#147;<U>Offer Amount</U>&#148;), including information as to any other Senior
Indebtedness included in the Offer for repurchase, (B)&nbsp;the allocation of the Net Available Cash from the Asset Dispositions pursuant to which such Offer is being made and (C)&nbsp;the compliance of such allocation with the provisions of
Section&nbsp;6.06(a). By 11:00 a.m. New York City time on the Purchase Date, the Company shall irrevocably deposit with the Trustee or with a Paying Agent (or, if the Company or a Wholly Owned Subsidiary is acting as Paying Agent, segregate and hold
in trust) an amount equal to the Offer Amount to be held for payment in accordance with the provisions of this Section&nbsp;6.06. Upon the expiration of the period for which the Offer remains open (the &#147;<U>Offer Period</U>&#148;), the Company
shall deliver to the Trustee for cancellation the Securities or portions thereof which have been properly tendered to and are to be accepted by the Company. The Trustee (or the Paying Agent, if not the Trustee) shall, on the Purchase Date, mail or
deliver payment (or cause the delivery of payment) to each tendering Holder in the amount of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
purchase price. In the event that the aggregate purchase price of the Securities delivered by the Company to the Trustee is less than the Offer Amount applicable to the Securities, the Trustee
shall deliver the excess to the Company immediately after the expiration of the Offer Period for application in accordance with this Section&nbsp;6.06. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Holders electing to have a Security purchased shall be required to surrender the Security, with an appropriate form duly
completed, to the Company at the address specified in the notice at least three Business Days prior to the Purchase Date. A Holder shall be entitled to withdraw its election if the Trustee or the Company receives, not later than one Business Day
prior to the Purchase Date, a telex, facsimile transmission or letter setting forth the name of such Holder, the principal amount of the Security that was delivered for purchase by such Holder and a statement that such Holder is withdrawing its
election to have such Security purchased. Holders whose Securities are purchased only in part shall be issued new Securities equal in principal amount to the unpurchased portion of the Securities surrendered. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) At the time the Company delivers Securities to the Trustee which are to be accepted for purchase, the Company shall also
deliver an Officers&#146; Certificate stating that such Securities are to be accepted by the Company pursuant to and in accordance with the terms of this Section&nbsp;6.06. A Security shall be deemed to have been accepted for purchase at the time
the Trustee, directly or through an agent, mails or delivers payment therefor to the surrendering Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The Company shall comply,
to the extent applicable, with the requirements of Section&nbsp;14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section&nbsp;6.06. To the extent that the
provisions of any securities laws or regulations conflict with provisions of this Section&nbsp;6.06, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this
Section&nbsp;6.06 by virtue of its compliance with such securities laws or regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.07. <U>Limitation on Transactions with
Affiliates</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary to, enter into or permit to exist any transaction (including the purchase, sale, lease or exchange of any property, employee compensation arrangements or
the rendering of any service) with, or for the benefit of, any Affiliate of the Company (an &#147;<U>Affiliate Transaction</U>&#148;) unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the terms of the Affiliate Transaction are no less favorable to the Company or such Restricted Subsidiary than those that
could be obtained at the time of the Affiliate Transaction in <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> dealings with a Person who is not an Affiliate; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if such Affiliate Transaction involves an amount in excess of $50,000,000, the terms of the Affiliate Transaction are set
forth in writing and a majority of the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the Company disinterested with respect to such Affiliate Transaction have determined in good faith that the criteria set forth in clause
(1)&nbsp;are satisfied and have approved the relevant Affiliate Transaction as evidenced by a resolution of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
The provisions of Section&nbsp;6.07(a) shall not prohibit: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) any Investment (other than a Permitted Investment) or other
Restricted Payment, in each case permitted to be made pursuant to Section&nbsp;6.04; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) any employment or consulting
agreement, employee benefit plan, officer or director indemnification agreement or any similar arrangement entered into by the Company or any of its Restricted Subsidiaries in the ordinary course of business or approved by the Board of Directors,
and payments pursuant thereto; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) loans or advances to employees in the ordinary course of business of the
Company or its Restricted Subsidiaries, but in any event not to exceed $10,000,000 in the aggregate outstanding at any one time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the payment of reasonable fees or other reasonable compensation to, or the provision of customary benefits or
indemnification arrangements to, directors of the Company and its Restricted Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) any transaction with the
Company, a Restricted Subsidiary or any Person that would constitute an Affiliate Transaction solely because the Company or a Restricted Subsidiary owns an equity interest in or otherwise controls such Restricted Subsidiary or Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) the issuance or sale of any Capital Stock (other than Disqualified Stock) of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) any agreement as in effect on the Issue Date or any renewals or extensions of any such agreement (so long as such renewals
or extensions are not less favorable in any material respect to the Company or the Restricted Subsidiaries) and the transactions evidenced thereby; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) the provision of services to directors or officers of the Company or any of its Restricted Subsidiaries of the nature
provided by the Company or any of its Restricted Subsidiaries to customers in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)
transactions effected as a part of a Qualified Receivables Transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) any transaction entered into by a Person
prior to the time such Person becomes a Restricted Subsidiary or is merged or consolidated into the Company or a Restricted Subsidiary (provided such transaction is not entered into in contemplation of such event); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) any transaction with the Company&#146;s or any Restricted Subsidiary&#146;s customers, clients, suppliers, landlords,
lessors, or purchasers or sellers of goods or services, in each case, in the ordinary course of business and otherwise in compliance with the terms of the Indenture that are fair to the Company, or are on terms at least as favorable as would
reasonably have been entered into at such time with a Person who is not an Affiliate of the Company (as determined in good faith by the Board of Directors or senior management of the Company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.08. <U>Change of Control</U>. (a)&nbsp;Upon the occurrence of a Change of Control, each Holder shall have the right to require that
the Company purchase all or any part of such Holder&#146;s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the date of purchase plus accrued and unpaid interest, if any, to the date of purchase (subject to the
right of Holders of record on the relevant Record Date to receive interest due on the relevant Interest Payment Date), in accordance with Section&nbsp;6.08(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Within 30 days following any Change of Control, the Company shall mail (or with respect to Global Securities, to the extent permitted or
required by applicable Depositary procedures or regulations, send electronically) a notice to each Holder with a copy to the Trustee (the &#147;<U>Change of Control Offer</U>&#148;) stating: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) that a Change of Control has occurred and that such Holder has the right to require the Company to purchase such
Holder&#146;s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the date of purchase, plus accrued and unpaid interest, if any, to the date of purchase (subject to the right of Holders of record on the relevant
Record Date to receive interest on the relevant Interest Payment Date); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the circumstances and relevant facts and
financial information regarding such Change of Control; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the purchase date (which shall be no earlier than 30 days nor later
than 60 days from the date such notice is sent); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the instructions, as determined by the Company, consistent with
this Section&nbsp;6.08, that a Holder must follow in order to have its Securities purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The Company shall not be required to
make a Change of Control Offer following a Change of Control if a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Indenture applicable to a Change of
Control Offer made by the Company and purchases all Securities validly tendered and not withdrawn under such Change of Control Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)
The Company shall comply, to the extent applicable, with the requirements of Section&nbsp;14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section&nbsp;6.08. To
the extent that the provisions of any securities laws or regulations conflict with the provisions of this Section&nbsp;6.08, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its
obligations under this Section&nbsp;6.08 by virtue thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Holders electing to have a Security purchased will be required to
surrender the Security, with an appropriate form duly completed, to the Company at the address specified in the notice at least three Business Days prior to the purchase date. Holders will be entitled to withdraw their election if the Trustee or the
Company receives not later than one Business Day prior to the purchase date, a telegram, telex, facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Security which was delivered for purchase by the
Holder and a statement that such Holder is withdrawing his election to have such Security purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) On the purchase date, all
Securities purchased by the Company under this Section&nbsp;6.08 shall be delivered by the Company to the Trustee for cancellation, and the Company shall pay the purchase price plus accrued and unpaid interest, if any, to the Holders entitled
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.09. <U>Limitation on Liens</U>. The Company shall not, and shall not permit any Restricted Subsidiary to, directly or
indirectly, Incur or permit to exist any Lien (the &#147;<U>Initial Lien</U>&#148;) of any nature whatsoever on any of its properties (including Capital Stock of a Restricted Subsidiary), whether owned at the Issue Date or thereafter acquired,
securing any Indebtedness, other than Permitted Liens, without effectively providing that the Securities shall be secured equally and ratably with (or prior to) the obligations so secured for so long as such obligations are so secured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any Lien created for the benefit of the Holders pursuant to the preceding sentence shall provide by its terms that such Lien shall be
automatically and unconditionally released and discharged upon the release and discharge of the Initial Lien. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.10.
<U>Limitation on Sale/Leaseback Transactions</U>. The Company shall not, and shall not permit any Restricted Subsidiary to, enter into any Sale/Leaseback Transaction with respect to any property unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company or such Restricted Subsidiary would be entitled to (A)&nbsp;Incur Indebtedness in an amount equal to the
Attributable Debt with respect to such Sale/Leaseback Transaction pursuant to Section&nbsp;6.03 and (B)&nbsp;create a Lien on such property securing such Attributable Debt without equally and ratably securing the Securities pursuant to
Section&nbsp;6.09; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the gross proceeds received by the Company or any Restricted Subsidiary in connection with such
Sale/Leaseback Transaction are at least equal to the Fair Market Value of such property; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company applies the
proceeds of such transaction in compliance with Section&nbsp;6.06. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.11. <U>Future Guarantors</U>. (a)&nbsp;The Company shall cause each Restricted
Subsidiary that Guarantees any Indebtedness of the Company or any Subsidiary Guarantor in respect of the Credit Agreement or Capital Markets Indebtedness (or Incurs any such Indebtedness) to, at the same time, execute and deliver to the Trustee a
Guaranty Agreement pursuant to which such Restricted Subsidiary will Guarantee payment of the Securities on the same terms and conditions as those set forth in Article V of the Supplemental Indenture.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Sections 6.04 and 6.06 of the Base Indenture are hereby deleted in their entirety, but only with respect to the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Sections 6.02, 6.03, 6.05 and 6.07 of the Base Indenture are hereby amended, but only with respect to the Securities, by renumbering such
Sections 6.12, 6.13, 6.14, and 6.15, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.06. <U>Amendments of Article VII of Base Indenture</U>. (a) Section 7.01(b)
of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(b) the Company (A)&nbsp;defaults in the payment of principal of any Security when the same becomes due and payable at its Stated
Maturity, upon optional redemption, upon declaration of acceleration or otherwise or (B)&nbsp;fails to purchase Securities when required pursuant to this Indenture or the Securities;&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Section 7.01(c) the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(c) the Company fails to comply with Section&nbsp;5.01;&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Sections 7.01(d), (e) and (f)&nbsp;of the Base Indenture are hereby amended and restated, but only with respect to the Securities, to read
in their entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(d) the Company or any Subsidiary Guarantor fails to comply with any of its agreements contained in
the Securities or this Indenture (other than those referred to in (a), (b) or (c)&nbsp;above) and such failure continues for 60 days after the notice from the Trustee or the Holders specified below; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the Company, any Subsidiary Guarantor or any Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) commences a voluntary case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) consents to the entry of an order for relief against it in an involuntary case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) consents to the appointment of a Custodian of it or for any substantial part of its property; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) makes a general assignment for the benefit of its creditors; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">or takes any comparable action under any foreign laws relating to insolvency; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) is for relief against the Company, any Subsidiary Guarantor or any Significant Subsidiary in an involuntary case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) appoints a Custodian of the Company, any Subsidiary Guarantor or any Significant Subsidiary or for any substantial part of
its property; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) orders the winding up or liquidation of the Company, any Subsidiary
Guarantor or any Significant Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">or any similar relief is granted under any foreign laws and the order or decree remains unstayed
and in effect for 60 days;&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 of the Base Indenture is hereby amended, but only with respect to the Securities, by
the addition of the following new Sections 7.01(g), (h) and (i)&nbsp;as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(g) Indebtedness of the Company, any Subsidiary
Guarantor or any Significant Subsidiary is not paid within any applicable grace period after final maturity or is accelerated by the holders thereof because of a default and the total amount of such Indebtedness unpaid or accelerated exceeds
$50,000,000 or its foreign currency equivalent at the time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any judgment or decree for the payment of money in excess of $50,000,000
(or its foreign currency equivalent at the time) is entered against the Company, any Subsidiary Guarantor or any Significant Subsidiary, remains outstanding for a period of 60 consecutive days following the entry of such judgment or decree and is
not discharged, waived or effectively stayed; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any Subsidiary Guarantee ceases to be in full force and effect (other than in
accordance with the terms of such Subsidiary Guarantee) or any Subsidiary Guarantor denies or disaffirms its obligations under its Subsidiary Guarantee; or&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Section 7.01(g) of the Base Indenture is hereby amended, but only with respect to the Securities, by renumbering such section 7.01(j) and
by replacing the semi-colon at the end of such section with a period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The paragraph immediately following Section&nbsp;7.01(g) of the
Base Indenture and the last paragraph of Section&nbsp;7.01 of the Base Indenture are hereby deleted, but only with respect to the Securities, and replaced with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;The foregoing shall constitute Events of Default whatever the reason for any such Event of Default and whether such Event of Default is
voluntary or involuntary or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">However, a default under Section (d)&nbsp;of this Section&nbsp;7.01 will not constitute an Event of Default until the Trustee or the holders of
at least 25% in principal amount of the outstanding Securities notify the Company of the default and the Company does not cure such default within the time specified after receipt of such notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The term &#147;<U>Bankruptcy Law</U>&#148; means Title 11, United States Code, or any similar federal or state law for the relief of debtors.
The term &#147;<U>Custodian</U>&#148; means any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice in the form of an Officers&#146;
Certificate of any Event of Default under clause (g)&nbsp;or (i) and any event which with the giving of notice or the lapse of time or both would become an Event of Default under clause (d)&nbsp;or (h), its status and what action the Company is
taking or proposes to take with respect thereto.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Section 7.02 of the Base Indenture is hereby amended, but only with respect to
the Securities, by adding the following sentences to end of the Section: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;The holders of a majority in principal amount of the
Securities by notice to the Trustee may rescind an acceleration and its consequences if the rescission would not conflict with any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
judgment or decree and if all existing Events of Default have been cured or waived except nonpayment of principal or interest that has become due solely because of acceleration. No such
rescission shall affect any subsequent Default or impair any right consequent thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In the case of any Event of Default occurring by
reason of any willful action (or inaction) taken (or not taken) by or on behalf of the Company with the intention of avoiding payment of the premium that the Company would have had to pay if the Company then had elected to redeem the Securities
pursuant to the optional redemption provisions hereof, an equivalent premium shall also become and be immediately due and payable to the extent permitted by law upon the acceleration of the Securities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Section 7.07 the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 7.07. <U>Limitation on Suits</U>. Except to enforce the right to receive payment of principal or interest when
due, no Holder may pursue any remedy with respect to this Indenture or the Securities unless: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Holder gives to the Trustee written
notice stating that an Event of Default is continuing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the holders of at least 25% in principal amount of the outstanding Securities
make a written request to the Trustee to pursue the remedy; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) such Holder or Holders offer to the Trustee satisfactory security or
indemnity against any loss, liability or expense; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the Trustee does not comply with the request within 60 days after receipt of the
request and the offer of security or indemnity; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the holders of a majority in principal amount of the outstanding Securities do
not give the Trustee a direction inconsistent with the request during such <FONT STYLE="white-space:nowrap">60-day</FONT> period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A Holder
may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder. In the event that the definitive Securities are not issued to any beneficial owner promptly after the Registrar has
received a request from the Holder of a Global Security to issue such definitive Securities to such beneficial owner or its nominee, the Company expressly agrees and acknowledges, with respect to the right of any Holder to pursue a remedy pursuant
to this Indenture, the right of such beneficial holder of Securities to pursue such remedy with respect to the portion of the Global Security that represents such beneficial holder&#146;s Securities as if such definitive Securities had been issued.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.07. <U>Amendment of Article XI of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.03 of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Within 90 days after the occurrence thereof, and if known to the Trustee, the Trustee shall give to the Holders of the
Securities of a series notice of each Default or Event of Default with respect to the Securities of such series known to the Trustee, by transmitting such notice to Holders at their mailing addresses as the same shall then appear on the Register of
the Company (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or regulations, electronically), unless such Default shall have been cured or waived before the giving of such notice (the
term &#147;Default&#148; being hereby defined to be the events specified in Section&nbsp;7.01, which are, or after notice or lapse of time or both would become, Events of Default as defined in said Section). Except in the case of a Default or Event
of Default in payment of the principal of or interest on any of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities of such series when and as the same shall become payable, or to make any sinking fund payment as to Securities of the same series, the Trustee shall be protected in withholding such
notice, if and so long as a committee of Responsible Officers of the Trustee in good faith determines that the withholding of such notice is in the interests of the Holders of the Securities of such series.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.08. <U>Amendment of Article XII of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Article XII of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows:
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;ARTICLE XII </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Discharge
of Indenture; Defeasance </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.01. <U>Discharge of Liability on Securities; Defeasance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) When (1)&nbsp;the Company delivers to the Trustee all outstanding Securities (other than Securities replaced pursuant to
Section&nbsp;3.07) for cancellation or (2)&nbsp;all outstanding Securities have become due and payable, whether at maturity or on a redemption date as a result of the sending of a notice of redemption pursuant to Article IV hereof and the Company
irrevocably deposits with the Trustee funds in an amount sufficient, or U.S. Government Obligations the principal of and interest on which will be sufficient, or a combination thereof sufficient, to pay at maturity or upon redemption all outstanding
Securities, including interest thereon to maturity or such redemption date (other than Securities replaced pursuant to Section&nbsp;3.07), and if in either case the Company pays all other sums payable hereunder by the Company, then this Indenture
shall, subject to Section&nbsp;12.01(c), cease to be of further effect. The Trustee shall acknowledge satisfaction and discharge of this Indenture on demand of the Company accompanied by an Officers&#146; Certificate and an Opinion of Counsel, each
stating that all conditions precedent set forth herein relating to the satisfaction and discharge of this Indenture have been satisfied, and at the cost and expense of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to Sections 12.01(c) and 12.02, the Company at any time may terminate (1)&nbsp;all its obligations under the Securities and this
Indenture (&#147;legal defeasance option&#148;) or (2)&nbsp;its obligations under Sections 6.02, 6.03, 6.04, 6.05, 6.06, 6.07, 6.08, 6.09, 6.10 and 6.11 and the operation of Sections 7.01(e), 7.01(f), 7.01(g) and 7.01(h) (but, in the case of
Sections 7.01(e) and (f), with respect to Subsidiary Guarantors and Significant Subsidiaries only) and the limitations contained in Section&nbsp;5.01(a)(3) (&#147;covenant defeasance option&#148;). The Company may exercise its legal defeasance
option notwithstanding its prior exercise of its covenant defeasance option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Company exercises its legal defeasance option,
payment of the Securities may not be accelerated because of an Event of Default with respect thereto. If the Company exercises its covenant defeasance option, payment of the Securities may not be accelerated because of an Event of Default specified
in Sections 7.01(e), 7.01(f), 7.01(g) or 7.01(h) (but, in the case of Sections 7.01(e) and (f), with respect to Subsidiary Guarantors and Significant Subsidiaries only) or because of the failure of the Company to comply with Section&nbsp;5.01(a)(3).
If the Company exercises its legal defeasance option or its covenant defeasance option, each Subsidiary Guarantor, if any, shall be released from all of its obligations with respect to its Subsidiary Guarantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Upon satisfaction of the conditions set forth herein and upon request of the Company, the Trustee shall acknowledge in writing the discharge
of those obligations that the Company terminates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding clauses (a)&nbsp;and (b) above, the Company&#146;s obligations in
Sections 3.04, 3.06, 3.07 and 6.12 and in this Article XII shall survive until the Securities have been paid in full. Thereafter, the Company&#146;s obligations in Sections 11.01, 12.04 and 12.05 shall survive. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.02. <U>Conditions to Defeasance</U>. The Company may exercise its legal
defeasance option or its covenant defeasance option only if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company irrevocably deposits in trust with the
Trustee money or U.S. Government Obligations, or a combination thereof, for the payment of the principal of and interest on the Securities to redemption or maturity, as the case may be; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the Company delivers to the Trustee a certificate from a nationally recognized firm of independent accountants expressing
their opinion that the payments of principal and interest when due and without reinvestment on the deposited U.S. Government Obligations plus any deposited money without investment will provide cash at such times and in such amounts as will be
sufficient to pay principal of and interest when due on all the Securities to maturity or redemption, as the case may be; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) 123 days pass after the deposit is made and during the 123 day period no Default specified in Section&nbsp;7.01(e) or
(f)&nbsp;with respect to the Company occurs which is continuing at the end of the period; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the deposit does not
constitute a default under any other agreement binding on the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) the Company delivers to the Trustee an Opinion
of Counsel to the effect that the trust resulting from the deposit does not constitute, or is qualified as, a regulated investment company under the Investment Company Act of 1940; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) in the case of the legal defeasance option, the Company shall have delivered to the Trustee an Opinion of Counsel stating
that (A)&nbsp;the Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (B)&nbsp;since the date of this Indenture there has been a change in the applicable federal income tax law, in either case to the
effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders will not recognize income, gain or loss for federal income tax purposes as a result of such deposit and defeasance and will be subject to federal income tax on
the same amounts, in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) in the case of the covenant defeasance option, the Company shall have delivered to the Trustee an Opinion of Counsel to the
effect that the Holders will not recognize income, gain or loss for federal income tax purposes as a result of such covenant defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would
have been the case if such covenant defeasance had not occurred; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) the Company delivers to the Trustee an
Officers&#146; Certificate and an Opinion of Counsel, each stating that all conditions precedent to the defeasance and discharge of the Securities as contemplated by this Article XII have been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before or after a deposit, the Company may make arrangements satisfactory to the Trustee for the redemption of Securities at a future date in
accordance with Article IV. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.03. <U>Application of Trust Money</U>. The Trustee shall hold in trust money or U.S. Government
Obligations deposited with it pursuant to this Article XII. It shall apply the deposited money and the money from U.S. Government Obligations through the Paying Agent and in accordance with this Indenture to the payment of principal of and interest
on the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.04. <U>Repayment to Company</U>. The Trustee and the Paying Agent shall promptly turn over to the Company
upon request any excess money or securities held by them at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to any applicable abandoned property law, the Trustee and
the Paying Agent shall pay to the Company upon request any money held by them for the payment of principal or interest that remains unclaimed for two years, and, thereafter, Holders entitled to the money must look to the Company for payment as
general creditors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.05. <U>Indemnity for Government Obligations</U>. The Company shall pay and shall
indemnify the Trustee against any tax, fee or other charge imposed on or assessed against deposited U.S. Government Obligations or the principal and interest received on such U.S. Government Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.06. <U>Reinstatement</U>. If the Trustee or Paying Agent is unable to apply any money or U.S. Government Obligations in accordance
with this Article XII by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company&#146;s and each Subsidiary
Guarantor&#146;s obligations under this Indenture, each Subsidiary Guarantee and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this Article XII until such time as the Trustee or Paying Agent is
permitted to apply all such money or U.S. Government Obligations in accordance with this Article XII; <U>provided</U>, <U>however</U>, that, if the Company has made any payment of principal of or interest on any Securities because of the
reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or Paying Agent.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.09. <U>Amendment of Article XIII of Base Indenture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13.01 of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 13.01. <U>No Personal Liability</U>. No director, officer, employee, incorporator or stockholder of
the Company or any Subsidiary Guarantor shall have any liability for any obligations of the Company or any Subsidiary Guarantor under the Securities, any Subsidiary Guarantee or this Indenture or for any claim based on, in respect of, or by reason
of such obligations or their creation. By accepting a Security, each Holder shall waive and release all such liability. The waiver and release shall be part of the consideration for the issue of the Securities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.10. <U>Amendment of Article XIV of Base Indenture</U>. (a)&nbsp;Sections 14.01 and 14.02 of the Base Indenture are hereby amended
and restated, but only with respect to the Securities, to read in their entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 14.01.
<U>Without Consent of Holders</U>. The Company, the Subsidiary Guarantors and the Trustee may amend this Indenture or the Securities without notice to or consent of any Holder: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to cure any ambiguity, omission, defect or inconsistency; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) to comply with Article V; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to provide for uncertificated Securities in addition to or in place of certificated Securities; <U>provided</U>,
<U>however</U>, that the uncertificated Securities are issued in registered form for purposes of Section&nbsp;163(f) of the Code or in a manner such that the uncertificated Securities are described in Section&nbsp;163(f)(2)(B) of the Code; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to add Guarantees with respect to the Securities, including any Subsidiary Guaranties, or to secure the Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) to add to the covenants of the Company or a Subsidiary Guarantor for the benefit of the Holders or to surrender any right
or power herein conferred upon the Company or a Subsidiary Guarantor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) to make any change that does not adversely
affect the rights of any Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) to conform the text of this Indenture or the Securities to any provision of the
&#147;Description of Notes&#148; section of the Prospectus Supplement to the extent that such provision of the &#147;Description of Notes&#148; section of the Prospectus Supplement was intended to be a verbatim recitation of a provision of this
Indenture or the Securities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) to comply with any requirement of the SEC in connection with qualifying,
or maintaining the qualification of, this Indenture under the TIA; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) to make any amendment to the provisions of this
Indenture relating to the transfer and legending of Securities; <U>provided</U>, <U>however</U>, that (A)&nbsp;compliance with this Indenture as so amended would not result in Securities being transferred in violation of the Securities Act or any
other applicable securities law and (B)&nbsp;such amendment does not materially and adversely affect the rights of Holders to transfer Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">After an amendment under this Section&nbsp;14.01 becomes effective, the Company shall mail (or with respect to Global
Securities, to the extent permitted or required by applicable Depositary procedures or regulations, send electronically) to Holders a notice briefly describing such amendment. The failure to give such notice to all Holders, or any defect therein,
shall not impair or affect the validity of an amendment under this Section&nbsp;14.01. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 14.02. <U>With Consent of
Holders</U>. (a)&nbsp;The Company, the Subsidiary Guarantors and the Trustee may amend this Indenture, but only with respect to the Securities, or the Securities with the written consent of the holders of at least a majority in principal amount of
the Securities then outstanding (including consents obtained in connection with a purchase of, or tender offer or exchange for, the Securities) and any past Default or compliance with any provisions may also be waived with the consent of the holders
of at least a majority in principal amount of the Securities then outstanding. Notwithstanding the foregoing, without the consent of each Holder affected thereby, an amendment or waiver may not: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) reduce the amount of Securities whose Holders must consent to an amendment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) reduce the rate of or extend the time for payment of interest on any Security; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) reduce the principal of or change the Stated Maturity of any Security; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) (i) reduce the amount payable upon the redemption of any Security or (ii)&nbsp;change the time at which any Security may be
redeemed, in each case in accordance with Article IV; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) make any Security payable in money other than that stated in the
Security; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) impair the right of any Holder to receive payment of principal of and interest on such Holder&#146;s
Securities on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such Holder&#146;s Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) make any change in the amendment provisions that require each Holder&#146;s consent or in the waiver provisions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) make any change in the ranking or priority of any Security that would adversely affect the Securityholders; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) make any change in, or release other than in accordance with this Indenture, any Subsidiary Guarantee that would adversely
affect the Securityholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It shall not be necessary for the consent of the Holders under this Section&nbsp;14.02 to
approve the particular form of any proposed amendment, but it shall be sufficient if such consent approves the substance thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">After an amendment under this Section&nbsp;14.02 becomes effective, the
Company shall mail (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or regulations, send electronically) to Holders a notice briefly describing such amendment. The failure to give such
notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment under this Section&nbsp;14.02.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Article XIV of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new
Sections 14.07 and 14.08: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 14.07. <U>Revocation and Effect of Consents and Waivers</U>. A consent to an
amendment or a waiver by a Holder of a Security shall bind the Holder and every subsequent Holder of that Security or portion of the Security that evidences the same debt as the consenting Holder&#146;s Security, even if notation of the consent or
waiver is not made on the Security. However, any such Holder or subsequent Holder may revoke the consent or waiver as to such Holder&#146;s Security or portion of the Security if the Trustee receives the notice of revocation before the date on which
the amendment or waiver becomes effective. After an amendment or waiver becomes effective, it shall bind every Holder. An amendment or waiver becomes effective upon execution of such amendment or waiver by the Trustee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give
their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those Persons who were Holders at such
record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after such record
date. No such consent shall be valid or effective for more than 120 days after such record date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 14.08. <U>Payment
for Consent</U>. Neither the Company nor any Affiliate of the Company shall, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent,
waiver or amendment of any of the terms or provisions of this Indenture or the Securities unless such consideration is offered to all Holders and is paid to all Holders that so consent, waive or agree to amend in the time frame set forth in
solicitation documents relating to such consent, waiver or agreement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.11. <U>Amendment of Article XVI of Base
Indenture</U>. Section&nbsp;16.11 of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the first sentence of such section and replacing such deleted sentence with the following: &#147;This Indenture and the
Securities shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to applicable principles of conflicts of law to the extent that the application of the laws of another jurisdiction would be
required thereby.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.12. <U>Amendment of Base Indenture</U>. The Base Indenture is hereby amended, but only with respect to
the Securities, (a)&nbsp;by replacing cross-references to Sections and Articles therein to reflect the <FONT STYLE="white-space:nowrap">re-numbering</FONT> of such Sections and Articles as amended herein and (b)&nbsp;so that any definitions, and any
definitions included exclusively within such definitions, in the Base Indenture shall be deemed deleted or amended when all references in the Base Indenture to such definitions would be eliminated or amended as a result of the amendments effected by
this Supplemental Indenture. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSIDIARY GUARANTEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.01. <U>Guarantees</U>. (a)&nbsp;Each Subsidiary Guarantor hereby unconditionally and irrevocably guarantees, jointly and severally,
to each Holder and to the Trustee and its successors and assigns (i)&nbsp;the full and punctual payment of principal of and interest on the Securities when due, whether at maturity, by acceleration, by redemption or otherwise, and all other monetary
obligations of the Company under the Indenture and the Securities and (ii)&nbsp;the full and punctual performance within applicable grace periods of all other obligations of the Company under the Indenture and the Securities (all the foregoing being
hereinafter collectively called the &#147;<U>Guaranteed </U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Obligations</U>&#148;). Each Subsidiary Guarantor further agrees that the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice or further assent from such
Subsidiary Guarantor and that such Subsidiary Guarantor will remain bound under this Article V notwithstanding any extension or renewal of any Obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Subsidiary Guarantor waives presentation to, demand of, payment from and protest to the Company of any of the Guaranteed Obligations
and also waives notice of protest for nonpayment. Each Subsidiary Guarantor waives notice of any default under the Securities or the Guaranteed Obligations. The obligations of each Subsidiary Guarantor hereunder shall not be affected by (1)&nbsp;the
failure of any Holder or the Trustee to assert any claim or demand or to enforce any right or remedy against the Company or any other Person (including any Subsidiary Guarantor) under the Indenture, the Securities or any other agreement or
otherwise; (2)&nbsp;any extension or renewal of any thereof; (3)&nbsp;any rescission, waiver, amendment or modification of any of the terms or provisions of the Indenture, the Securities or any other agreement; (4)&nbsp;the release of any security
held by any Holder or the Trustee for the Guaranteed Obligations or any of them; (5)&nbsp;the failure of any Holder or the Trustee to exercise any right or remedy against any other guarantor of the Guaranteed Obligations; or (6)&nbsp;except as set
forth in Section&nbsp;5.06, any change in the ownership of such Subsidiary Guarantor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Subsidiary Guarantor further agrees that its
Subsidiary Guarantee herein constitutes a guarantee of payment, performance and compliance when due (and not a guarantee of collection) and waives any right to require that any resort be had by any Holder or the Trustee to any security held for
payment of the Guaranteed Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as expressly set forth in Sections 5.02, 5.05, 5.06 and 12.01(b), the obligations of
each Subsidiary Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of
setoff, counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, the obligations of each
Subsidiary Guarantor herein shall not be discharged or impaired or otherwise affected by the failure of any Holder or the Trustee to assert any claim or demand or to enforce any remedy under the Indenture, the Securities or any other agreement, by
any waiver or modification of any thereof, by any default, failure or delay, willful or otherwise, in the performance of the obligations, or by any other act or thing or omission or delay to do any other act or thing which may or might in any manner
or to any extent vary the risk of such Subsidiary Guarantor or would otherwise operate as a discharge of such Subsidiary Guarantor as a matter of law or equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each Subsidiary Guarantor further agrees that its Subsidiary Guarantee herein shall continue to be effective or be reinstated, as the case
may be, if at any time payment, or any part thereof, of principal of or interest on any Obligation is rescinded or must otherwise be restored by any Holder or the Trustee upon the bankruptcy or reorganization of the Company or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the foregoing and not in limitation of any other right which any Holder or the Trustee has at law or in equity against any
Subsidiary Guarantor by virtue hereof, upon the failure of the Company to pay the principal of or interest on any Obligation when and as the same shall become due, whether at maturity, by acceleration, by redemption or otherwise, or to perform or
comply with any other Obligation, each Subsidiary Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid, in cash, to the Holders or the Trustee an amount equal to the sum of
(A)&nbsp;the unpaid amount of such Guaranteed Obligations, (B)&nbsp;accrued and unpaid interest on such Guaranteed Obligations (but only to the extent not prohibited by law) and (C)&nbsp;all other monetary Guaranteed Obligations of the Company to
the Holders and the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Each Subsidiary Guarantor agrees that it shall not be entitled to any right of subrogation in respect of
any Obligations guaranteed hereby until payment in full of all Obligations. Each Subsidiary Guarantor further agrees that, as between it, on the one hand, and the Holders and the Trustee, on the other hand, (A)&nbsp;the maturity of the Guaranteed
Obligations guaranteed hereby may be accelerated as provided in Article VII of the Indenture for the purposes of any Subsidiary Guarantee herein, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of
the Guaranteed Obligations guaranteed hereby, and (B)&nbsp;in the event of any declaration of acceleration of such Guaranteed Obligations as provided in Article VII of the Indenture, such Guaranteed Obligations (whether or not due and payable) shall
forthwith become due and payable by such Subsidiary Guarantor for the purposes of this Section&nbsp;5.01. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Each Subsidiary Guarantor also agrees to pay any and all costs and expenses (including
reasonable attorneys&#146; fees and expenses) incurred by the Trustee or any Holder in enforcing any rights under this Section&nbsp;5.01. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.02. <U>Limitation on Liability</U>. Any term or provision of the Indenture to the contrary notwithstanding, the maximum aggregate
amount of the Guaranteed Obligations guaranteed hereunder by any Subsidiary Guarantor shall not exceed the maximum amount that can be hereby guaranteed without rendering the Indenture, as it relates to such Subsidiary Guarantor, voidable under
applicable law relating to fraudulent conveyance or fraudulent transfer or similar laws affecting the rights of creditors generally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.03. <U>Successors and Assigns</U>. This Article V shall be binding upon each Subsidiary Guarantor and its successors and assigns and
shall inure to the benefit of the successors and assigns of the Trustee and the Holders and, in the event of any transfer or assignment of rights by any Holder or the Trustee, the rights and privileges conferred upon that party in the Indenture and
in the Securities shall automatically extend to and be vested in such transferee or assignee, all subject to the terms and conditions of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.04. <U>No Waiver</U>. Neither a failure nor a delay on the part of either the Trustee or the Holders in exercising any right, power
or privilege under this Article V shall operate as a waiver thereof, nor shall a single or partial exercise thereof preclude any other or further exercise of any right, power or privilege. The rights, remedies and benefits of the Trustee and the
Holders herein expressly specified are cumulative and not exclusive of any other rights, remedies or benefits which either may have under this Article V at law, in equity, by statute or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.05. <U>Modification</U>. No modification, amendment or waiver of any provision of this Article V, nor the consent to any departure
by any Subsidiary Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by the Trustee, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which
given. No notice to or demand on any Subsidiary Guarantor in any case shall entitle such Subsidiary Guarantor to any other or further notice or demand in the same, similar or other circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.06. <U>Release of Subsidiary Guarantor</U>. A Subsidiary Guarantor will be automatically released from its obligations under this
Article V: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) upon the sale or other disposition (including by way of consolidation or merger) of such Subsidiary
Guarantor, including the sale or disposition of Capital Stock of such Subsidiary Guarantor, following which such Subsidiary Guarantor is no longer a Subsidiary of the Company; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) upon the sale or disposition of all or substantially all of the assets of such Subsidiary Guarantor; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in each case other than to the Company or an Affiliate of the Company and as permitted by the Indenture and if in connection therewith the
Company provides an Officers&#146; Certificate to the Trustee to the effect that the Company shall comply with its obligations under Section&nbsp;6.06 in respect of such disposition. Upon any sale or disposition described in clause (1)&nbsp;or (2)
above, the obligor on the related Subsidiary Guarantee will be released from its obligations thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Subsidiary Guarantor also
will be automatically released from its obligations under this Article V: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) upon the designation of such Subsidiary
Guarantor as an Unrestricted Subsidiary in accordance with the terms of the Indenture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) at such time as any Guarantee
by such Subsidiary Guarantor of the obligations under the Credit Agreement and under all Capital Markets Indebtedness has been released and discharged, except a discharge or release by or as a result of payment under such Guarantee; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) if the Company exercises its legal defeasance option or its covenant
defeasance option as described in Article XII of the Indenture or if the Company&#146;s obligations under the Indenture are discharged in accordance with the terms of the Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">For avoidance of doubt, clause (b)&nbsp;above shall include a situation whereby the Guarantee of Capital Markets Indebtedness
by a Subsidiary Guarantor, including the Securities, would be released and discharged (&#147;released&#148;) immediately upon such release under the Credit Agreement but for the existence of one or more guarantees of other Capital Markets
Indebtedness the terms of which also provide that such guarantees would be released immediately upon such release under the Credit Agreement, <I>provided that</I>, in each case, all conditions precedent to such release have been satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the request of the Company, the Trustee shall execute and deliver an appropriate instrument evidencing such release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.07. <U>Contribution</U>. Each Subsidiary Guarantor that makes a payment under its Subsidiary Guarantee shall be entitled upon
payment in full of all Guaranteed Obligations under the Indenture to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor&#146;s pro rata portion of such payment based on the respective net assets
of all the Subsidiary Guarantors at the time of such payment determined in accordance with GAAP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
6.01. <U>Integral Part</U>. This Supplemental Indenture constitutes an integral part of the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.02. <U>Adoption,
Ratification and Confirmation</U>. The Base Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects hereby adopted, ratified and confirmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.03. <U>Counterparts</U>. This Supplemental Indenture may be executed in any number of counterparts, each of which when so executed
shall be deemed an original; and all such counterparts shall together constitute but one and the same instrument. Signatures of the parties hereto transmitted by facsimile or PDF may be used in lieu of the originals and shall be deemed to be their
original signatures for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.04. <U>Severability</U>. Should any provision of this Supplemental Indenture for any
reason be declared invalid or unenforceable, such decision shall not affect the validity or enforceability of any of the other provisions of this Supplemental Indenture, which other provisions shall remain in full force and effect and the
application of such invalid or unenforceable provision to persons or circumstances other than those as to which it is held invalid or unenforceable shall be valid and be enforced to the fullest extent permitted by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.05. <U>Governing Law</U>. THIS SUPPLEMENTAL INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.06. <U>Trustee Makes No Representation</U>. The Trustee makes no representation and shall not be responsible or accountable as to
the validity, execution by the other parties hereto or thereto or sufficiency of this Supplemental Indenture or of the Securities or Subsidiary Guarantees. The recitals and statements herein are deemed to be those of the Company and Subsidiary
Guarantors and not of the Trustee and the Trustee shall not be held responsible in any manner whatsoever for their correctness. The Trustee shall not be accountable for the use or application by the Company of the Securities or the proceeds thereof.
The Trustee assumes no responsibility for the accuracy or completeness of the information concerning the Company or its Affiliates or any other Person contained in the Prospectus Supplement or any related documents or for any failure by the Company
or any other Person to disclose events that may have occurred and may affect the significance or accuracy of such information, except to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the extent such information relates to the Trustee. Neither the Trustee nor any Paying Agent shall be responsible for determining whether any Asset Disposition has occurred and whether any
related offer to purchase with respect to the Securities is required. Neither the Trustee nor any Paying Agent shall be responsible for determining whether any Change of Control has occurred and whether any Change of Control Offer with respect to
the Securities is required. Neither the Trustee nor any Paying Agent shall be responsible for monitoring the credit ratings of the Company or making any request upon any rating agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.07. <U>Damages Limitation</U>. In no event shall the Trustee be responsible or liable for any special, indirect, punitive or
consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit), irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.08. <U>U.S.A. PATRIOT Act</U>. The Company and the Subsidiary Guarantors acknowledge that in accordance with Section&nbsp;326 of the
U.S.A. PATRIOT Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that
establishes a relationship or opens an account with the Trustee. The parties to this Supplemental Indenture agree that they shall provide the Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the
U.S.A. PATRIOT Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Supplemental Indenture on the date
first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ENCOMPASS HEALTH CORPORATION, as Issuer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Patrick Darby</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Patrick Darby</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.750% Senior Notes due 2030] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">GUARANTORS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health C Corp Sub Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Central Arkansas Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Jonesboro Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Columbia, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Concord, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Dothan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Florence, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Manati, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Panama City, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of San Juan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Tyler Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Yuma Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of City View, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of San Antonio, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of Texarkana, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Rehabilitation Hospital of The Woodlands, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">HealthSouth Rehabilitation Hospital of Austin, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehab Concepts Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Reliant Blocker Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Western Neuro Care, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.750% Senior Notes due 2030] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Encompass Health Rehabilitation Hospital of Tustin, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Western Neuro Care, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">HealthSouth Rehabilitation Hospital of North Houston, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">HealthSouth North Houston GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.750% Senior Notes due 2030] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Continental Medical Systems, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings Subsidiary, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Alabama Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Arizona Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Arkansas Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Boise Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Bryan Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health California Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Colorado Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Deaconess Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Fairlawn Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health GKBJH Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Gulfport Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Iowa Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Johnson City Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Joint Ventures Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Kansas Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Kentucky Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Littleton Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Lubbock Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Martin County Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Maryland Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Massachusetts Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Midland Odessa Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Myrtle Beach Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Nevada Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health New Mexico Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health North Houston GP, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Ohio Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Owned Hospitals Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Pennsylvania Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Properties, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Albuquerque, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bakersfield, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bluffton, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Braintree, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Charleston, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cincinnati, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dayton, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of East Valley, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Erie, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fort Smith, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Franklin, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Gadsden, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Harmarville, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Henderson, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Kingsport, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Lakeview, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Largo, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Las Vegas, LLC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.750% Senior Notes due 2030] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Littleton, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Miami, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Middletown, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Modesto, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of New England, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Newnan, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Ocala, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Petersburg, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Reading, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sarasota, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Scottsdale, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Shelby County, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sunrise, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tallahassee, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Toms River, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Utah, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Vineland, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of York, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Institute of Tucson, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Savannah Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Sea Pines Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Sewickley Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health South Carolina Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health South Dakota Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Support Companies, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Texas Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Tucson Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Tulsa Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Utah Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Virginia Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Walton Rehabilitation Hospital, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health West Tennessee Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health West Virginia Real Estate, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Westerville Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Health Winston-Salem Holdings, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Abilene, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Arlington, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Austin, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Cypress, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Dallas, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Humble, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Pearland, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Plano, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Richardson, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Round Rock, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Sugar Land, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of the <FONT STYLE="white-space:nowrap">Mid-Cities,</FONT> LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital The Vintage, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Fort Worth, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Print Promotions Group, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:48%; font-size:10pt; font-family:Times New Roman">Rebound, LLC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.750% Senior Notes due 2030] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital Corporation of America, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital of North Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Rehabilitation Hospital of Plano, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.750% Senior Notes due 2030] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">WELLS FARGO BANK, NATIONAL<BR>ASSOCIATION, as Trustee</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stefan Victory</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stefan Victory</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.750% Senior Notes due 2030] </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF FACE OF SECURITY] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Global Securities Legend] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS
SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#147;DTC&#148;), NEW YORK, NEW YORK OR A NOMINEE OF DTC, WHICH MAY BE
TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE
IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE
LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#146;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS
SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Definitive Securities Legend] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>4.750% Senior Note Due 2030 </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">NO.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">CUSIP No. 29261A AB6</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">ISIN No. US29261AAB61</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION, a Delaware corporation, promises to pay to Cede&nbsp;&amp; Co., or registered
assigns, the principal sum of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dollars on February&nbsp;1, 2030. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: February&nbsp;1 and August 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: January&nbsp;15 and July 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Security are set forth on the other side of this Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date of authentication: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WELLS FARGO BANK, NATIONAL
ASSOCIATION, as Trustee </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF REVERSE SIDE OF SECURITY] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>4.750% Senior Note Due 2030 </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Interest</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred
to, being herein called the &#147;<U>Company</U>&#148;), promises to pay interest on the principal amount of this Security at the rate per annum shown above. The Company shall pay interest semiannually on February&nbsp;1 and August&nbsp;1 of each
year, commencing February&nbsp;1, 2020. Interest on the Securities will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from September&nbsp;18, 2019. Interest will be computed on the basis of a <FONT
STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. The Company shall pay interest on overdue principal at the rate borne by this Security plus 1.0% per annum, and it shall pay interest on
overdue installments of interest at the same rate to the extent lawful. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Method of Payment</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall pay interest on the Securities (except defaulted interest) to the Persons who are registered holders of Securities at the
close of business on the January&nbsp;15 or July&nbsp;15 next preceding the Interest Payment Date even if Securities are canceled after the Record Date and on or before the Interest Payment Date. Holders must surrender Securities to a Paying Agent
to collect principal payments. The Company shall pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts. Payments in respect of the Securities represented by a
Global Security (including principal and interest) will be made by wire transfer of immediately available funds to the accounts specified by the Depositary. The Company shall make all payments in respect of a certificated Security (including
principal and interest) by mailing a check to the registered address of each Holder thereof; <U>provided</U>, <U>however</U>, that payments on a certificated Security will be made by wire transfer to a U.S. dollar account maintained by the payee
with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such account no later than 30 days immediately preceding the relevant due date for
payment (or such other date as the Trustee may accept in its discretion). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Paying Agent and Registrar</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, Wells Fargo Bank, National Association, a national banking association (the &#147;<U>Trustee</U>&#148;), will act as Paying Agent
and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act as Paying
Agent, Registrar or <FONT STYLE="white-space:nowrap">co-Registrar.</FONT> The transferor of any Security shall provide or cause to be provided to the Trustee all information necessary to allow the Trustee to comply with any applicable tax reporting
obligations, including without limitation any cost basis reporting obligations under Section&nbsp;6045 of the Code. In connection with any proposed exchange of a certificated Security for a Global Security, there shall be provided to the Trustee all
information necessary to allow the Trustee to comply with any applicable tax reporting obligations, including without limitation any cost basis reporting obligations under Section&nbsp;6045 of the Code. The Trustee may rely on information provided
to it by other Persons and shall have no responsibility to verify or ensure the accuracy of such information. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Indenture</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued the Securities under the ninth supplemental indenture (the &#147;<U>Supplemental Indenture</U>&#148;), dated as of
September&nbsp;18, 2019, to the indenture dated as of December&nbsp;1, 2009 (together with the Supplemental Indenture, the &#147;<U>Indenture</U>&#148;), among the Company, the Subsidiary Guarantors and the Trustee. The terms of the Securities
include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. &#167;&#167; 77aaa-77bbbb) (the &#147;<U>Act</U>&#148;). Terms defined in the Indenture and not defined herein have
the meanings ascribed thereto in the Indenture. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and the Act for a statement of those terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities are general unsecured obligations of the Company. The Company shall be
entitled, subject to its compliance with Section&nbsp;6.03 of the Indenture, to issue Additional Securities pursuant to Section&nbsp;3.14 of the Indenture. The Securities issued on the Issue Date, and any Additional Securities, will be treated as a
single class for all purposes under the Indenture. The Indenture contains covenants that limit the ability of the Company and its subsidiaries to incur additional indebtedness; pay dividends or distributions on, or redeem or repurchase capital
stock; make investments; issue or sell capital stock of subsidiaries; engage in transactions with affiliates; create liens on assets; transfer or sell assets; guarantee indebtedness; restrict dividends or other payments of subsidiaries; consolidate,
merge or transfer all or substantially all of its assets; and engage in sale/leaseback transactions. These covenants are subject to important exceptions and qualifications. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Optional Redemption</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth below, the Company shall not be entitled to redeem the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On and after February&nbsp;1, 2025, the Company shall be entitled at its option to redeem all or a portion of the Securities upon not less
than 30 nor more than 60 days&#146; notice, at the redemption prices (expressed in percentages of principal amount on the redemption date), plus accrued interest to the redemption date (subject to the right of Holders of record on the relevant
Record Date to receive interest due on the relevant Interest Payment Date), if redeemed during the <FONT STYLE="white-space:nowrap">12-month</FONT> period commencing on February&nbsp;1 of the years set forth below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Redemption&nbsp;Price</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102.375</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101.583</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.792</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2028 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.000</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, prior to February&nbsp;1, 2025, the Company shall be entitled at its option on one or more occasions to redeem
Securities (which includes Additional Securities, if any) in an aggregate principal amount not to exceed 35% of the aggregate principal amount of the Securities (which includes Additional Securities, if any) originally issued at a redemption price
(expressed as a percentage of principal amount) of 104.75%, plus accrued and unpaid interest to the redemption date, with the net cash proceeds from one or more Equity Offerings; <U>provided</U>, <U>however</U>, that (1)&nbsp;at least 65% of such
aggregate principal amount of Securities (which includes Additional Securities, if any) remains outstanding immediately after the occurrence of each such redemption (other than Securities held, directly or indirectly, by the Company or its
Affiliates); and (2)&nbsp;each such redemption occurs within 90 days after the date of the related Equity Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to
February&nbsp;1, 2025, the Company shall be entitled at its option to redeem all or a portion of the Securities at a redemption price equal to 100% of the principal amount of the Securities plus the Applicable Premium as of, and accrued and unpaid
interest to, the redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notice of Redemption</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption will be mailed (or with respect to Global Securities, to the extent permitted or required by applicable DTC procedures or
regulations, send electronically) at least 30 days but not more than 60 days before the redemption date to each Holder of Securities to be redeemed at his registered address. Securities in denominations larger than $2,000 principal amount may be
redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Securities (or portions thereof) to be redeemed on the redemption date is deposited with the Paying Agent on or
before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Securities (or such portions thereof) called for redemption. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Put Provisions</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon a Change of Control, any Holder will have the right to cause the Company to repurchase all or any part of the Securities of such Holder at
a repurchase price equal to 101% of the principal amount of the Securities to be repurchased plus accrued interest to the date of repurchase (subject to the right of Holders of record on the relevant Record Date to receive interest due on the
related Interest Payment Date) as provided in, and subject to the terms of, the Indenture. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Guarantee</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payment by the Company of the principal of and interest on the Securities is fully and unconditionally guaranteed on a joint and several
senior unsecured basis by each of the Subsidiary Guarantors to the extent set forth in the Indenture. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.<U></U></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Denominations; Transfer; Exchange</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities are in registered form without coupons in denominations of $2,000 principal amount and any greater integral multiple of $1,000.
A Holder may transfer or exchange Securities in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Registrar need not register the transfer of or exchange any Securities selected for redemption (except, in the case of a Security to be redeemed in part, the portion of the Security not to be redeemed) or any
Securities for a period of 15 days before a selection of Securities to be redeemed or 15 days before an Interest Payment Date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Persons Deemed Owners</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in paragraph 2 hereof, the registered Holder of this Security may be treated as the owner of it for all purposes. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Unclaimed Money</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If money for the payment of principal or interest on any Securities remains unclaimed for two years, the Trustee or Paying Agent shall pay the
money back to the Company at its request at the end of the two years after such principal or interest has become due or payable, unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must
look only to the Company as general creditors and not to the Trustee for payment. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Discharge and Defeasance</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time shall be entitled to terminate some or all of its obligations under the Securities and
the Indenture if the Company irrevocably deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Securities to redemption or maturity, as the case may be. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Amendment, Waiver</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (a)&nbsp;the Indenture and the Securities may be amended with the written consent of
the holders of at least a majority in principal amount outstanding of the Securities and (b)&nbsp;any default or noncompliance with any provision may be waived with the written consent of the holders of a majority in principal amount outstanding of
the Securities. Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company, the Subsidiary Guarantors and the Trustee shall be entitled to amend the Indenture or the Securities to cure any
ambiguity, omission, defect or inconsistency, or to comply with Article V of the Indenture, or to provide for uncertificated Securities in addition to or in place of certificated Securities, or to add guarantees with respect to the Securities,
including Subsidiary Guarantees, or to add additional covenants or surrender rights and powers conferred on the Company or the Subsidiary Guarantors, or to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conform the text of the Indenture or the Securities to any provision of the &#147;Description of Notes&#148; section of the Prospectus Supplement under certain circumstances, or to comply with
any requirement of the SEC in connection with qualifying the Indenture under the Act, or to make any change that does not adversely affect the rights of any Securityholder, or to make amendments to provisions of the Indenture relating to the form,
authentication, transfer and legending of the Securities. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Defaults and Remedies</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Indenture, Events of Default include (a)&nbsp;default for 30 days in payment of interest on the Securities; (b)&nbsp;default in
payment of principal on the Securities at maturity, upon redemption pursuant to paragraph 5 of the Securities, upon acceleration or otherwise, or failure by the Company to redeem or purchase Securities when required; (c)&nbsp;failure by the Company
or any Subsidiary Guarantor to comply with other agreements in the Indenture or the Securities, in certain cases subject to notice and lapse of time; (d)&nbsp;certain accelerations (including failure to pay within any grace period after final
maturity) of other Indebtedness of the Company, any Subsidiary Guarantor or any Significant Subsidiary if the amount accelerated (or so unpaid) exceeds $50&nbsp;million; (e)&nbsp;certain events of bankruptcy or insolvency with respect to the
Company, a Subsidiary Guarantor or any Significant Subsidiary; (f)&nbsp;certain judgments or decrees for the payment of money in excess of $50&nbsp;million against the Company, a Subsidiary Guarantor or any Significant Subsidiary; and
(g)&nbsp;certain defaults with respect to Subsidiary Guarantees. If an Event of Default occurs and is continuing, the Trustee or the holders of at least 25% in principal amount of the Securities may declare all the Securities to be due and payable
immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Securities being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securityholders may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Securities unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Securities may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Securityholders notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding notice is in the interest of the Holders. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Trustee Dealings with the Company</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the Act, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Securities and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any
Paying Agent, Registrar, <FONT STYLE="white-space:nowrap">co-Registrar</FONT> or <FONT STYLE="white-space:nowrap">co-Paying</FONT> Agent may do the same with like rights. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>No Recourse Against Others</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or any Subsidiary Guarantor shall not have any liability for any
obligations of the Company or any Subsidiary Guarantor under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security, each Securityholder waives and
releases all such liability. The waiver and release are part of the consideration for the issue of the Securities. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authentication</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Security shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the other side of this Security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Abbreviations</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Securityholder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by
the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>CUSIP Numbers</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers
to be printed on the Securities and has directed the Trustee to use CUSIP numbers in notices of redemption as a convenience to Securityholders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as
contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE
PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company will furnish to any Securityholder upon written request and without charge to the Securityholder a copy of the Indenture which has in it the text of the form of this Security. Requests may be made to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assign this Security, fill in the form below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I or we
assign and transfer this Security to </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(Print or type assignee&#146;s name, address and zip code) </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(Insert assignee&#146;s Social
Security or Tax I.D. No.)&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> agent to transfer this
Security on the books of the Company. The agent may substitute another to act for him. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DATE: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YOUR SIGNATURE:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sign exactly as your name appears on the other side of this Security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[TO BE ATTACHED TO GLOBAL SECURITIES] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following increases or decreases in this Global Security have been made: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Date of Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount&nbsp;of&nbsp;decrease<BR>in Principal amount<BR>of this Global<BR>Security</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount&nbsp;of&nbsp;increase<BR>in&nbsp;Principal&nbsp;amount<BR>of this Global<BR>Security</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal&nbsp;amount&nbsp;of<BR>this&nbsp;Global&nbsp;Security<BR>following such<BR>decrease&nbsp;or&nbsp;increase</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Signature of<BR>authorized&nbsp;officer&nbsp;of<BR>Trustee&nbsp;or&nbsp;Securities<BR>Custodian</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OPTION OF HOLDER TO ELECT PURCHASE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you want to elect to have this Security purchased by the Company pursuant to Section&nbsp;6.06 or 6.08 of the Indenture, check the box:
&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you want to elect to have only part of this Security purchased by the Company pursuant to Section&nbsp;6.06 or 6.08 of the
Indenture, state the amount in principal amount: $ </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Your</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Signature:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">(Sign exactly as your name appears on the other side of this Security.)</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature&nbsp;Guarantee:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(Signature must be guaranteed)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signatures must be guaranteed by an &#147;eligible guarantor institution&#148; meeting the requirements of the Registrar,
which requirements include membership or participation in the Security Transfer Agent Medallion Program (&#147;<U>STAMP</U>&#148;) or such other &#147;signature guarantee program&#148; as may be determined by the Registrar in addition to, or in
substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF GUARANTY AGREEMENT] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">GUARANTY AGREEMENT (this &#147;<U>Guaranty Agreement</U>&#148;) dated as of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; among [GUARANTOR] (the
&#147;<U>New Guarantor</U>&#148;), a subsidiary of ENCOMPASS HEALTH CORPORATION (or its successor), a Delaware corporation (the &#147;<U>Company</U>&#148;), the subsidiary guarantors party to the Indenture (defined below) (the &#147;<U>Subsidiary
Guarantors</U>&#148;), in favor of WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee under the Indenture (the &#147;<U>Trustee</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H : </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS
the Company and the Subsidiary Guarantors (the &#147;<U>Existing Guarantors</U>&#148;) have heretofore executed and delivered to the Trustee a ninth supplemental indenture (the &#147;<U>Ninth Supplemental Indenture</U>&#148;) dated as of
September&nbsp;18, 2019, to the indenture (together with the Ninth Supplemental Indenture, the &#147;<U>Indenture</U>&#148;) dated as of December&nbsp;1, 2009, providing for the issuance of the Company&#146;s 4.750% Senior Notes due 2030 (the
&#147;<U>Securities</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS Section&nbsp;6.11 of the Indenture provides that under certain circumstances the Company is
required to cause the New Guarantor to execute and deliver to the Trustee an agreement pursuant to which the New Guarantor shall unconditionally guarantee all the Company&#146;s obligations under the Securities pursuant to a Subsidiary Guarantee on
the terms and conditions set forth herein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the New Guarantor and the Company mutually covenant and agree for the equal and ratable benefit of the holders of the Securities as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Agreement to Guarantee</U>. The New Guarantor hereby agrees, jointly and severally with all Existing Guarantors, to unconditionally
guarantee the Company&#146;s obligations under the Securities on the terms and subject to the conditions set forth in Article V of the Ninth Supplemental Indenture and to be bound by all other applicable provisions of the Indenture and the
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Ratification of Indenture; Supplemental Indentures and Guaranty Agreements Part of Indenture</U>. Except as expressly
amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Guaranty Agreement shall form a part of the Indenture for all purposes, and
every holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Governing Law</U>. <B>THIS
GUARANTY AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION
WOULD BE REQUIRED THEREBY.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Trustee Makes No Representation</U>. The Trustee makes no representation and shall not be
responsible or accountable as to the validity, execution by the parties hereto or thereto or sufficiency of this Guaranty Agreement or the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Counterparts</U>. The parties may sign any number of copies of this Guaranty Agreement. Each signed copy shall be an original, but all
of them together represent the same agreement. Signatures of the parties hereto transmitted by facsimile or PDF may be used in lieu of the originals and shall be deemed to be their original signatures for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Effect of Headings</U>. The Section headings herein are for convenience only and shall not affect the construction thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Guaranty Agreement to be duly
executed as of the date first above written. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[NEW GUARANTOR], </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">by </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Name: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">by </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d760186dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Letterhead of Maynard, Cooper&nbsp;&amp; Gale, P.C.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">September&nbsp;18, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health
Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as
counsel to Encompass Health Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), and special counsel to each of the subsidiaries of the Company named on <U>Schedule</U><U></U><U>&nbsp;I</U> attached hereto (the &#147;<U>Subsidiary
Guarantors</U>&#148;), in connection with the issuance of $500,000,000 in aggregate principal amount of the Company&#146;s 4.500% Senior Notes due 2028 (the &#147;<U>2028 Notes</U>&#148;), $500,000,000 in aggregate principal amount of the
Company&#146;s 4.750% Senior Notes due 2030 (the &#147;<U>2030 Notes</U>&#148; and, together with the 2028 Notes, the &#147;<U>Notes</U>&#148;) and the related guarantees of such Notes issued by the Subsidiary Guarantors (the
&#147;<U>Guarantees</U>,&#148; and together with the Notes, the &#147;<U>Securities</U>&#148;). Such issuance has been made pursuant to (i)&nbsp;the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File
No.&nbsp;333-220519), including a base prospectus dated September&nbsp;18, 2017 (the &#147;<U>Base Prospectus</U>&#148;), initially filed with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) pursuant to the Securities Act
of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), on September&nbsp;19, 2017, as amended by the Post-Effective Amendment No.&nbsp;1 filed with the Commission on September&nbsp;9, 2019 (the registration statement and such amendment
thereto, collectively, the &#147;<U>Registration Statement</U>&#148;), (ii)&nbsp;the preliminary prospectus supplement dated September&nbsp;9, 2019 and filed with the Commission on September&nbsp;9, 2019 pursuant to Rule 424(b) under the Securities
Act (together with the Base Prospectus, the &#147;<U>Preliminary Prospectus</U>&#148;), (iii)&nbsp;the document identified by the Company as a &#147;free writing prospectus&#148; (within the meaning of Rule&nbsp;433 and Rule&nbsp;405 under the
Securities Act) (the &#147;<U>FWP</U>&#148;) dated September&nbsp;9, 2019 and filed with the Commission on September&nbsp;10, 2019 pursuant to Rule 433(d) under the Securities Act and (iv)&nbsp;the final prospectus supplement dated September&nbsp;9,
2019 and filed with the Commission on September&nbsp;11, 2019 pursuant to Rule 424(b) under the Securities Act (together with the Base Prospectus, the &#147;<U>Prospectus</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes and the Guarantees are being issued under an Indenture, dated as of December&nbsp;1, 2009 (the &#147;<U>Base Indenture</U>&#148;),
between the Company and Wells Fargo Bank, National Association (as successor to The Bank of Nova Scotia Trust Company of New York), as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by an eighth supplemental indenture, dated as of
September&nbsp;18, 2019, among the Company, the Guarantors and the Trustee, relating to the 2028 Notes (the &#147;<U>Eighth Supplemental Indenture</U>&#148;), and as further supplemented by a ninth supplemental indenture, dated as of September 18,
2019, among the Company, the Guarantors and the Trustee, relating to the 2030 Notes (the &#147;<U>Ninth Supplemental Indenture</U>&#148; and, together with the Eighth Supplemental Indenture, the </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 18, 2019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<U>Supplemental Indentures</U>&#148; and, the Supplemental Indentures together with the Base Indenture, the &#147;<U>Indenture</U>&#148;). The Notes are being sold pursuant to an
Underwriting Agreement, dated September 9, 2019 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company, the Guarantors, Citigroup Global Markets Inc., as representative of the several underwriters named in Schedule&nbsp;1 therein (the
&#147;<U>Underwriters</U>&#148;), and the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In rendering our opinions herein, we have relied upon certificates signed by
officers of the Company and the Subsidiary Guarantors with respect to various factual matters without having independently verified such factual matters, and certificates, correspondence and representations from public officials referred to below.
We are opining herein solely as to (i)&nbsp;the Alabama Business and Nonprofit Entity Code, the Delaware General Corporation Law, the Delaware Limited Liability Company Act, the Delaware Revised Uniform Limited Partnership Act, the Florida Business
Corporation Act and the Tennessee Limited Liability Company Act (collectively, the &#147;<U>Business Codes</U>&#148;), as applicable to those certain Subsidiary Guarantors that are identified in <U>Schedule I</U> hereto as being incorporated or
otherwise organized under Alabama, Delaware, Florida or Tennessee law (the &#147;<U>Specified Guarantors</U>&#148;), and (ii)&nbsp;with respect to the opinions set forth in paragraphs 6 and 7 below, the internal laws of the State of New York. We
express no opinion with respect to the applicability thereto, or the effect thereon, of the federal laws of the United States or the laws of any other jurisdiction or, in the case of the States of Alabama, Delaware, Florida and Tennessee, any laws
other than the Business Codes listed above, or as to any matters of municipal law or the laws of any local agencies within any state. Additionally, we are not rendering any opinion, and we are not providing any assurance, as to compliance with any
antifraud law, rule or regulation or any state &#147;blue sky&#148; securities law relating to the Securities or the offering, issuance or sale thereof. We are not admitted to practice in the State of Delaware; however, we are generally familiar
with the Delaware General Corporation Law, the Delaware Limited Liability Company Act and the Delaware Revised Uniform Limited Partnership Act as currently in effect and have made such inquiries as we consider necessary to render the opinions below.
We call to your attention that certain of the Subsidiary Guarantors are incorporated or otherwise organized, as the case may be, in the States of Massachusetts, South Carolina and Texas, as indicated in <U>Schedule I</U> hereto. Various matters
concerning the laws of the States of Massachusetts, South Carolina and Texas are addressed in the letter of Bradley Arant Boult Cummings LLP, and we express no opinion with respect to those matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In rendering our opinions herein, we have examined originals or copies of the following documents: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Registration Statement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Preliminary Prospectus; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the FWP; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Prospectus; </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 18, 2019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;the Underwriting Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;the Indenture, including the Guarantees contained therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;the global note executed by the Company pursuant to the Indenture, dated as of September&nbsp;18, 2019,
representing the 2028 Notes (the &#147;<U>2028 Global Note</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;the global note executed by the
Company pursuant to the Indenture, dated as of September&nbsp;18, 2019, representing the 2030 Notes (the &#147;<U>2030 Global Note</U>&#148; and, together with the 2028 Global Note, the &#147;<U>Global Notes</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;the certificate of incorporation and bylaws for the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;the certificate of incorporation, articles of incorporation, articles of organization, certificate of formation,
bylaws, limited liability company agreement, operating agreement and partnership agreement or the equivalents thereto, as applicable, for each Specified Guarantor; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;certain resolutions adopted by the Company&#146;s board of directors, and a committee thereof, relating to the
Securities and certain related matters; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;certain resolutions adopted by the board of directors, board of
managers or partners, as applicable, and any resolutions authorizing the same, of each Specified Guarantor, relating to the Securities and certain related matters; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate with respect to various factual matters signed by an officer of the Company dated as of the date
of this opinion letter; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;a certificate with respect to various factual matters signed by an officer of each
of the Subsidiary Guarantors dated as of the date of this opinion letter; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv)&nbsp;&nbsp;&nbsp;&nbsp;certificates of public
officials or other written evidence of good standing, existence or compliance, as applicable, for each of the Company and the Specified Guarantors in its respective jurisdiction of incorporation or formation, as applicable (the &#147;<U>Public
Certificates</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of
such documents, corporate records, certificates of officers of the Company and the Subsidiary Guarantors and of public officials and other instruments or documents as we have deemed necessary or advisable for the purposes of rendering these
opinions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed the genuineness of all signatures, the legal capacity of each natural person signing any document reviewed by
us, the authority of each person signing in a representative capacity (other than with respect to the Company and the Specified Guarantors) any document reviewed by us, the authenticity of all documents submitted to us as originals, the conformity
to authentic original documents of all copies submitted to us or filed with the Commission as conformed and certified or reproduced copies, and the absence of duress, fraud or </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 18, 2019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
mutual mistake of material facts on the part of the parties to any agreement with respect to which an opinion is expressed herein. We have further assumed (a)&nbsp;that, other than with respect
to the Company and each of the Specified Guarantors, the Underwriting Agreement, the Indenture and the Global Notes (collectively, the &#147;<U>Subject Documents</U>&#148;) have been duly authorized, executed and delivered by the parties thereto,
(b)&nbsp;that, other than with respect to the Company and each of the Specified Guarantors, the Subject Documents constitute legally valid and binding obligations of the parties thereto, enforceable against each of them in accordance with their
respective terms, and (c)&nbsp;that the status of the Subject Documents as legally valid and binding obligations of the parties is not affected by any (i)&nbsp;breaches of, or defaults under, agreements or instruments, (ii)&nbsp;violations of
statutes, rules, regulations or court or governmental orders, or (iii)&nbsp;failures to obtain required consents, approvals or authorizations from, or make required registrations, declarations or filings with, governmental authorities. As to any
facts material to these opinions, we have relied to the extent we deemed appropriate and without independent investigation upon statements and representations of officers and other representatives of the Company, the Subsidiary Guarantors and
others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to our opinion in paragraph 1 below with respect to the Company&#146;s and the Specified Guarantors&#146; good
standing, we have based our opinions solely upon examination of the Public Certificates. With regard to our opinions in paragraphs 3, 5 and 7 below, we express no opinion as to compliance with <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Section&nbsp;48-249-306</FONT></FONT> of the Tennessee Revised Limited Liability Company Act or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Section&nbsp;48-236-105</FONT></FONT> of the Tennessee
Limited Liability Company Act, insofar as the incurrence of the obligations governed by the Indenture may be deemed to be a distribution by the Specified Guarantor that is formed in Tennessee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the qualifications, assumptions and limitations herein set forth, we are of the opinion that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Company and the Specified Guarantors is validly existing and in good standing under the laws of its
respective jurisdiction of incorporation or formation, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;The Company has the requisite corporate
power under the laws of the State of Delaware to execute, deliver and perform its obligations under the Indenture and to issue the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Specified Guarantors has the requisite corporate, limited liability company or partnership power, as
applicable, under the laws of its state of incorporation or formation, as applicable, to execute, deliver and perform its obligations under the Indenture and to issue the Guarantees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery by the Company of the Indenture and the performance of its obligations thereunder,
including the issuance of the Notes in accordance with the provisions of the Indenture, have been duly authorized by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery by each of the Specified Guarantors of the Indenture and the performance of its
obligations thereunder, including the issuance of the Guarantees in accordance with the provisions of the Indenture, have been duly authorized by each of the Specified Guarantors. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 18, 2019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;The Notes are legally valid and binding obligations of the
Company, enforceable against the Company in accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;The Guarantees are legally valid and
binding obligations of the Subsidiary Guarantors, enforceable against the Subsidiary Guarantors in accordance with their respective terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinions expressed in paragraphs 6 and 7 above with respect to the valid and binding nature of obligations of the Securities are subject
to the following exceptions, limitations and qualifications: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;we express no opinion with respect to any
provision of any of the Subject Documents relating to: (a)&nbsp;the effect of bankruptcy, insolvency, reorganization, receivership, moratorium or other laws affecting creditors&#146; rights (including, without limitation, the effect of statutory and
other law regarding fraudulent conveyances, fraudulent transfers and preferential transfers)&nbsp;(b) <FONT STYLE="white-space:nowrap">non-reliance,</FONT> exculpation, disclaimer, limitation of liability, indemnification, contribution, waiver,
limitation or exclusion of remedies; (b)&nbsp;liquidated damages, forfeitures, default interest, late charges, make-whole premiums, payment of attorneys&#146; fees, collection upon acceleration of amounts that might be determined to constitute
unearned interest thereon, or other economic remedies, in each case to the extent that it constitutes a penalty, is prohibited by law or is deemed to be contrary to public policy; (c)&nbsp;concepts or principles of materiality, reasonableness,
equity, good faith, fair dealing or unconscionability (regardless of whether the Securities are considered in a proceeding in equity or at law); (d) governing law (except for the enforceability of any provision choosing New York law as a Subject
Document&#146;s governing law pursuant to the statutes referred to in paragraph (ii)&nbsp;below); (e) the waiver of the right to trial by jury or of usury, stay, extension and similar laws; (f)&nbsp;rights or remedies not being exclusive, not
preventing the concurrent assertion of any other right or remedy, being cumulative and exercisable in addition to any other right and remedy, or any delay or omission to exercise any right or remedy not impairing any right or remedy or not
constituting a waiver thereof; (g)&nbsp;any obligation or agreement to use best efforts, reasonable best efforts or commercially reasonable efforts; (h)&nbsp;any requirement that a party take further action or enter into further agreements or
instruments or provide further assurances; (i)&nbsp;any requirement that amendments or waivers be in writing insofar as they suggest that oral or other modifications, amendments or waivers could not be effectively agreed upon by the parties or that
the doctrine of promissory estoppel might not apply; (j)&nbsp;service of process by any method not provided for under applicable statute or court rule; and (k)&nbsp;the severability of any provisions to the foregoing effect to the extent such
provisions are unenforceable; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to the extent that any opinions set forth herein relate to the
enforceability of the choice of New York law and selection of a New York forum or exclusive jurisdiction provisions in any of the Subject Documents, such opinions are subject to the qualifications that such enforceability may be subject to, in each
case, (a)&nbsp;the exceptions and limitations in Sections <FONT STYLE="white-space:nowrap">5-1401</FONT> and <FONT STYLE="white-space:nowrap">5-1402</FONT> of the New York General Obligations Law and (b)&nbsp;principles of comity and
constitutionality. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 18, 2019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion letter is rendered as of the date hereof, and we assume no obligation to revise
or supplement the opinions contained herein in the event of any future changes in the facts or laws relating to the matters covered by such opinions. This opinion letter is being furnished in accordance with the requirements of Item 16 of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> and Item 601(b)(5)(i) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> as promulgated by the Commission under the Securities Act, and is limited to the matters expressly stated herein, and no opinions
are to be inferred or may be implied beyond those expressly stated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion letter as an exhibit
to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> dated September&nbsp;18, 2019, which is incorporated by reference into the Registration Statement, and to the reference to our firm under the heading
&#147;Legal Matters&#148; in the Prospectus. In giving such consent, we do not admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:65%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:65%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Maynard, Cooper&nbsp;&amp; Gale, P.C. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SCHEDULE I </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Subsidiary Guarantors </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Medical Systems, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Rehabilitation Hospital of Arizona, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings Subsidiary, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Alabama Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arizona Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arkansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Boise Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Bryan Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health C Corp Sub Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health California Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Central Arkansas Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Colorado Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Deaconess Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Fairlawn Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health GKBJH Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Gulfport Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Iowa Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Johnson City Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Joint Ventures Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Jonesboro Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kentucky Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Littleton Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Lubbock Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Martin County Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Maryland Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Massachusetts Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Midland Odessa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Myrtle Beach Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Nevada Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health New Mexico Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health North Houston GP, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Ohio Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Owned Hospitals Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Pennsylvania Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Properties, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bluffton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Braintree, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Charleston, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">South&nbsp;Carolina</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Columbia, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Concord, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dayton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dothan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of East Valley, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Erie, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Florence, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">South&nbsp;Carolina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Franklin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Tennessee</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Gadsden, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Harmarville, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Henderson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Kingsport, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Lakeview, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Largo, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Littleton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Manati, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Miami, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Middletown, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Modesto, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Newnan, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Ocala, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Panama City, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Petersburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Reading, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of San Juan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sarasota, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Shelby County, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sunrise, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Toms River, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tustin, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Utah, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Vineland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of York, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Institute of Tucson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Savannah Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sea Pines Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sewickley Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Carolina Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Dakota Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Support Companies, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Texas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tucson Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tulsa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tyler Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Utah Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Walton Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Tennessee Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Westerville Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Winston-Salem Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Yuma Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Abilene, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Arlington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Austin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of City View, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Cypress, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Dallas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Humble, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Pearland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Richardson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Round Rock, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of San Antonio, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Sugar Land, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of Texarkana, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of the <FONT STYLE="white-space:nowrap">Mid-Cities,</FONT>
LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital of The Woodlands, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Rehabilitation Hospital The Vintage, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Austin, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of North Houston, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Print Promotions Group, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rebound, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehab Concepts Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital Corporation of America, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of North Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reliant Blocker Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Western Neuro Care, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>d760186dex52.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Letterhead of Bradley Arant Boult Cummings LLP] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;18, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as special
counsel to each of the Opinion Guarantors (as defined below), each Opinion Guarantor being a direct or indirect subsidiary of Encompass Health Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), in connection with the Opinion
Guarantors&#146; guarantee, along with the other Guarantors (as defined below), of the $1,000,000,000 aggregate principal amount of the Company&#146;s 4.500% Senior Notes due 2028 (the &#147;<U>2028 Notes</U>&#148;) and 4.750% Senior Notes due 2030
(the &#147;<U>2030 Notes</U>&#148; and, together with the 2028 Notes, the &#147;<U>Notes</U>&#148;). The Notes are being issued under an Indenture (the &#147;<U>Base Indenture</U>&#148;) between the Company and Wells Fargo Bank, National
Association, as trustee (the &#147;<U>Trustee</U>&#148;), dated as of December&nbsp;1, 2009, as amended and supplemented by the Eighth Supplemental Indenture thereto (the &#147;<U>Eighth Supplemental Indenture</U>&#148;), dated as of
September&nbsp;18, 2019, among the Company, the guarantors named therein (the &#147;<U>Guarantors</U>&#148;) and the Trustee relating to the 2028 Notes and the Ninth Supplemental Indenture thereto (the &#147;<U>Ninth Supplemental
Indenture</U>&#148;), dated as of September&nbsp;18, 2019, among the Company, the Guarantors and the Trustee relating to the 2030 Notes. The Base Indenture, as amended and supplemented by the Eighth Supplemental Indenture and the Ninth Supplemental
Indenture, is referenced herein as the &#147;<U>Indenture</U>.&#148; The Notes are being guaranteed by the Guarantors pursuant to the guarantees included in the Indenture (the &#147;<U>Guarantees</U>&#148;), and are being sold pursuant to an
Underwriting Agreement dated as of September&nbsp;9, 2019 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company, the Guarantors, and Citigroup Global Markets Inc. as representative of the underwriters listed on Schedule 1 to the
Underwriting Agreement (the &#147;<U>Underwriters</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined originals or copies,
certified or otherwise identified to our satisfaction, of: (i)&nbsp;the registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-220519)</FONT> filed by the Company and
the <FONT STYLE="white-space:nowrap">co-registrants</FONT> named therein with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), on
September&nbsp;19, 2017, as amended by the Post-Effective Amendment No.&nbsp;1, filed with the Commission on September&nbsp;9, 2019 (such registration statement, as amended and including the form of prospectus included therein and the documents
incorporated by reference therein at the time of effectiveness pursuant to Rule 430B under the Securities Act, being referred to herein as the &#147;<U>Registration Statement</U>&#148;); (ii) the prospectus dated September&nbsp;18, 2017, included in
the Registration Statement, relating to the offering from time to time of the Company&#146;s securities and the related guarantees of the <FONT STYLE="white-space:nowrap">co-registrants</FONT> (the &#147;<U>Base Prospectus</U>&#148;); (iii) the
preliminary prospectus supplement dated September&nbsp;9, 2019, relating to the Notes, in the form filed on September&nbsp;9, 2019, with the Commission, pursuant to Rule 424(b)(5) under the Securities Act (the &#147;<U>Preliminary
Prospectus</U>&#148;); (iv)&nbsp;the prospectus supplement dated September&nbsp;9, 2019, relating to the Notes, in the form filed on September&nbsp;11, 2019, with the SEC, pursuant to Rule 424(b)(5) under the Securities Act (such prospectus
supplement, together with the Base Prospectus, being referred to herein as the &#147;<U>Prospectus</U>&#148;); (v) the Underwriting Agreement; (vi)&nbsp;the Indenture; (vii)&nbsp;the form of the Notes, including the Guarantees therein, attached to
the Eighth Supplemental Indenture and the Ninth Supplemental Indenture; (viii)&nbsp;the global note executed by the Company pursuant to the Indenture, in the aggregate principal amount of $500,000,000, representing the 2028 Notes purchased and sold
pursuant to the Underwriting Agreement (the &#147;<U>2028 Global Note</U>&#148;); (ix)&nbsp;the global note executed by the Company pursuant to the Indenture, in the aggregate principal amount of $500,000,000, representing the 2030 Notes purchased
and sold pursuant to the Underwriting Agreement (the &#147;<U>2030 Global Note</U>&#148; and, together with the 2028 Global Note, the &#147;<U>Global Notes</U>&#148;); (x)&nbsp;the articles of incorporation, articles of organization, certificate of
organization or other constituent documents, as applicable, and bylaws or operating agreements (or certificates of assumed name and the partnership agreements or similar documents) of each of the Guarantors listed on
<U>Appendix</U><U></U><U>&nbsp;I</U> to this opinion (the &#147;<U>Opinion Guarantors</U>&#148;); (xi)&nbsp;certain resolutions adopted by the board of directors, board of managers or partners, as applicable, and any resolutions authorizing the
same, of each Opinion Guarantor, relating to the Notes and Guarantees and certain related matters; (xii)&nbsp;originals, or copies certified or otherwise identified, of certificates of public officials (the &#147;<U>Public Certificates</U>&#148;)
and of representatives of the Company and the Opinion Guarantors and (xiii)&nbsp;statutes and such other documents as we have deemed necessary or appropriate for the basis of our opinions set forth herein. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed the genuineness of all signatures, the legal capacity of each natural person
signing any document reviewed by us, the authority of each person signing in a representative capacity (other than with respect to the Opinion Guarantors) any document reviewed by us, the authenticity of all documents submitted to us as originals,
the conformity to authentic original documents of all copies submitted to us or filed with the Commission as conformed and certified or reproduced copies, and the absence of duress, fraud or mutual mistake of material facts on the part of the
parties to any agreement with respect to which an opinion is expressed herein. In conducting our examination of documents, we have also assumed that, to the extent such documents purport to constitute agreements, such documents constitute valid and
binding obligations of such parties and, except with respect to the Opinion Guarantors, (i)&nbsp;the power, corporate or other, of all parties thereto to enter into and perform all obligations thereunder, (ii)&nbsp;the due authorization by all
requisite action, corporate or other, thereof, and (iii)&nbsp;the due execution and delivery by such parties of such documents. As to any facts material to our opinion, we have made no independent investigation of such facts and have relied, to the
extent that we deem such reliance proper, upon certificates of public officials and officers or other representatives of the Company and Guarantors. We have further assumed that the Public Certificates have been properly given and are accurate as of
the date thereof and as of the date of this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinions set forth herein are limited in all respects to the Massachusetts
Limited Liability Company Act, the South Carolina Business Corporation Act of 1988, the South Carolina Uniform Limited Liability Company Act of 1996 and the Texas Business Organizations Code, and we do not express any opinion with respect to the
federal laws of the United States or of any other jurisdiction, or any effect which such laws may have on the opinions expressed herein. The opinions set forth below are limited to the laws, including the rules and regulations, as in effect on the
date hereof, which laws are subject to change with possible retroactive effect, and the facts as they currently exist. We assume no obligation to revise or supplement this opinion in the event of future changes in such laws, rules or regulations or
the interpretations thereof or such facts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the limitations, qualifications, exceptions and
assumptions set forth herein, we are of the opinion that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the Opinion Guarantors is validly existing under the laws of its respective jurisdiction of
incorporation or formation, as applicable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the Opinion Guarantors has the requisite corporate, limited liability company or partnership power, as
applicable, under the laws of its state of incorporation or formation, as applicable, to execute, deliver and perform its obligations under the Indenture, including the Guarantees of the Notes in accordance with the provisions of the Indenture.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The execution and delivery by each of the Opinion Guarantors of the Indenture and the performance of its
obligations thereunder, including the Guarantees of the Notes in accordance with the provisions of the Indenture, have been duly authorized by each of the Opinion Guarantors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Opinion Guarantors have each duly executed and delivered the Eighth Supplemental Indenture and the Ninth
Supplemental Indenture. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion rendered in paragraph (1)&nbsp;above with respect to the existence of the Opinion
Guarantors under the laws of their respective jurisdiction of incorporation or formation is based solely on our review of the Public Certificates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation
<FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. This opinion is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission as an exhibit to the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> dated September&nbsp;18, 2019, which is incorporated by reference into the Registration Statement, and to the references to this firm under the caption &#147;Legal Matters&#148; in the Prospectus. In giving
this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:65%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:65%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Bradley Arant Boult Cummings LLP </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Opinion Guarantors </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass
Health Rehabilitation Hospital of Western Massachusetts, LLC, a Massachusetts limited liability company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of
Charleston, LLC, a South Carolina limited liability company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Florence, Inc., a South Carolina corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of North Houston, LP, a Texas limited partnership </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ehc-20190918.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/18/2019 8:19:08 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:ehc="http://www.encompasshealth.com/20190918"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.encompasshealth.com/20190918"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20190918_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20190918_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>ehc-20190918_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/18/2019 8:19:08 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>ehc-20190918_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 9/18/2019 8:19:09 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ehc-20190918.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6627528240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 18, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Encompass Health Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000785161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 18,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">63-0860407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9001 Liberty Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Birmingham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">35242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-7116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-19-247756-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-19-247756-xbrl.zip
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MALS-T&;"BT-LQS0,,1A\/IZV2KJNJT.08X< 64;G\G_KP'6I78GF^\LZ@\@
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M.<,J,-J9D,PC@((5J_F&2CV?O?)A$LF;,%_I)F#38<V=92]W19 ]U5I5ZPE
MDIG XRUW6T^HGI,I'C9,UQ]IER;O*!D)S%H]"L.@4ZM-)I,J*!E5D)!K79#U
M0,27->8,J:@Y-*2UPZ.V=6#5\%C0'RUU1%A6S02G_=7"-PG7[ZJC<*QRE)O
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M%1_L&LJK; )&V#0K)WF"JO%P$&AF!T]:FAG=!O]<@+BXP'<OZZ*<%$MX;+;
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M(QKWC(94>W=[,XKZZ*[C'B[4C*V0@(O4@_ QW'YR+2[R^@)1!VBD8A4FP0-
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MJK)/['4.'=;X9<G)1HY5T=B0#NT5TNC=YW\.YRTAL@FYWW2O=T?T(>2I<<+
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M\7QX\#V?.?K[-J>!9#20(PU7X[0@WP;36OC!=9X"+_YG6#TLHP#YYS7\?SB
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MUJU=0' K;]76>H&J9MN-2@-RL3]8TY^@VE]4=]BQV%]/:Z_(8PFUUTAZN[J
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ML\VAJHI:FP./4 (:L4=.!*XYK_%'33LQQQ*D\\RB9;%HU7# M1]M"R*GV+C
MVE8K(L$PNB*<%SZS:X2R6I\>(YMZI!C0 J:$C$HJ\3ELV[,R-'RJS"M7OB7.
M]VX*4OT0I;O^5A:<J8>8@D85S!5>;O<^M,R%,G"YS$'ZV LVMUZ;@8[KVV\H
M(M3?V?0KW=2L<2AKMDEAZS54;)X@6>@#Q- +,JN;C(;(V->Y%"6RFBHE25E
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M+W1D,Z3:!@U.G/$[K.ZM9P6_ XZ+!V#QI"V7W17IJSGZ]$'VP+M+*L8*7US
M[0QDP4_+RZK,^>>(X]Y$\ZE7_UN57O4Q7T#; BK"GU;C2:R3AFB%$[B5(,E.
MV&$V_WIB#>.N&@:5K0)=79GBM;(R59(K[_^K7$H9G&Y(!/"I0"FC%^^5]2E[
M(;NX@,,#101"(6K!1DUAI3>H,&267$RX0K'1&'GQ\FX1*V!O!AT/:5#@EH+)
MYLRN6YHDX<T#T0](@N63+7+AC9T=9*QF*U5IK!=D5:\G 8NT96(PVP6#5;A<
M86A K+B]9=Q=##]SY5F6\XS=X.CR6AJ]WQ^CG0&;E.N)6"+V_^!1;FSD@%X0
MUUVK;J(7L-R0:1C0GM%;"S5V?L# \K3;E\-*(V)1MLG6-;0S*RVMW<A5C?>F
MQGNJYNSD.$4YTHFTK='0Y2(7%9%EP',.G@E=M.7''@ZXR(<-;EBJO)3+--KX
MAK\B>.*]>4_MI!N-&[.5S13/UN@8##>*'2.E3IB^]%2D@+>+,ZB]2=D-@/%X
M;SS:.QA]_\,I;/:O3\-BR/!U:KY7"]M^S92.L^%@[T]18;4?E%(+;+A;M4TM
M20G::2Y%QV?C^/AXS=GR;A( 2\/OJQ@!\U6UGD]-:$SDH.=T/9,V4KDJHKP1
M%RVVYO'^-X?8@H/]AX$W=CC0[MCD+KVQ/-9MEVS*ANO>M6(D6Q'14@<%-TV@
M)".8J>IP?L,D?V/L%%OE6ES9^)X+0F?1_MPKU/L7V9_%8KW8V(()39&6!!ZW
MDZEUQ^QE-$&L>#=FIG*QI(K"X9+DA98V[F:-$0\ Z1+K.AR7CGV4,B,<R:?X
M&Y0DY.U[&GN\#3<\D^Z,\WG%+H4@Z& 'J2=P&G>B.VCN'0Y\<5 _12)47*3"
M]OR;T>@S3E X_!)?N &&CI<%IJUK]F2P[IGNM,TH["<TM.I>"R:N5?ZZLSK5
M336YYK94N6[,WP<I:L*7!)I:#_H[XLC:,]E5E-P?!E^+9;1DXZE=.HK/Q;PT
M4S+8/I;&6VJ82^Z)JV+NY:FTVO*9+@XDBKJQ&M_'XCC8;-U%>:9H-COG93BP
M ._69/YQ6:$5_)K&>-/,WODX/&J-0PRNUS"G.06KL+URS7"@+T+_H]/R.7O"
M:A,FE437R.NCOX]'CNNH*J,P7HXWS"7KPU FD]2X7B*8IU4+HX.]>BO\QBN;
MT.VSZ4 5Z2?UA:OR/;B1K _\J!;\SZ;R7B_)"XC3X9@T1AG'YD_CHY1\0/OQ
M@BHY2&8Y\L=CP!<%7G[#PJ3:Q^:[Q?!!,_3;6<JA#8Y!SV83QT>GZR5T[8E-
M'K)B]#(-;=>:C9>FL)DF=<[>UZFI:L$!U$C8V^+&6@D9)^_EDA<,90]8@6Q)
M-I<%;FC:O8@)G?C,M\O/M>'6CCAK:J(QT>N<I4H<Y.,<Q!"5<D,0KU %H1."
M,W]B[35TP%+%3 6,XV\48YKD$XDTVX3A@-J0_[DLJ.CAW0OCB,^(8X=2(@=&
M?(\SQRC%\7VN?VI&C#&^@K,U-R.&.S0U<>P.0Q=9#^4$V,GT>PIF-)B6\*]O
M"=6"FN6.2M@FYH"G'6,J7Z'M0V/Z<6-\-.+%4>97#(QP%%/S8E&(>)-D:!P]
M(VB:;*&<C.04DZ1H"G/):&*(QV6)(CL%Z':.+;#QO AN#1N4-\]"ACLL%3^'
MK /O*M^[NYRO&]]K3JV;2!HL^\V],J $#W"D3W5 N"?>N]$VZOF[F;'GH[9'
M6WEIJ&,\;*J,B8O*&]HPUO)AK;/?QWC#;$GJ9KUHN<:T+Z==&YFK8LN#A$>4
M5#V_I*K7<%?SCE?)ICTECK(@9N O%3">,Z*L\.%_+6>;[;=CE,1P>\;$F2VN
M4VW-"0T4,3NQ$F@T^MH)'_P1D2;TITKOL.D<%. QS%^]'++/1AY *6[G:+L>
M] =68K#/2K$/J]+NX./6*&=$1'?!G&_LB/3!S\]V!3^[@?AX7W]'?TEXX1:T
MCGUF'KT-SWYR[QS[K?,/0S#H7 Q#,RF.B5<$V# _QJ?R2CN[D\RR(\:C2JDS
MYKKL>)8>\^MMX035!E29Y&5:%?%#1EH[DS(G0<L:WV:F5DZKO(GX8IP71KG9
M[O!,YDW2?2B3HFB>KZ4R@DP_[FQ.=CJ:>:M*8G#'E$2*_C@E>Y?95^?_Y^CD
M?_K%R;_SX?CM#H?C]XY\SCI4'3*FK1_-@LT04]JT!=@1JP2-_6\PL.E#_I]!
M9,+Q\''Y.9_NW!@.=LK/2?;<<TV99'*QV'PU@2??TJ%L?222@JC1$\AZ:J6.
M$3(], &^"@Y'SP)-Q948I+KHZO6B\Q,=D#T*G=*-SD2M<;>4;2Q$+<.):&*7
MLL9G  X<)W#@PX]<(MZ1>/D-D03SQ<R%LL1^(D;H",WQ1@Z._:1=8) JSADG
M*\,L<)';XFENUKV:>]YA8,;)I1N7EA0OY%KMB\FPJ>*%A7!,012MD:=V4M5(
MQ27X,MB! @Q,K47OJB%,#('@OV!!K9+W['A/*4Q#;.?T$/KQ 1'BN#M6R.R(
MF@2,F[R1E M'H9'J;!H)%4G)'9S "HG544PTZS&VGC('9*_9R!()X9PR1/LD
MXK327(T^AWM,;HYCO7627X2)O8:T'[[$4 F3)RIUC&%!\6Q;VF&ZEH).,*"2
MFE(T'$0ADL:IJQN'!-_O:?/8DNS]+%<0RS^16#[&H^$L0V&]8R(>.S&E^&=M
M&?\I^-$8A18!K?UP;UH!EJU8&34VB E_>_%>*G.2S2=K=A=0*4LX>0OI1F'9
M,'(IDX:(29.;L3U!YNS!_QB(LU/KSQQ/U=%DI8@&Z/0DN3U5Y[AFC>@C0_K1
M:#@H$!.)LL(!+_VRW5?"6&<0C9H3HSWJX@"G&XH_,1( YZBK=$=I<O.YQ&25
MRD$:070.+7-;LUYBQIV-!OX;SZIBQDPRTG2:BODUJ3V."8Z+[ECT\G!@>DB:
M&5)=2I,G# 7F]!#$B!HS1+DT8-28M-Q4R5P+[MQND\MLRN8-3[XWY>,<IK!4
MY*^RZ?H4LR R2 RL$6*QE.40I1:/7ID8+XI7C?);+D;))N*ZB<=02=!4,$JU
MC(B_B?H4HP8A_BO%LK0NTAH9W]@V:T6DB^J8*38V' 0E.H@FR2!8PHJ"&NS@
M$^.QW*&*]%VE!E,#*/$I'?13R$VG/OL1+AC(-9K^1/, BLI:9=.:U S?P^)7
ML"2V,YKF!6;9XND:M0J4"\;:7[B]\4@G&J(FGZWGH$/- G'!$$_!^HOS$+8H
MST%'.L"V"NK=]=.=U/.@1C8Y@/('E:,EM1['#9'H] :<'N(%XE31&"K!T17%
MG# JND0BFC$3D^A8<FS!%XRM5)I9\2?JKDUT.+B2F3\>K"MY3_'CI=02S.1>
MK6 940@T,CJS=8T+>UO.5Q>@W)Q300(!MT M#F_*>ZWX<!/8BK-05CZK3)-S
M2=R9_L''=WLH"G]OD"J\ _(L'EV\&:T>>WOG9%@A-;3%?A$]F2716U4]T49$
M^8CV@MV2N89^"+?@R"B%=]L[85GST+.;>Q8;C%'Z^?ILO_DK^6QOM#@J+DI!
M#D*8]E8=9?@C%>1M&\*W9X),8$.I9(!:GV?D:EOCD3*BS.,;;QK'[R=1&!LO
M-LDOZJ":SW7&N_4WRS'0ZD$J=QCF%5,W4_!S>=X!48V4/HL^W?@^J>==EZG<
M6.FA2S0WK.;%_-IN4 X^18%+K>EK6D\Q:+N8JD$GM:'D$ZY6[UQ1=(?M?K3/
M=5CI79!I%UR26I5()XYP9<HD=L7<4$5=><4:7849X^2RRA!T\1WT@*D"]WP?
M?2M%GZ0?U3F:F2I(B3!S!X[Z/CS6YQ2NR*02:'1?=F[+#]EE'9%?L&QNDE"H
MPB[.)[P#KK9'N_"_UY54!CNZ\*QDDUS \$]$CZ*Q(76NKI,7H/)2Z=8Y>P1\
M?:#'#K5/[I8BN9=9ZFT-F1\.?-M(+R+C8IOF6!-)$YRTJY'1UG/E0S&'34"$
M$14+ R5CZXWQ=)2\O,@NY!C981$Y<*^MY\-243\NM_2("O++!IT32;CEHH<%
M<V_F!1\(SIUDQI,[TX\SM:Q")O<PU4(1A^O#; _//^AVKEBM42D?V;.- P>]
M0_:.1K@"[=G<Q8G3N8B'@SU715T?\3/O<-=@K3 08=: #6VE 1V;)R0QW(B;
MX\P_4G]#-\^**D8UHE5WG"UW!H6D^F/BR&"OKHQ('JUNTBTGY%@"A=D;Q]BP
M@+C9."X;'>AW,S+'(^,E;P( D>AJ'6=MY_BD6,DF%L-E_C_>A7/?.$ZM<T=7
MJ##*S[91WKCX^D!,/AH)Y,'0U1*5%QR_H'O-"Q4]4&-:4&DYN87$/$OV4D2Q
MOKS<ND8OLX9!NR9%Q%H J7:T*LI?; ,Y9QWVT8TZ3@9IG%:Y-2]2)?W@%"Q
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M8/$[S1=$MD8130Y59.^EU'< X?-4R=1&=XNI#-T[M( QN.<2Y.ABEMZV#80
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MA,%"OIP*]U6EB4=*KL4LC<6G=XH4V&S:]G4ZEX''H*G4^M\5D"MTVC99+,
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M];L[OPF3I98PT6UVC.2Y_S!ZH5^IXA07Q4Q**'$'DY_BQW.X1G^ "W/!Q!&
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M!\R=%N USR>F+$T_AB0+=UN."#F"A95>T]$90M#PSU3'R@ 31+[%$\]+I-Z
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MA>3MA=RB#;<R,O)D\:\',7%DJ:3TF.I?&,6A]:7'A5;) 8:F<S7GC^@8F[S
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M++5QYFAGV*D9HF G 0Z7D@P9T15QIN1N9)GI=E+'2OPH 0%:5I#J'NZIVTG
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M:37V8ALT&'K!XR\XVI'C_#'Q3^X8O1["2ZO#\NGE$VKM(T^R,LBZ-)R=='E
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M')Z3(J=K-\?:@^DTC562@E!!3,5"*\P>L/>^X'%>=X,$4$CO.M*D*%$ ^S@
M\W6"/KCFPQP3'9DS"+>(K;)4;S<W++[S/87%'_=JO:F8.DQJ2C1"3M'5P5[
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MA2Q?&G>[!KC;$%S""<1UPY;W*$ZE9QX3[4T+LN(3JGRG@R'\2#J]+6NQVN@
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M7)P%Y1;T:,A^BFY$<GT\/ O.+DY./AU\/C@Z[W\*#H_VX1\7IP=!_V@?_GZ
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M,2F'!:<XH#UIICB>B=R7BY](NS21!F!NX%M&F0%]?]!*7"K@C%@(WLSZVFC
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M&:_Y@3'L'YW#EZ7@M'+X?U!+ P04    "  B:3)/F#?H4B<  0!X!08 $
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M5I>4? S6T1IE!.,_#[_[]@E'U184$[+F)^D9!A[L$C#R2TE'(*J=Q7I^F=F
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MNZ#]@I MLK>.3O17G< ?&+>"L*1$UQ+R70:62JA#RU!I_YNZ>6>$[('/TO*
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M\L$U'-.IUP]37PA/49,@S+I9Y9)TZ)8/IQQ996_R!U7]  8AX!IAV8#5P F
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MDS?Y#-I%]E@%Q[-9W=;U. _XR>#>1@<@ZVI]>970,A]7;_/ 8[A]3L/!C!6
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M>/E.#/P2Q ;95J@.K^9YJ&KP,I;'^2 NPE1@S'=.61,DKK(Y'43-5<Z .8&
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ML#S:H+#\T:6OW'WT/!N9H20M"S]_$CV)+04!VEQ7];21R5=BD'S!))_GY%=
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M&*7);3%F]V"B'WW@1*<A<C,<2$<<)A%8QO4A7E9!^BS,SULEG568#,(OJ!8
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MJ&&9U4%!7?2S"FW+_\_>NS:UC:;KPM]=Y?^@FC6S"U>IF4#.G=Y=Y0!)F$F
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M"'3]X!@+KOQF(;@B!:/3Z.LZ'Q[9*@%)5=&>03BOYFPW.2_GU*@L'1WSI8*
MU7COS02J59^3EY@P_' PH@O=)M=Z=*\UY_KM4PBO*(50Z9_J)0HTR$U:N E
ML;8CL86<MIN_4=@LN;@DK2TY-0D,>\E1R4_J_A1:#%O9>'4U[,1K3265:L9E
M$9.U- I64+C<PMDBCDP_TRYEJND0;,J.G&X?UA.V7"(8.+RT(O"1#X;+!DY/
M7NA&@3K4>,J_)B.,EI"P&<;,'LWCRG<.U1]5NS+\-D%J*REG/Y+U:FMP#V?S
M5D6&7[A 06&\+<8&-+>K)ZZ:;+R?T@*4+2O5%@0WEQ9$"N;CUA@HL33,IQ7(
MF L/;6AU;.>;!)^P <QSB2K4K^G07&G(6T'<7 J;7HW8</!U^GIQ7Y?U28CP
M_D5$L+R$P'AVNXA83CRLO\M"DK #-$R*X7R" 2_55$4/?4P-)*@"5SJ9$!;*
MU =@P*R@.%E]A_!''/!]]KT&?.\)'&IC#O@"2FVCAE%E*)P+M*^#2KD1P2#1
M:+$*CG0]"#W-KC5*2NK&V;L/MM;[0==1+"L#=V,^%$7EM2GVNAUYC4IQYC68
MGU>ADO2J% Z4EZANC@".N$Z!C$%J_UI3%;>>>LE:&(P'!^YVN/ZQ1I&IHB)M
MI=1\!J4^ I&*$5FS"ZJF9.W6]$!QPKA=;&AC)9;TOAS@6DNUN8<ZMX:/<69[
M2)3^]")#E%63_2O):K<V]@JN_LBN(<%/X^(J)&TF&*UZ&;VV(MJ1Y,5K48.>
MQ?C7 0V^0M @NV,^==X=08/51S0+D34!![N=>N1@=9 6<%#LP36<T'C5&@=%
ME>#(M%O5.*A*^H<H<7#4M(6B3UH*'&;$7]%>XF"RM9I9_X82AY9QJ0J'BR*:
MA/=0ZX#_7JG40>J 6VL=:-*WK'7 :[!\J<.#WX5Q+SC.:K<E30GX>V/U?>MU
MM\#UR]5X^>67H<X\>:1$T<(=-;ND*_N06A#(;2 1CJ"6]:*37]>@DS\F<7;O
M/<&M@@7N *::@5 _W"9 ,@[%BZT<9@EV>:0_V0$547F<)(/;%LW*'#F2B>'&
MI,4$GIRXG$!>H\A&=OI>J(E1\FL+'>OF7FEGA6E;.MXB4XUJAN/3]#OM% P<
MCK8AU&1-NCMZNA!* (?<PBX64G>!W@A/HKA)RF8@DOL,E*K&Z)L2F>QTV/JU
MS/43\+;X^6'[HX3'U!]?0TBRKPX+]YX?U<#%G6OH$S!-4<5P) (=Y4Q37:A6
MS"!-\/APNL/(8GJG6O!N)YHC &;&@421"YI(G'ZG62GQCYH<=L1<$2KP0[%U
M^^\F/V,._UH%Q\Z3;=C?NG9#_Z2V2H,([I%=YG#?\L0J9L /-K^YVI?6*E+8
M.-C_DN2<"J5OVU::RH,EJL>QT<"]T.WT9]SU5(+F@UD]JKME@=NPMD^9/T.1
M=_#M!.E*]T:Z?%N=NI2(9"!Y[<A(%M8(-/U=3QI:HZL6&+U>/R1@ES?^HLC+
MDC,52 '73@3;U)BHZFQRM+UE\XB>U^\]1:^L9=IT]FMCNALY[@WEW$L^W'H]
MU="])D-^2*:A5OY11J"??T\1Z'O3:SMD$+^;DQ6I6P[=7)3'*$S*%M9V5I!:
M=WEB3/'!Q8T=EU"SU75 <JDXZ5O$;AWT;<2_LFKY$I=^FZ:";>_2H %=6DU4
MLV)=ENCU8E@3%.^?(%N%WZ>)>*K;D:$NK $U<"XUT4_#FNK%LM'*GG@7JXD'
MR%B4;&0U;^%N7UC@YD17^^ "#$&M_*8?B5@=&B@LF"'Y9._BSO;LRNPGF&(7
M852BG_:,ID4EL:HV"8U$*SY<(&D28B-Q5^*9CN=@F"7#/BL8,T)8.]$7U)$W
MFE6]NP&_^H2'[H1W0_SO4_KO<S7YES=/'LX!_'JT]%1#;B:>S2>#6)L>VE#
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M@Q,XW<1,I$L3>.?@3TR(@ BFG ,?(!,GTS1?8-4HAI.*:5Y$PM]=SO+A5UU
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M"=-=%,)IG'*W@W/6/7WU0/1$R!"@(*2^6WB\)BP7X%;O[#HMAJQG!_SH#4K
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MTFD+*V[I!_MD))G*6#D:(F1F2N:H5+M:GY?G?7+";1+!U#&@3,N_*,#W,,B
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M?GV[^-D>F;=Y^I@V?V+IB[Z#OQJ0=#>_^C,@"';P7T_H_U:\^?\L_PEF-.(
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M)1MYRG3QPP:.;3^.ACD1H&W:GKZ+DB*-KC?OL+W_]]M_?=B\4<W3,1*&;]S
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M\H0/OY:#>7'Q" ;\/AJ5\)I',-(/40'OOP(]^Q@NV ?LDEB4CT+"_ALM;DR
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M*=S.\3RMI,8M&?#JAW*H*H?=S50.GV*P3T=4,,;Q[0W1$C??%T\4;<5_#D%
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MMU35T>VT[! !2^,",Z:2N!OF&9L2DB:#=2ZQB""DX>NH/FEF'H>:WA"S;UP
MPK5\\ 7ZF#=A^EUUUE(O.99L*8_R,:,HGCUR%,7WH,M>;J8N.YE3]TXA.=L0
M+?9Y2B4U>QHKC*V8BCP-">4A,IZT&N%9C1F':%Z&75N&+AEM&@JAC%F$)5O
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MDECBL-X8JTBZ';6'5 #"LSJT&$H\AI>P>8'4XH$N)@L/-M_ZG$005!94S4!
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M$2:E00(M<I\ &CBWB2C1+I,K]Z+H^P3(SEG4" F\L-I);CIABVU0_;_5C_S
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M065JR;,+=<KG0,2@@ERJ:[E >##)0:EE8+@OP > .(4G*I*Q7;-?>4IO Z>
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M/"3=@>2"Q^Q?^3UOE?"@?"\H"4]5Y@U]ES )@)PTY+X_KU.H3$0TG)OO@_#
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MNAHP4B$0(QY\J#X^TD:]:KLJB>\%I)ZB-5 D!L^:3Z$ TR#'8SJ,.^ \I),
MG8J@/;[M$DLSJ*SQJ(0O=\73()L?M>3!16!ZNY6*/W*I9$8'A1H6-9!&*\=C
M;79K<F%MC6#)D.&% (K%.P&A'S:I2,]*L]#$!CLJ+$V;9&&AIONWT%:<\4
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M;'N8FYONT-=7]=*AGS\!4$L#!!0    ( ")I,D_J_'W[9 8  $A$   4
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M4>RJ:;T48)Z+F,>;KVS&33H1?_$7K"Z?]K$=85II!,MC7* MUR-B-TT CQG
MI' FN+VZBR W+9X"Y].%GL'UG_@B\F=U.7XRJ". [:6CY: +LA8A(E9_*(.1
M=F:TA4*+<-:MEFZ.'>MDTH\N]0IC_8EMFDVR.X,[G67+K&!%D/L\:Q6DG6BS
M%)#D )V$:*IMI73+7-N@?@JPSS!8F1Z:: ]U>=X>TQ'&UL)Q]Y@+M+LZ1*SF
MPF"4G0&E+[/(9<U:*6&\89)C>"[",WWMWI3*)X,[QM-N!2N"*("U"%*3FZ8
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M,3@V9#AK+FAT;5!+ 0(4 Q0    ( ")I,D\E'.VD(  ! #@$!@ 0
M      "  3H=  !D-S8P,3@V9&5X-#(N:'1M4$L! A0#%     @ (FDR3Y@W
MZ%(G  $ > 4& !               ( !B!T! &0W-C Q.#9D97@T,RYH=&U0
M2P$"% ,4    "  B:3)/!GC1&3@@    5 $ $               @ '='0(
M9#<V,#$X-F1E>#4Q+FAT;5!+ 0(4 Q0    ( ")I,D]H)9\LTP\  .D^   0
M              "  4,^ @!D-S8P,3@V9&5X-3(N:'1M4$L! A0#%     @
M(FDR3_TV!51G P  . P  !               ( !1$X" &5H8RTR,#$Y,#DQ
M."YX<V102P$"% ,4    "  B:3)/ZOQ]^V0&  !(1   %
M@ '940( 96AC+3(P,3DP.3$X7VQA8BYX;6Q02P$"% ,4    "  B:3)/*E0T
M!KX$   3*P  %               @ %O6 ( 96AC+3(P,3DP.3$X7W!R92YX
8;6Q02P4&      @ " #V 0  7UT"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>d760186d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehc-20190918.xsd" xlink:type="simple"/>
    <context id="duration_2019-09-18_to_2019-09-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000785161</identifier>
        </entity>
        <period>
            <startDate>2019-09-18</startDate>
            <endDate>2019-09-18</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2019-09-18_to_2019-09-18"
      id="Hidden_dei_EntityRegistrantName">Encompass Health Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2019-09-18_to_2019-09-18">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2019-09-18_to_2019-09-18"
      id="Hidden_dei_EntityCentralIndexKey">0000785161</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2019-09-18_to_2019-09-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2019-09-18_to_2019-09-18">2019-09-18</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2019-09-18_to_2019-09-18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2019-09-18_to_2019-09-18">001-10315</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2019-09-18_to_2019-09-18">63-0860407</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2019-09-18_to_2019-09-18">9001 Liberty Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2019-09-18_to_2019-09-18">Birmingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2019-09-18_to_2019-09-18">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2019-09-18_to_2019-09-18">35242</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2019-09-18_to_2019-09-18">(205)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2019-09-18_to_2019-09-18">967-7116</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2019-09-18_to_2019-09-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2019-09-18_to_2019-09-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2019-09-18_to_2019-09-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2019-09-18_to_2019-09-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2019-09-18_to_2019-09-18">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2019-09-18_to_2019-09-18">EHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2019-09-18_to_2019-09-18">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2019-09-18_to_2019-09-18">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d760186d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d760186d8k.htm">d760186d8k.htm</File>
    <File>d760186dex42.htm</File>
    <File>d760186dex43.htm</File>
    <File>d760186dex51.htm</File>
    <File>d760186dex52.htm</File>
    <File>ehc-20190918.xsd</File>
    <File>ehc-20190918_lab.xml</File>
    <File>ehc-20190918_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MZP^_J[#OK=NY?VQ\$50-_+H+]0502P,$%     @ (FDR3YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M_VTP",\.&C'._MAL]3T[MU9.[Z5HM8*XEM\63&XL6&1\K4,ZX\2KYPLWI?(
M.$HNX%!41^2[X_8,(ZZW:6QNU9S^AYK_]CZWH,%Q>13MK_Z_O,M_HI@MW7-H
MT:L&W5!2#D*BT(O&3M0U1'GAA<SIE_#PRJL^V?O4TR,O_0-^Q>_GUM#P0>)S
M6/$<S.EN?PHO3?*P99TWBISN]F>HQ:#>S@7WOT3Q U!+ P04    "  B:3)/
M%FTC?T,!   \ @  #P   'AL+W=O<FMB;V]K+GAM;(U1RV[",!#\%<L?T 34
M(A41+J4/I*I%I>+N)!NRPH_(WD#+UW?M*(7>>K)W=CP[.UZ<G#^4SAW$E]$V
M%+(EZN99%JH6C HWK@/+G<9YHXA+O\]"YT'5H04@H[-IGL\RH]#*Y6+4VOCL
MNG $%:&S#$9@AW *EWXLA6+"$3Y56<A<"M63>T)-X%>*X-F[OD.[+^1$B@9]
MH&V<G9@&+1H\0YVJT+K3B_-X=I:4WE;>:9U>Q49ZQ!/"+[(#3UC](9(J/Q1[
M+>0L9\$C!BQ1(WT7,MTU2-XBNUHCY3">0XAS_Y\87=-@!2M7]08L#3EZT'&Z
M#2UV00JK#!1RI AE:_%HB=V(M1VDF!MWX='K>MB+.+&+6>'GR V_KB?)^.BV
MA@8MU&\\(##.(50;+^*1=*:W=Y-[#KO7^H&Q=_OJ5-*/&N/'+7\ 4$L#!!0
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MK_>PGPG;83UVX=\@J6$Z[];_:'29RZ!=_,W(1TKM05\-_\GR"U!+ 0(4 Q0
M   ( ")I,D\?(\\#P    !,"   +              "  0    !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( ")I,D\GZ(<.@@   +$    0              "
M >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ (FDR3\[=Q8OO
M*P(  !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ (FDR3YE<G",0!@  G"<  !,              ( !MP(  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    "  B:3)/"ZJ<K9H"  "3"P  &
M            @ 'X"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ (FDR3X:*!'U/ @  ^04  !0              ( !R L  'AL+W-H
M87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ (FDR3[JA.8K7 0  ,@8   T
M             ( !20X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  B:3)/
M%FTC?T,!   \ @  #P              @ %+$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ (FDR3__ )@B]    A0(  !H              ( !NQ$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ (FDR3PN/
MV ,A 0  5P0  !,              ( !L!(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      H "@"  @   A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d760186d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d760186d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehc-20190918_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehc-20190918_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ehc-20190918.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ehc",
   "nsuri": "http://www.encompasshealth.com/20190918",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d760186d8k.htm",
      "contextRef": "duration_2019-09-18_to_2019-09-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d760186d8k.htm",
      "contextRef": "duration_2019-09-18_to_2019-09-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20190918/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
